UNII	IIG-ID	Route	Strength	IIG-URL
21334LVV8W	.ALPHA.-TERPINEOL:TOPICAL:LOTION:%w/w	TOPICAL	11%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:BUCCAL:FILM, SOLUBLE:mg	BUCCAL	0.07mg BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	0.64mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:SOLUTION:mg/1ml	ORAL	1.05mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET, CHEWABLE:mg	ORAL	0.1mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:TOPICAL:SYSTEM:mg	TOPICAL	0.1mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
9E8X80D2L0	.ALPHA.-TOCOPHEROL ACETATE:BUCCAL:FILM:mg	BUCCAL	0.09mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
9E8X80D2L0	.ALPHA.-TOCOPHEROL ACETATE:ORAL:CAPSULE:mg	ORAL	2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
9E8X80D2L0	.ALPHA.-TOCOPHEROL ACETATE:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
WR1WPI7EW8	.ALPHA.-TOCOPHEROL ACETATE, DL-:TOPICAL:AEROSOL, FOAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
WR1WPI7EW8	.ALPHA.-TOCOPHEROL ACETATE, DL-:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:INTRAVENOUS:SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	0.08%w/v INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:SUSPENSION:mg/1ml	ORAL	0.01mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:TABLET:mg	ORAL	0.12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:TABLET, CHEWABLE:mg	ORAL	0.02mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:TOPICAL:AEROSOL, FOAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	0.14mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VSI4D701X	1-(PHENYLAZO)-2-NAPHTHYLAMINE:ORAL:CAPSULE:mg	ORAL	0.13mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
3VSI4D701X	1-(PHENYLAZO)-2-NAPHTHYLAMINE:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
W45XXM0XWE	1,2,6-HEXANETRIOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
043IPI2M0K	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:%w/v	INTRAVENOUS	2.8%w/v INTRAVENOUS INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
043IPI2M0K	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
043IPI2M0K	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE:RESPIRATORY (INHALATION):CAPSULE:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
AV0YTZ4E6J	1,4-SORBITAN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
0MMD46SPU6	2-(4-STYRYL-3-SULFOPHENOL)-6-METHOXYBENZOTRIAZOLE:TOPICAL:SOAP:%w/w	TOPICAL	0.75%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=2
5KV86114PT	2-AMINOETHANOL:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=2
5C5403N26O	ACACIA:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:BUCCAL:TABLET:mg	BUCCAL	9.1mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:INTRAMUSCULAR:SUSPENSION:mg	INTRAMUSCULAR	1mg INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER:mg	ORAL	800mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET:mg	ORAL	70mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, COATED:mg	ORAL	156mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	30mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	34.4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, FILM COATED:mg	ORAL	0.14mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:SUBLINGUAL:TABLET:mg	SUBLINGUAL	9.1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACACIA SYRUP:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	69.64mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACACIA SYRUP:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET, CHEWABLE:mg	ORAL	5.05mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	25.18mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	382.22mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	677.68mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93018509 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93018509 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93084720 PINK:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLIC ACID-ISOOCTYL ACRYLATE COPOLYMER:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	169mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLIC ADHESIVE 788:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADCOTE 72A103:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	16mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADHESIVE TAPE:TOPICAL:DISC:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADHESIVE TAPE:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADVANTIA PRIME 190100BA01 WHITE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADVANTIA PRIME 190100BA01 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALBUMINS:ORAL:TABLET, FILM COATED:mg	ORAL	4.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALUMINUM POLYESTER:TRANSDERMAL:FILM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALUMINUM POLYESTER:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALZAMER-50:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	32mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:CAPSULE:mg	ORAL	4.86mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:TABLET:mg	ORAL	110mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:TABLET, FILM COATED:mg	ORAL	25mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE XE-88:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE XE-88:ORAL:TABLET, COATED:mg	ORAL	11mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE XE-88:ORAL:TABLET, FILM COATED:mg	ORAL	30mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE XE-88:ORAL:WAFER:mg	ORAL	8mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMERCHOL-CAB:TOPICAL:OINTMENT:%w/w	TOPICAL	10%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMMONIO METHACRYLATE COPOLYMER:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMMONIO METHACRYLATE COPOLYMER:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMMONIUM CALCIUM ALGINATE:ORAL:TABLET:mg	ORAL	10.72mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMPHOTERIC-9:TOPICAL:CREAM:%w/w	TOPICAL	0.66%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANIDRISORB 85/70:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANIDRISORB 85/70:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANOXID SBN:TOPICAL:CREAM:%w/w	TOPICAL	0.16%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.16mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.12mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUAPHOR:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUAPHOR:TOPICAL:OINTMENT:%w/w	TOPICAL	47.3%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUARIUS BP 19008:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ARLACEL:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ARLACEL:TOPICAL:EMULSION:%w/w	TOPICAL	5.5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ASEPTOFORM M:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	BLACK INK:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.57mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.03mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET:mg	ORAL	0.14mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	1mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, FILM COATED:mg	ORAL	0.15mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:RESPIRATORY (INHALATION):CAPSULE:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:RESPIRATORY (INHALATION):POWDER:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	C13-14 ISOPARAFFIN/LAURETH-7/POLYACRYLAMIDE:TOPICAL:GEL:%w/w	TOPICAL	5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CALCIUM ALGINATE AND AMMONIUM ALGINATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CALCIUM PHOSPHATE, DIBASIC MONOHYDRATE:ORAL:TABLET:mg	ORAL	109.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CAPRYLIC/CAPRIC TRIGLYCERIDE/LECITHIN/ALCOHOL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARBOXYMETHYL STARCH:ORAL:CAPSULE:mg	ORAL	15mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARBOXYMETHYL STARCH:ORAL:TABLET:mg	ORAL	25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE:ORAL:SUSPENSION:mg/5ml	ORAL	50.4mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE:ORAL:SYRUP:mg	ORAL	0.15mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE:ORAL:TABLET:mg	ORAL	6.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE:ORAL:TROCHE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CASTILE SOAP:TOPICAL:SOAP:%w/w	TOPICAL	97.3%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLABURATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLABURATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE ACETATE CA-320S:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE ACETATE CA-398-10:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CETEARYL ALCOHOL/CETEARETH-20:TOPICAL:CREAM:%w/w	TOPICAL	8%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CETEARYL ALCOHOL/CETEARETH-20:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	4.72%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHOLETH:VAGINAL:CREAM:%w/w	VAGINAL	1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHONDRUS EXTRACT:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.8%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHROMA-KOTE T2956-Y YELLOW:ORAL:TABLET:mg	ORAL	2.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHROMA-KOTE T2956-Y YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:RECTAL:SUPPOSITORY:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:VAGINAL:TAMPON:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLD CREAM:TOPICAL:SOAP:%w/w	TOPICAL	1.5%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLLAGEN:TOPICAL:GEL:%w/w	TOPICAL	0.02%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLLAGEN:TOPICAL:LOTION:%w/w	TOPICAL	8%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLLAGEN:TOPICAL:SHAMPOO:%w/w	TOPICAL	4.9%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLORING SUSPENSION:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:CAPSULE:mg	ORAL	270mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	75mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	497.3mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, COATED:mg	ORAL	120mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	354mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:SUBLINGUAL:TABLET:mg	SUBLINGUAL	136mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CORN OIL MONO- AND DI- GLYCERIDES, C18:ORAL:CAPSULE, COATED:mg	ORAL	86mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CORN OIL MONO- AND DI- GLYCERIDES, C18:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CORN STARCH, PARTIALLY HYDROLYZED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CORN STARCH, PARTIALLY HYDROLYZED:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CUTINA:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.6mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CYCLOMETHICONE/DIMETHICONE COPOLYOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	D&C BLUE NO. 1 LAKE:ORAL:TABLET:mg	ORAL	15.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 1 LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	3.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:mg	ORAL	1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 2 LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 2 LAKE:ORAL:TABLET:mg	ORAL	0.24mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 2 LAKE:ORAL:TABLET, COATED:mg	ORAL	0.01mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C GREEN NO. 3 LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C GREEN NO. 3 LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 21--ALUMINUM LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 21--ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 27 LAKE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 27 LAKE:ORAL:TABLET:mg	ORAL	0.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 28--ALUMINUM LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 28--ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	0.11mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.3mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:mg	ORAL	5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.04mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.1mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:mg	ORAL	0.3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 ALUMINUM LAKE:ORAL:WAFER:mg	ORAL	0.9mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 33 LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 33 LAKE:ORAL:TABLET:mg	ORAL	0.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:TABLET:mg	ORAL	0.15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 6 LAKE:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 6 LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.13mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:TABLET:mg	ORAL	0.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.5mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.5mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.3mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:SOLUTION:mg/5ml	ORAL	0.25mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5.35mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.01mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DC ANTIFOAM AF TRITURATION 1% ON SUCROSE:ORAL:POWDER, FOR SOLUTION:mg/1ml	ORAL	2.63mg/1ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEHYDAG WAX SX:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEHYDAG WAX SX:TOPICAL:CREAM:%w/w	TOPICAL	8.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEHYMULS E:TOPICAL:OINTMENT:%w/w	TOPICAL	7.5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRAN:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	20%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRINS MODIFIED:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR 042:ORAL:TABLET:mg	ORAL	18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR 042:ORAL:TABLET, COATED:mg	ORAL	10mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR 042:ORAL:TABLET, FILM COATED:mg	ORAL	5.67mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 280-2516:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 280-2516:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2070:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2070:TRANSDERMAL:SYSTEM:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2194:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	208.28mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2287:TRANSDERMAL:FILM:mg	TRANSDERMAL	537.7mg TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2287:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	121.1mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2287:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	305.89mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2296:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	172mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2888:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	175.9mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2979:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2979:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	96.97mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLACK LB-1171:ORAL:TABLET:mg	ORAL	1.55mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLACK LB-442:ORAL:TABLET:mg	ORAL	0.33mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLACK LB-9972:ORAL:TABLET:mg	ORAL	0.19mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLUE LAKE BLEND LB-332:ORAL:CAPSULE:mg	ORAL	0.56mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLUE LAKE BLEND LB-332:ORAL:TABLET:mg	ORAL	0.11mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLUE LAKOLENE:ORAL:TABLET:mg	ORAL	0.12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LAKE BLEND:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LAKE BLEND:ORAL:TABLET:mg	ORAL	0.26mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LB-464:ORAL:TABLET:mg	ORAL	1.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CARAMEL ACID PROOF 100:ORAL:ELIXIR:mg/5ml	ORAL	0.05mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CARAMEL ACID PROOF 100:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CHROMA-TONE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CHROMA-TONE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	29.6mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CHROMA-TONE:ORAL:TABLET, FILM COATED:mg	ORAL	1.53mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE DC RED LAKE:ORAL:TABLET:mg	ORAL	2.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE DC RED LB NO. 9570:ORAL:TABLET:mg	ORAL	0.85mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BROWN R LB-56069:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BROWN R LB-56069:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC GREEN LB-1174:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC GREEN LB-3323:ORAL:TABLET:mg	ORAL	1.65mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GRAY NO. 2982:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN AL LB-265:ORAL:TABLET:mg	ORAL	0.64mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN ALUMINUM LB:ORAL:TABLET:mg	ORAL	8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LAKE BLEND LB-1236:ORAL:TABLET:mg	ORAL	0.35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LAKE BLEND LB-1441:ORAL:TABLET:mg	ORAL	1.32mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LAKE BLEND LB-333:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LAKE BLEND LB-333:ORAL:TABLET:mg	ORAL	0.11mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB:ORAL:TABLET:mg	ORAL	0.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-279:ORAL:TABLET:mg	ORAL	2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-482:ORAL:TABLET:mg	ORAL	1.27mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-555:ORAL:TABLET:mg	ORAL	0.44mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-820:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-883:ORAL:TABLET:mg	ORAL	0.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN PB-1543:ORAL:TABLET:mg	ORAL	1.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE MINT GREEN:ORAL:TABLET:mg	ORAL	0.01mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE MINT GREEN:ORAL:TABLET, CHEWABLE:mg	ORAL	0.08mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE MINT GREEN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.06mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE OCHRE 3506:ORAL:TABLET:mg	ORAL	0.76mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE OCHRE 3506:ORAL:TABLET, COATED:mg	ORAL	0.29mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE LB-1387:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE LB-1387:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE PB-2148:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PINK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PINK:ORAL:TABLET:mg	ORAL	0.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PINK:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	7.93mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PURPLE LB-1902:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.8mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PURPLE LB-562:ORAL:TABLET:mg	ORAL	0.81mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE RED PB-1595:ORAL:TABLET:mg	ORAL	0.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE TAN PB-1388:ORAL:TABLET:mg	ORAL	0.05mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE TAN PB-1388:ORAL:TABLET, FILM COATED:mg	ORAL	0.75mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE WHITE COATERIC YPA-6-7089:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE WILD CHERRY 7598:ORAL:SYRUP:mg/5ml	ORAL	0.18mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE YELLOW LB 9706:ORAL:TABLET:mg	ORAL	0.44mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE YELLOW PB-1381:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	EIDERDOWN SOAP:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.39mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	EMULSIFYING WAX:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	EMULSIFYING WAX:RECTAL:AEROSOL, METERED:%w/w	RECTAL	1.5%w/w RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	EMULSIFYING WAX:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	EMULSIFYING WAX:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	EMULSIFYING WAX:TOPICAL:LOTION:%w/w	TOPICAL	4%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	EMULSIFYING WAX:TOPICAL:OINTMENT:%w/w	TOPICAL	1.5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ESSENCE LEMON:ORAL:SYRUP:mg	ORAL	2.5mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ESSENCE ORANGE:ORAL:SYRUP:mg	ORAL	10mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-PROPYLENE COPOLYMER:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	31.67mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-PROPYLENE COPOLYMER:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:INTRAUTERINE:SUPPOSITORY, EXTENDED RELEASE:mg	INTRAUTERINE	160mg INTRAUTERINE SUPPOSITORY, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:OPHTHALMIC:INSERT, EXTENDED RELEASE:mg	OPHTHALMIC	14mg OPHTHALMIC INSERT, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:SUBCUTANEOUS:IMPLANT:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:TRANSDERMAL:FILM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	735mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	FATTY ACID ESTERS:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID ESTERS:TRANSDERMAL:SYSTEM:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID ESTERS, SATURATED:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.2mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID GLYCERIDES:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID PENTAERYTHRIOL ESTER:TOPICAL:OINTMENT:%w/w	TOPICAL	1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACIDS:TOPICAL:SOLUTION:%w/w	TOPICAL	13.58%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C GREEN NO. 3, ALUMINUM LAKE:ORAL:CAPSULE:mg	ORAL	0.01mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 30--ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 30--ALUMINUM LAKE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 30--ALUMINUM LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 30--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.32mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.05mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:POWDER:mg	ORAL	1mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	0.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:SOLUTION:mg/5ml	ORAL	0.35mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:SUSPENSION:mg/5ml	ORAL	2mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	21.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.19mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.03mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C RED NO. 40 ALUMINUM LAKE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:BUCCAL:TABLET:mg	BUCCAL	1mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	1.25mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.3mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	6.97mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET, COATED:mg	ORAL	0.34mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.01mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FD&C YELLOW NO. 6 ALUMINUM LAKE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FERRIC OXIDE BROWN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FERRIC OXIDE BROWN:ORAL:TABLET:mg	ORAL	1.13mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FILM COATING SOLUTION, AQUEOUS IM-163:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FILM COATING SOLUTION, AQUEOUS IM-163:ORAL:TABLET, FILM COATED:mg	ORAL	6.3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57000 IU:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57000 IU:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57820/A:ORAL:POWDER:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR APRICOT 24829:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 11090:ORAL:SOLUTION:mg/1ml	ORAL	10mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 15223:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 501013 AP0551:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 59256C:ORAL:SOLUTION:mg/5ml	ORAL	1.03mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 59256C:ORAL:SYRUP:mg/5ml	ORAL	1.03mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 8763:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA FN-6713:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA GIVAUDAN 85509:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA GIVAUDAN 85509:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	10mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:TABLET:mg	ORAL	2.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BERRY CITRUS BLEND 8409:ORAL:CONCENTRATE:mg	ORAL	8mg ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BERRY CITRUS BLEND 8409:ORAL:SOLUTION:ml/5ml	ORAL	0.05ml/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BITTER MASK 9885:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BITTERNESS MODIFIER 15555:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BITTERNESS MODIFIER 36734:ORAL:SYRUP:mg/1ml	ORAL	1mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLACK CHERRY 501027 AP0551:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLACK CHERRY 501027 AP0551:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLACK CHERRY 501027 AP0551:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLOOD ORANGE SA:ORAL:SYRUP:mg/5ml	ORAL	0.21mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLE GUM 15864:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLE GUM MC-4938:ORAL:SUSPENSION:mg/5ml	ORAL	18mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLE GUM MC-4938:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLEGUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUTTERMINT 24020:ORAL:SOLUTION:mg/1ml	ORAL	10mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUTTERSCOTCH F-1785:ORAL:SYRUP:ml/5ml	ORAL	0.35ml/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERI-BERI PFC-8573:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	25mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERI-BERI PFC-8580:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERI-BERI PFC-8580:ORAL:SYRUP:ml/5ml	ORAL	0.05ml/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 11929:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 349:ORAL:SOLUTION:mg/5ml	ORAL	16.45mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 349:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:TABLET, CHEWABLE:mg	ORAL	1.25mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 57.679/A:ORAL:SUSPENSION:mg/1ml	ORAL	50mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:POWDER, FOR SOLUTION:mg/1ml	ORAL	0.13mg/1ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	7.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:TABLET:mg	ORAL	0.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 825.476WC:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 842:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 842:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 8513:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 8513:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY BURGUNDY 11650:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY BURGUNDY 11650:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY BURGUNDY 11650:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY F-232:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY F-232:ORAL:SOLUTION:mg/5ml	ORAL	15mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY F-232:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY FMC 8513:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY FMC 8513:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY FT-9496:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:CONCENTRATE:ml/1ml	ORAL	0.01ml/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:SOLUTION:ml/5ml	ORAL	0.1ml/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:SYRUP:ml/5ml	ORAL	0.1ml/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY R-6556:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY VANILLA COMPOUND A77487:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY WL-1093:ORAL:SOLUTION:mg/5ml	ORAL	1.6mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY WL-1093:ORAL:SYRUP:mg/5ml	ORAL	4mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHOCOLATE MINT:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON SD 516:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON VEKO 3726:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CITRUS FN-7176:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CITRUS FN-7176:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CITRUS/FRUIT FREEZE 1100609500:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COCONUT 41:ORAL:CAPSULE:mg	ORAL	0.79mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COCONUT 41:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COLA FMC 15740:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COOL MINT:ORAL:TABLET:mg	ORAL	0.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COOL MINT:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.06mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COOL VANILLA BP18114:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COOL VANILLA BP18114:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREAM EP-17688:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	4mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREAMY VANILLA 16345:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE MENTHE 14677:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE MENTHE 14677:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	0.1mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:SUSPENSION:mg/5ml	ORAL	4mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR F-5397A:ORAL:CONCENTRATE:ml/1ml	ORAL	0.08ml/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT 01-10428:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT FN-6714:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT TAK 20008:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 10273:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 501417C:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 59.145/APO5.51:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 61.13252:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SYRUP:mg/5ml	ORAL	59.7mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 856.085:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE MANHEIMER 522463:ORAL:SOLUTION:mg/1ml	ORAL	4.38mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE MANHEIMER 522463:ORAL:SUSPENSION:mg/5ml	ORAL	25mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE NECTOR PFC-8599:ORAL:SYRUP:mg/5ml	ORAL	10mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE PFC-9924:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE PFC-9924:ORAL:SYRUP:mg/5ml	ORAL	9.97mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE ST6835/09:ORAL:SOLUTION:mg/5ml	ORAL	3.11mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE ST6835/09:ORAL:SYRUP:mg/5ml	ORAL	3.11mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON 812:ORAL:SUSPENSION:mg/1ml	ORAL	1.76mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON GIVAUDAN 74940-74:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME SD 935:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME SD 935:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME SD 935:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON MINT 862.547:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON N&A 397:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON N&A 397:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON SPRAY V3938-1N1:ORAL:POWDER, FOR SOLUTION:mg	ORAL	340mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON SPRAY V3938-1N1:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MAGNASWEET 110:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MENTHOL MINT PFC-9926:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MENTHOL MINT PFC-9926:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	7mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MENTHOL VERALOCK:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT 287:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT 51296 TP0551:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT SN027513:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT SN027513:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	9.31mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED BERRY 13.13489:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED BERRY 807.0246U:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	19.33mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED BERRY 807.0246U:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED BERRY 807.0246U:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED FRUIT PFC-9970:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	17.5mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED FRUIT PFC-9970:ORAL:SYRUP:mg/1ml	ORAL	2.35mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 57.458/AP05.51:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 57.458/AP05.51:ORAL:SUSPENSION:mg/5ml	ORAL	50mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 739K (PB82):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 74016-71:ORAL:GRANULE, FOR SOLUTION:mg	ORAL	70mg ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 9/79J839:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 9/79J839:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE GIVAUDAN 74388-74:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE NO. 7679:ORAL:SOLUTION:mg	ORAL	4mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE NO. 7679:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH 13503584:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH 13503584:ORAL:SYRUP:mg/5ml	ORAL	3.7mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH 57695:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH PINEAPPLE FMC 14258:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH PINEAPPLE FMC 14258:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 104:ORAL:SOLUTION:mg/5ml	ORAL	10.8mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 104:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT ART F-10012:ORAL:SOLUTION:mg/1ml	ORAL	2.1mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT ART F-10012:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT EXTRACT FN-2356:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT F94249:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT FM-4134:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT PFC 9927:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT PFC 9927:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT SN583865:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT WL-6167:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT WONF 33864:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT, NATURAL SPRAYLENE:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 21028D:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 21028D:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 28106:ORAL:SUSPENSION:mg/5ml	ORAL	12.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 28106:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954K (BK77):ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954K (BK77):ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954K (BK77):ORAL:SOLUTION:mg/1ml	ORAL	0.16mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 998:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 998:ORAL:SUSPENSION:mg/120ml	ORAL	260mg/120ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 998:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1784:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1784:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1784:ORAL:SYRUP:ml/5ml	ORAL	0.07ml/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1840:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1840:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ROOT BEER 180339:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	2.1mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	35mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 14953:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17.36.8509:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17.36.8509:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	12mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17.36.8509:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17C56217:ORAL:SOLUTION:mg/5ml	ORAL	15mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17C56217:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.25mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 52.311AP:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	25mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 52312/AP0551:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	15mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 55058:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 55058:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 5951:ORAL:SUSPENSION:mg/5ml	ORAL	5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 5951:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY BANANA 24020:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY BANANA 24020:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY FN-13819:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:TABLET, CHEWABLE:mg	ORAL	14.42mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY PFC-9626:ORAL:SYRUP:mg/5ml	ORAL	15.8mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY WD FO-1022:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY WD FO-1022:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET TONE 28837:ORAL:SOLUTION:mg/5ml	ORAL	0.5mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET-AM 918.005:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET-AM 918.005:ORAL:SOLUTION:mg/5ml	ORAL	2mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TROPICAL FRUIT PUNCH N&A 50432:ORAL:SOLUTION:mg	ORAL	8mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TROPICAL FRUIT PUNCH N&A 50432:ORAL:SYRUP:mg/1ml	ORAL	5.2mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	1.25mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI PERMASEAL 77919-31:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI PERMASEAL 77919-31:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.2mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI WL-18481:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA 20.4573.5P PHA:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA 20.4573.5P PHA:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA 501441 AP2004:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA F-6257:ORAL:SOLUTION:mg	ORAL	6mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA PFC-9772:ORAL:CONCENTRATE:ml/1ml	ORAL	0.01ml/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY GIVAUDAN F-1813:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	2000mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY GIVAUDAN F-1813:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	68.2mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY NO. 24038:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY NO. 24038:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY NO. 24038:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY NV-101-1489:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY PFC-14783:ORAL:SUSPENSION:mg/1ml	ORAL	0.37mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY PFC-14783:ORAL:SYRUP:mg/5ml	ORAL	12.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR YELLOW PLUM LEMON 39K 020:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLOUR:ORAL:TABLET:mg	ORAL	9.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLOUR:ORAL:TABLET, COATED:mg	ORAL	140mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLOUR:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLUOROCHLOROHYDROCARBONS:RESPIRATORY (INHALATION):AEROSOL, METERED:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLUOROCHLOROHYDROCARBONS:RESPIRATORY (INHALATION):AEROSOL, SPRAY:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLUOROPOLYMER COATED RELEASE LINER:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE 91-122:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	3%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE 91-122:TOPICAL:SOAP:%w/w	TOPICAL	0.86%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE 91-122:TOPICAL:SOLUTION:%w/w	TOPICAL	0.03%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE 9128-Y:TOPICAL:CREAM:%w/w	TOPICAL	0.07%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE BALSAM PINE NO. 5124:TOPICAL:OIL:%w/w	TOPICAL	0.03%w/w TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE CREAM NO. 73457:TOPICAL:OIL:%w/w	TOPICAL	1.15%w/w TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE CS-28197:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE P O FL-147:TOPICAL:AEROSOL:%w/w	TOPICAL	0.27%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE P O FL-147:TOPICAL:EMULSION:%w/w	TOPICAL	0.27%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE P O FL-147:TOPICAL:SOLUTION:%w/w	TOPICAL	0.13%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.1%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:CREAM:%w/w	TOPICAL	0.06%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.75%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:SOAP:%w/w	TOPICAL	0.03%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:SOLUTION:%w/w	TOPICAL	0.03%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:VAGINAL:CREAM:%w/w	VAGINAL	0.1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE SOAP:TOPICAL:OINTMENT:%w/w	TOPICAL	0.21%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE SOAP:TOPICAL:POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE UNGERER N5195:TOPICAL:LOTION:%w/w	TOPICAL	0.07%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	GLYCERIN POLYMER SOLUTION I-137:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERIN POLYMER SOLUTION IM-137:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL OLEATE/PROPYLENE GLYCOL:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL OLEATE/PROPYLENE GLYCOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	3%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL STEARATE/PEG-40 STEARATE:RECTAL:SUPPOSITORY:mg	RECTAL	35mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GUM BASE, CHEWING:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	HYDROCARBON GEL, PLASTICIZED:DENTAL:PASTE:%w/w	DENTAL	50.6%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:TOPICAL:OINTMENT:%w/w	TOPICAL	97.7%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	13.26mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET:mg	ORAL	104.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYSTRENE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYSTRENE:ORAL:TABLET:mg	ORAL	7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	INK BLACK 2271:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK A-10464:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK A-10527:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.19mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK FGE-1386:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9007:ORAL:TABLET:mg	ORAL	0.09mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9007:ORAL:TABLET, FILM COATED:mg	ORAL	0.09mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:NASAL:POWDER:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9009:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEK PRINT SB-6029:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEK PRINT SB-6029:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEKPRINT SB-6018:ORAL:CAPSULE:mg	ORAL	0.22mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEKPRINT SB-6018:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.04mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:CAPSULE:mg	ORAL	0.25mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET, COATED:mg	ORAL	0.4mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	1mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:TABLET, COATED:mg	ORAL	0.04mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BROWN:ORAL:TABLET, COATED:mg	ORAL	0.04mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE GRAY:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:TABLET:mg	ORAL	0.01mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.04mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.19mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK FINE BLACK 2212:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK FINE BLACK 2212:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK RED A-8032:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK RED A-8032:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK S-1-7085:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE A-8154:ORAL:CAPSULE:mg	ORAL	0.8mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE A-8154:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SB-0007P:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SW-0012:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SW-0012:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SW-0012:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	LACTOSE MONOHYDRATE - CELLULOSE, MICROCRYSTALLINE:ORAL:TABLET:mg	ORAL	614.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LACTOSE MONOHYDRATE - CELLULOSE, MICROCRYSTALLINE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	121.5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANETH:TOPICAL:CREAM:%w/w	TOPICAL	0.4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANETH:TOPICAL:LIQUID:%w/w	TOPICAL	5.5%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANETH:TOPICAL:SOAP:%w/w	TOPICAL	0.5%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANETH:TOPICAL:SOLUTION:%w/w	TOPICAL	0.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN ALCOHOL - MINERAL OIL:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN ALCOHOL - MINERAL OIL:TOPICAL:LOTION:%w/w	TOPICAL	11%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN CHOLESTEROLS:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN CHOLESTEROLS:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN, ETHOXYLATED:TOPICAL:SOLUTION:%w/w	TOPICAL	1.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAURETH SULFATE:TOPICAL:SPONGE:%w/w	TOPICAL	20%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAURIC MYRISTIC MONOETHANOLAMIDE:TOPICAL:EMULSION:%w/w	TOPICAL	1.1%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAURIC MYRISTIC MONOETHANOLAMIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	4%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:CAPSULE:mg	ORAL	218mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:TABLET:mg	ORAL	0.15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:TABLET, FILM COATED:mg	ORAL	0.15mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.6%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE:mg	ORAL	15mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	167mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.14mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:RECTAL:SUPPOSITORY:mg	RECTAL	6.5mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:TOPICAL:GEL:%w/w	TOPICAL	1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:TOPICAL:SOLUTION:%w/w	TOPICAL	1.4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:VAGINAL:CREAM:%w/w	VAGINAL	1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LEMON TINCTURE:ORAL:SYRUP:mg/1ml	ORAL	0.5mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LINEAR TRIDECYL BENZENE SULFONATE:TOPICAL:SOAP:%w/w	TOPICAL	0.05%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LUDIPRESS:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LUDIPRESS:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	MEDICAL ANTIFOAM EMULSION C:ORAL:SUSPENSION:mg/5ml	ORAL	0.17mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MEDICAL ANTIFOAM EMULSION C:ORAL:TABLET:mg	ORAL	1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MEDICAL ANTIFOAM EMULSION C:ORAL:TABLET, EFFERVESCENT:mg	ORAL	0.05mg ORAL TABLET, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MEDICAL ANTIFORM A-F EMULSION:TOPICAL:CREAM:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	44.6mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:GRANULE, DELAYED RELEASE:mg	ORAL	430.8mg ORAL GRANULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:GRANULE, FOR SUSPENSION:mg	ORAL	69.48mg ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	24.6mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYL ACRYLATE - METHYL METHACRYLATE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:ORAL:CAPSULE:mg	ORAL	289.47mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.54%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:CREAM:%w/w	TOPICAL	15%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:OINTMENT:%w/w	TOPICAL	7%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MULTISTEROL EXTRACT:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MYVACET TYPE 5-00:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MYVACET TYPE 5-00:ORAL:TABLET, COATED:mg	ORAL	0.31mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MYVACET TYPE 5-00:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.04mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	NEUTRAL OIL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	240mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
NA	OLETH-10/OLETH-5:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OLETH-10/OLETH-5:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACOAT NA4108 BLUE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACOAT NA7013 CLEAR:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE A-10450 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE A-10509 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-17502 GRAY:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET:mg	ORAL	0.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET, COATED:mg	ORAL	0.1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET, FILM COATED:mg	ORAL	0.1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8001:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8001:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NSP-78-17734 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-13001 ORANGE:ORAL:TABLET:mg	ORAL	0.03mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-16507:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17734 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17762 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-3110 GREEN:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-4160 BLUE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7077:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7078:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7085 WHITE:ORAL:CAPSULE:mg	ORAL	0.03mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7085 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.03mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8025 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8025 BLACK:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8081 BLACK:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:CAPSULE:mg	ORAL	0.05mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET:mg	ORAL	0.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, COATED:mg	ORAL	2.4mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, FILM COATED:mg	ORAL	0.7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8092 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET:mg	ORAL	0.09mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET, COATED:mg	ORAL	0.09mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8105 BLACK:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8105 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8105 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8106 BLACK:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8110 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-9032:ORAL:TABLET:mg	ORAL	9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NS-78-17715 BLACK:ORAL:TABLET:mg	ORAL	0.09mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NS-78-17715 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NSP-78-18022 WHITE:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 00B57513 GREY:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 00B57513 GREY:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02B14941 PINK:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02B22429 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G22555 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G28619 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G28619 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G59011 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B11434 GREEN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B12878 YELLOW:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B17495 BEIGE:ORAL:TABLET:mg	ORAL	18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B17495 BEIGE:ORAL:TABLET, FILM COATED:mg	ORAL	2.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B20024 PURPLE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B20024 PURPLE:ORAL:TABLET, FILM COATED:mg	ORAL	3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B20556 BLUE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B22082 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B240011 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B32034 YELLOW:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B34399 PINK:ORAL:TABLET:mg	ORAL	19.05mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B52155 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B56518 BROWN:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B56518 BROWN:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B58902 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B68903 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B80829 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B80829 BLUE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B82316 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B86636 BROWN:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	9mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F12967 YELLOW:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F12967 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F14895 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F14895 PINK:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F43101 ORANGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F505071 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F58991 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F59016 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F59016 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F59016 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F82788 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03G24389 PINK:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03G24389 PINK:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K19229 CLEAR:ORAL:TABLET:mg	ORAL	4.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K19229 CLEAR:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	8.4mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K19229 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K29121 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K54121 PINK:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K80846 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10446 PURPLE:ORAL:TABLET:mg	ORAL	16mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10446 PURPLE:ORAL:TABLET, COATED:mg	ORAL	23mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10457 PURPLE:ORAL:TABLET:mg	ORAL	16mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10457 PURPLE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B11781 GREEN:ORAL:TABLET:mg	ORAL	7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B15325 RED:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B17055 TAN:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B17055 TAN:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58802 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58802 WHITE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58802 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58894 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58894 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13F58866 WHITE:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13F58866 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	4.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13K52177 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13M86920 BROWN:ORAL:TABLET:mg	ORAL	28mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 15B11947 GREEN:ORAL:TABLET:mg	ORAL	2.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 15B50612 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A54901 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A54901 PINK:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A58806 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A58806 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20B50135 PURPLE:ORAL:TABLET, FILM COATED:mg	ORAL	25mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 321A180025 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 32K14834 PINK:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 85G689183 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 85G93096 ORANGE:ORAL:TABLET:mg	ORAL	4.53mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB 80W64837 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB II 88A180040 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB OY-B-28920 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB OY-B-28920 WHITE:ORAL:TABLET:mg	ORAL	2.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB OY-B-28920 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F23111 ORANGE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	8mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F23111 ORANGE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	16mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F58914 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31K58902 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31K84972 PINK:ORAL:TABLET:mg	ORAL	29.1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31K84972 PINK:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32B10817 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K12884 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K13357 ORANGE:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K14833 PINK:ORAL:TABLET:mg	ORAL	21mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K14833 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K17573 GRAY:ORAL:TABLET:mg	ORAL	7.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K17573 GRAY:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	14mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28435 WHITE:ORAL:TABLET:mg	ORAL	22.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28523 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28707 WHITE:ORAL:TABLET:mg	ORAL	31.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28707 WHITE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28707 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28707 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 39B18529 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C10881 BLUE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C10881 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C18303 WHITE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C18303 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L10039 PURPLE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L10039 PURPLE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L11438 GREEN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L11588 GREEN:ORAL:TABLET:mg	ORAL	26.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L11588 GREEN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	22mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L12979 YELLOW:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L12979 YELLOW:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	30mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L13950 ORANGE:ORAL:TABLET:mg	ORAL	9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L14190 PINK:ORAL:TABLET:mg	ORAL	24.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 49B10882 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F10919 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F10919 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	1.65mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F130017 ORANGE:ORAL:TABLET:mg	ORAL	5.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F13980 ORANGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F14399 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F14452 PINK:ORAL:TABLET:mg	ORAL	9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F15642 RED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F15642 RED:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18442 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F22055 YELLOW:ORAL:TABLET:mg	ORAL	18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F23470 PINK:ORAL:TABLET:mg	ORAL	7.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F24307 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F24307 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F28751 WHITE:ORAL:TABLET:mg	ORAL	24mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F32121 YELLOW:ORAL:TABLET:mg	ORAL	2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F32782 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F32782 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	10.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F34610 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F48105:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F48105:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F64732 PINK:ORAL:TABLET:mg	ORAL	4.65mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F66775 BROWN:ORAL:TABLET:mg	ORAL	9.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F66775 BROWN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F90093 PURPLE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F90093 PURPLE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F92209 YELLOW:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F92716 YELLOW:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F94172 PINK:ORAL:TABLET:mg	ORAL	46.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F94552 PINK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	10.98mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85G20583 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II BROWN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	50.7mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II OY-L-28900 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II OY-L-28900 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	5.55mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II PINK 85G94065:ORAL:TABLET:mg	ORAL	4.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II PINK 85G94065:ORAL:TABLET, FILM COATED:mg	ORAL	7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-19054 CLEAR:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-19054 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	45.14mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET:mg	ORAL	5.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	34mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10274 LAVENDER:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	14.95mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10274 LAVENDER:ORAL:TABLET, FILM COATED:mg	ORAL	8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10508 BLUE:ORAL:TABLET:mg	ORAL	14.83mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10519 BLUE:ORAL:TABLET:mg	ORAL	29.66mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10538 BLUE:ORAL:TABLET:mg	ORAL	90mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10702 BLUE:ORAL:TABLET:mg	ORAL	6.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10702 BLUE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5.25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10764 BLUE:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12553 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12664 YELLOW:ORAL:TABLET:mg	ORAL	86.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12664 YELLOW:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	12mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12720 PALE YELLOW:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12720 PALE YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	4.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12780 YELLOW:ORAL:TABLET:mg	ORAL	21mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12780 YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, COATED:mg	ORAL	13mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	40mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	6.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13083 ORANGE:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13167 ORANGE:ORAL:TABLET:mg	ORAL	25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13167 ORANGE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13577 FLESH:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13577 FLESH:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	15mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13577 FLESH:ORAL:TABLET, FILM COATED:mg	ORAL	9.3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13603 ORANGE:ORAL:TABLET:mg	ORAL	67.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13603 ORANGE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	12mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-10671A BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12736A YELLOW:ORAL:TABLET:mg	ORAL	21mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12736A YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12736A YELLOW:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	7mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12737A YELLOW:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12737A YELLOW:ORAL:TABLET, COATED:mg	ORAL	6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12737A YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-17528 GRAY:ORAL:TABLET:mg	ORAL	25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-17528 GRAY:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5.6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:TABLET, COATED:mg	ORAL	9.9mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	24.1mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, COATED:mg	ORAL	4.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-22-18096 WHITE:ORAL:TABLET:mg	ORAL	28.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-17265A BEIGE:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-17265A BEIGE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-18105 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-18105 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-29020 CLEAR:ORAL:CAPSULE:mg	ORAL	2.08mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-29020 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-29020 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-52945 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-52945 YELLOW:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-52945 YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-54937 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-58900 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-58900 WHITE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	7.5mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-58900 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-7300 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-B-28920 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-B-32830:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-GM-28900:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-GM-28900:ORAL:TABLET, FILM COATED:mg	ORAL	26mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-L-34836 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-23016 ORANGE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-23018 ORANGE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	6mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-23018 ORANGE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-28908 WHITE:ORAL:TABLET:mg	ORAL	7.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-28908 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-28914 WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	7mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-28914 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-37200 BUFF:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-37200 BUFF:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-58900 WHITE:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-22815 YELLOW:ORAL:TABLET:mg	ORAL	1.22mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-24900 PINK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	13.8mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-24900 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	4.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28849 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28876 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28924 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28924 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	16.52mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-30913 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-30913 BLUE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-30913 BLUE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-32921 YELLOW:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-32921 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-33016 ORANGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-33016 ORANGE:ORAL:TABLET, COATED:mg	ORAL	3.3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-38956 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-54902 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	5.24mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7322 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7322 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	9mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7399 WHITE:ORAL:TABLET:mg	ORAL	19mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7399 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	10mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-SR-34907:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-3211 GREEN:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-3211 GREEN:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-4234 BLUE:ORAL:TABLET:mg	ORAL	3.06mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, COATED:mg	ORAL	3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	37.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000B WHITE:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000H WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000H WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000H WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7006 BLUE:ORAL:TABLET:mg	ORAL	3.23mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7503 GRAY:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-30-14565 PINK:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-30-17267 BEIGE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-30-17267 BEIGE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-1244 PINK:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-1727 RED:ORAL:TABLET:mg	ORAL	7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2028 YELLOW:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2042 YELLOW:ORAL:TABLET:mg	ORAL	0.03mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2042 YELLOW:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	18.3mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2394 ORANGE:ORAL:TABLET:mg	ORAL	31.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2450 ORANGE:ORAL:TABLET:mg	ORAL	20.9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2450 ORANGE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2646 BEIGE:ORAL:TABLET:mg	ORAL	14mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-4270 BLUE:ORAL:TABLET:mg	ORAL	14mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7058 WHITE:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7058 WHITE:ORAL:TABLET, COATED:mg	ORAL	3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET, COATED:mg	ORAL	21mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	22.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7072 WHITE:ORAL:TABLET:mg	ORAL	2.7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-8050 BLACK:ORAL:TABLET:mg	ORAL	7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9006 BROWN:ORAL:TABLET:mg	ORAL	8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9006 BROWN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	15mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9020 BROWN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9020 BROWN:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-003 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10547A BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10547A BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	35mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10690A BLUE:ORAL:TABLET:mg	ORAL	7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10699 BLUE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10748A LIGHT BLUE:ORAL:TABLET:mg	ORAL	4.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-11051 GREEN:ORAL:TABLET:mg	ORAL	17.56mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-11051 GREEN:ORAL:TABLET, COATED:mg	ORAL	16mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1246 PINK:ORAL:TABLET:mg	ORAL	4.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1252 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	4.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12524A YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12525A YELLOW:ORAL:TABLET:mg	ORAL	19.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12525A YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12526A YELLOW:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12526A YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12541 YELLOW:ORAL:TABLET:mg	ORAL	22mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12541 YELLOW:ORAL:TABLET, COATED:mg	ORAL	12mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12625 YELLOW:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12702A YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	12.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12732 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	20.96mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12826 YELLOW:ORAL:TABLET:mg	ORAL	8.1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13065A ORANGE:ORAL:TABLET:mg	ORAL	41mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13148A ORANGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13148A ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13271 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14012 PINK:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14129 PINK:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14129 PINK:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14129 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	19mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14130 PINK:ORAL:TABLET:mg	ORAL	12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14130 PINK:ORAL:TABLET, COATED:mg	ORAL	5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1418 PINK:ORAL:TABLET:mg	ORAL	2.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1441G:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14518A PINK:ORAL:TABLET:mg	ORAL	4.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14518A PINK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	12mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14518A PINK:ORAL:TABLET, FILM COATED:mg	ORAL	8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1456G PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14725 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14779A PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14779A PINK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	7.48mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-15050 RED:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1510 PINK:ORAL:TABLET:mg	ORAL	4.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1543 PINK:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1543 PINK:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1543 PINK:ORAL:TABLET, FILM COATED:mg	ORAL	4.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-15585A RED:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17180A BEIGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17209 BEIGE:ORAL:TABLET:mg	ORAL	30mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17222A TAN:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1724 RED:ORAL:TABLET:mg	ORAL	18.57mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17307A BUTTERSCOTCH:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17307A BUTTERSCOTCH:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17506A GRAY:ORAL:TABLET:mg	ORAL	15.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17506A GRAY:ORAL:TABLET, FILM COATED:mg	ORAL	15mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027 WHITE:ORAL:TABLET:mg	ORAL	12.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	16.32mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027A WHITE:ORAL:TABLET:mg	ORAL	21mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027A WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	5.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18111 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18111 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	32mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18177A WHITE:ORAL:TABLET:mg	ORAL	18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18177A WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	8.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18202A WHITE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	6.25mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18202A WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18202A WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2013 YELLOW:ORAL:TABLET:mg	ORAL	8.19mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2074 YELLOW:ORAL:TABLET:mg	ORAL	19.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2074 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	4.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2122 YELLOW:ORAL:TABLET:mg	ORAL	0.15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2134 YELLOW:ORAL:TABLET:mg	ORAL	147.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2141 YELLOW:ORAL:TABLET:mg	ORAL	18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2152 YELLOW:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2398 ORANGE:ORAL:TABLET:mg	ORAL	25.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2465:ORAL:TABLET:mg	ORAL	1.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2527 ORANGE:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2527 ORANGE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2534:ORAL:TABLET:mg	ORAL	147.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2534:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2546 ORANGE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2546 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	14mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2548 ORANGE:ORAL:TABLET:mg	ORAL	6.9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2548 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	13mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2549 ORANGE:ORAL:TABLET:mg	ORAL	120mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2558 ORANGE:ORAL:TABLET:mg	ORAL	25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2558 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	14mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2563 ORANGE:ORAL:TABLET:mg	ORAL	11.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2596 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2604 BEIGE:ORAL:TABLET:mg	ORAL	7.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2604 BEIGE:ORAL:TABLET, FILM COATED:mg	ORAL	0.15mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2619:ORAL:TABLET:mg	ORAL	23mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2621 RUST:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2621 RUST:ORAL:TABLET, FILM COATED:mg	ORAL	17mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2623 BROWN:ORAL:TABLET, FILM COATED:mg	ORAL	34mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3105 GREEN:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3130 GREEN:ORAL:TABLET:mg	ORAL	36mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3130 GREEN:ORAL:TABLET, COATED:mg	ORAL	20mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3130 GREEN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	8.08mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3166 GREEN:ORAL:TABLET:mg	ORAL	12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4018 BLUE:ORAL:TABLET:mg	ORAL	22mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4112 BLUE:ORAL:TABLET:mg	ORAL	147.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4215:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4216:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4221 BLUE:ORAL:TABLET:mg	ORAL	0.15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4228 BLUE:ORAL:TABLET:mg	ORAL	19.94mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4235 BLUE:ORAL:TABLET:mg	ORAL	20.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4236 BLUE:ORAL:TABLET:mg	ORAL	4.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4236 BLUE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4236 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	12.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4241 BLUE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4241 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4249 BLUE:ORAL:TABLET:mg	ORAL	22.68mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4256 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	15.7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4256 BLUE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	35.4mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4282 BLUE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4298 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4700 PURPLE:ORAL:TABLET:mg	ORAL	0.01mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4710:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4845 PURPLE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6378G YELLOW:ORAL:TABLET:mg	ORAL	13.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6382G YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6382G YELLOW:ORAL:TABLET, COATED:mg	ORAL	6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7002 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	11.7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE:mg	ORAL	7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, COATED:mg	ORAL	14mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	36mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	6.24mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003H WHITE:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003H WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE:mg	ORAL	6.25mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:GRANULE:mg	ORAL	0.01mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, COATED:mg	ORAL	11.16mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	11mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	2.63mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7027 WHITE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7027 WHITE:ORAL:TABLET:mg	ORAL	37mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7027 WHITE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	16mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7059 WHITE:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7059 WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	30mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7059 WHITE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7086 WHITE:ORAL:TABLET:mg	ORAL	12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7086 WHITE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7444G WHITE:ORAL:TABLET, COATED:mg	ORAL	22mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET:mg	ORAL	2.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	2.9mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7507 GREY:ORAL:TABLET:mg	ORAL	19.06mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7507 GREY:ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7507 GREY:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	34.23mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7552 GREY:ORAL:CAPSULE:mg	ORAL	7.3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7552 GREY:ORAL:TABLET:mg	ORAL	7.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7700 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7700 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706 CLEAR:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706 CLEAR:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706G WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706G WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-8325 BEIGE:ORAL:TABLET:mg	ORAL	16mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-8608 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	10mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-9012 BROWN:ORAL:TABLET:mg	ORAL	13.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-9012 BROWN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1R-7006 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1R-7006 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1R-7006 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-19071A CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	8.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-19114A CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-19114A CLEAR:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	1.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-19114A CLEAR:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-22-18119 WHITE:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7013 CLEAR:ORAL:TABLET:mg	ORAL	4.44mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7013 CLEAR:ORAL:TABLET, COATED:mg	ORAL	2.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7013 CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	1.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7063 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7011 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7011 CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	5.25mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7031 CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET, COATED:mg	ORAL	2.4mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	1.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-1296 PINK:ORAL:TABLET:mg	ORAL	7.46mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-2370 ORANGE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-2370 ORANGE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-7068:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS GS 2-0300:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS GS 2-0310:ORAL:TABLET:mg	ORAL	3.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS GS 2-0310:ORAL:TABLET, COATED:mg	ORAL	0.76mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 1589 PINK:ORAL:TABLET, COATED:mg	ORAL	0.07mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET:mg	ORAL	15.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET, COATED:mg	ORAL	22.13mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	11.8mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2269 YELLOW:ORAL:TABLET:mg	ORAL	0.57mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2413:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2498 ORANGE:ORAL:TABLET:mg	ORAL	0.27mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2498 ORANGE:ORAL:TABLET, COATED:mg	ORAL	3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2676 SALMON JASPER RED:ORAL:TABLET:mg	ORAL	1.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3389 GREEN:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3391 GREEN:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3391 GREEN:ORAL:TABLET, COATED:mg	ORAL	1.18mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4151 BLUE:ORAL:CAPSULE:mg	ORAL	2.76mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4151 BLUE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	8.43mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4270 BLUE:ORAL:TABLET, COATED:mg	ORAL	12.63mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4855 PURPLE:ORAL:TABLET:mg	ORAL	0.02mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 5212 GREEN:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 7000-B:ORAL:TABLET, COATED:mg	ORAL	4.95mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 7000-P WHITE:ORAL:TABLET:mg	ORAL	3.81mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 7535 GRAY:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 9010 BROWN:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 9010 BROWN:ORAL:TABLET, COATED:mg	ORAL	0.45mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 100:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 100:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 147:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 147:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 605:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE GREEN 97:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE GREEN 97:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE MAROON 6 DAR:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE WHITE 002:ORAL:CAPSULE:mg	ORAL	62mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE WHITE 8:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE WHITE 8:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY IM-176:ORAL:TABLET:mg	ORAL	23.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1230 PINK:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1279:ORAL:TABLET:mg	ORAL	21.13mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1414 PINK:ORAL:TABLET:mg	ORAL	11.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1437:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1573 LAVENDER:ORAL:TABLET:mg	ORAL	12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2013 YELLOW:ORAL:TABLET:mg	ORAL	8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2158 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	0.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2182 YELLOW:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2182 YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET, COATED:mg	ORAL	0.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	6.8mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2227 YELLOW:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2228 YELLOW:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	17.8mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2301 PEACH:ORAL:TABLET:mg	ORAL	4.7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2303 ORANGE:ORAL:TABLET:mg	ORAL	0.35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2304 ORANGE:ORAL:TABLET:mg	ORAL	1.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2314 ORANGE:ORAL:TABLET:mg	ORAL	3.74mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2327 ORANGE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2406 ORANGE:ORAL:TABLET:mg	ORAL	4.42mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2406 ORANGE:ORAL:TABLET, FILM COATED:mg	ORAL	2.1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2430:ORAL:TABLET:mg	ORAL	13.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2441 ORANGE:ORAL:TABLET:mg	ORAL	5.95mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2473:ORAL:TABLET:mg	ORAL	22.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2473:ORAL:TABLET, FILM COATED:mg	ORAL	2.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2492:ORAL:TABLET:mg	ORAL	36mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2614 BEIGE:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2614 BEIGE:ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2656 BEIGE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2711:ORAL:TABLET:mg	ORAL	12.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3000:ORAL:TABLET:mg	ORAL	0.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3000:ORAL:TABLET, COATED:mg	ORAL	0.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3142 GREEN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5.1mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3147:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3147:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3147:ORAL:TABLET, FILM COATED:mg	ORAL	0.6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3148 GREEN:ORAL:TABLET:mg	ORAL	1.35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3148 GREEN:ORAL:TABLET, FILM COATED:mg	ORAL	0.74mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3178 GREEN:ORAL:TABLET:mg	ORAL	1.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3220 GREEN:ORAL:TABLET:mg	ORAL	1.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3220 GREEN:ORAL:TABLET, FILM COATED:mg	ORAL	0.7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3300-C GREEN:ORAL:TABLET:mg	ORAL	2.1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4108 BLUE:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4108 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	1.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4119:ORAL:TABLET:mg	ORAL	0.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4119:ORAL:TABLET, COATED:mg	ORAL	0.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4122 BLUE:ORAL:TABLET:mg	ORAL	2.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4122 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	4.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4136 BLUE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4136 BLUE:ORAL:TABLET, COATED:mg	ORAL	0.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4136 BLUE:ORAL:TABLET, FILM COATED:mg	ORAL	3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4214:ORAL:TABLET:mg	ORAL	2.7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4214:ORAL:TABLET, COATED:mg	ORAL	2.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4234 BLUE:ORAL:TABLET:mg	ORAL	1.53mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4728:ORAL:TABLET:mg	ORAL	4.68mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4731 PURPLE:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4743 LAVENDER:ORAL:TABLET:mg	ORAL	2.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4786:ORAL:TABLET:mg	ORAL	2.1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4786:ORAL:TABLET, COATED:mg	ORAL	2.1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET:mg	ORAL	22.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET, COATED:mg	ORAL	0.9mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	6.25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	7.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-70008 WHITE:ORAL:TABLET:mg	ORAL	22.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9027 BROWN:ORAL:TABLET:mg	ORAL	1.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9039-L BROWN:ORAL:TABLET:mg	ORAL	12.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9039-L BROWN:ORAL:TABLET, FILM COATED:mg	ORAL	4.65mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9060 RED:ORAL:TABLET:mg	ORAL	2.9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9080 BROWN:ORAL:TABLET:mg	ORAL	3.28mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-3459 B ORANGE:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7111-B:ORAL:TABLET:mg	ORAL	40mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7111-B:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7111-B:ORAL:TABLET, FILM COATED:mg	ORAL	2.9mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7120 WHITE:ORAL:TABLET:mg	ORAL	4.57mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7120 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	1.52mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPATINT DD-1800 WHITE:ORAL:TABLET:mg	ORAL	84mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPATINT DD-18000 WHITE:ORAL:CAPSULE:mg	ORAL	3.07mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPATINT DD-18000 WHITE:ORAL:TABLET, FILM COATED:mg	ORAL	0.68mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	PARABENS:ORAL:CAPSULE:mg	ORAL	0.16mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARFUM CREME 45/3:TOPICAL:GEL:%w/w	TOPICAL	0.1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PEG 6-32 STEARATE/GLYCOL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	19.6%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PEG 6-32 STEARATE/GLYCOL STEARATE:VAGINAL:CREAM:%w/w	VAGINAL	19.6%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PENTAERYTHRITOL COCOATE:TOPICAL:OINTMENT:%w/w	TOPICAL	1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PERFUME GD 5604:TOPICAL:CREAM:%w/w	TOPICAL	0.12%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST B1:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	671.13mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST B2:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	792mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST B2:SUBLINGUAL:TABLET:mg	SUBLINGUAL	132.75mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST C1:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHENONIP:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	0.23mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHENONIP:TOPICAL:GEL:%w/w	TOPICAL	0.04%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHENONIP:TOPICAL:SYSTEM:mg	TOPICAL	0.23mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHOSPHOLIPID:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHOSPHOLIPID:INTRAVENOUS:INJECTION, EMULSION:mg	INTRAVENOUS	120mg INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHOSPHOLIPID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	120mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PIGMENT BLEND PB-2417 PINK:ORAL:TABLET:mg	ORAL	1.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PIGMENT BLEND PB-2417 PINK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.7mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PIGMENTED POLYETHYLENE/POLYESTER 1501 FILM:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PLASTIBASE-50W:TOPICAL:OINTMENT:%w/w	TOPICAL	99.95%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLISHING SOLUTION IM-182:ORAL:TABLET:mg	ORAL	0.7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYDEXTROSE K:ORAL:TABLET, FILM COATED:mg	ORAL	8.13mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	24mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER:VAGINAL:INSERT, EXTENDED RELEASE:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER POLYAMINE COPOLYMER:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	6.67mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYETHYLENE GLYCOL 540:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:DENTAL:POWDER:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	132.4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:INTRAMUSCULAR:POWDER, FOR SUSPENSION:%w/v	INTRAMUSCULAR	28.32%w/v INTRAMUSCULAR POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	25.2mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	211.5mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:SUBCUTANEOUS:INJECTION, POWDER, FOR SUSPENSION:mg	SUBCUTANEOUS	132.6mg SUBCUTANEOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:SUBCUTANEOUS:INJECTION, SUSPENSION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYGLACTIN:SUBCUTANEOUS:PELLET, IMPLANTABLE:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TOPICAL:SYSTEM:mg	TOPICAL	270.06mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:FILM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	615.4mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	42.1mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE/POLYBUTENE ADHESIVE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	221.25mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE ALCOHOLS:TOPICAL:CREAM:%w/w	TOPICAL	7.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE ALCOHOLS:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	14%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	14%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:TOPICAL:CREAM:%w/w	TOPICAL	1.9%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:TOPICAL:DISC:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	20%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE:TOPICAL:LOTION:%w/w	TOPICAL	5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL DISTEARATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL GLYCERYL STEARATE:ORAL:TABLET:mg	ORAL	23.33mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL GLYCERYL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL GLYCERYL STEARATE:TOPICAL:LOTION:%w/w	TOPICAL	1.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:AURICULAR (OTIC):SUSPENSION:%w/w	AURICULAR (OTIC)	0.01%w/w AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:ORAL:TABLET, COATED:mg	ORAL	2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	4.36%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:LOTION:%w/w	TOPICAL	2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:VAGINAL:CREAM:%w/w	VAGINAL	0.25%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE:TOPICAL:SPONGE:%w/w	TOPICAL	22.68%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	13.5mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	151.4mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE GLYCOL:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	15%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE GLYCOL:ORAL:SOLUTION:mg/5ml	ORAL	1000mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE GLYCOL:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE GLYCOL:ORAL:TABLET:mg	ORAL	1.26mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE GLYCOL:TOPICAL:LIQUID:%w/w	TOPICAL	1.7%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYPROPYLENE GLYCOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYQUATERNIUM-10:TOPICAL:SHAMPOO:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSILOXANE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSILOXANE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSORB 85/70/00:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSORB 85/70/00:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYVINYL CHLORIDE-POLYVINYL ACETATE COPOLYMER:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	899.88mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYVINYLACETAL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	5mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYVINYLACETAL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POTASSIUM SOAP:TOPICAL:SOLUTION:%w/w	TOPICAL	37.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POVIDONE K25/30:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POVIDONE/EICOSENE COPOLYMER:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POVIDONE/EICOSENE COPOLYMER:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROMULGEN D:TOPICAL:LOTION:%w/w	TOPICAL	3.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROMULGEN G:TOPICAL:LOTION:%w/w	TOPICAL	2.16%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROMULGEN G:TOPICAL:SHAMPOO:%w/w	TOPICAL	4%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROPYLENE GLYCOL - LECITHIN:BUCCAL:SYSTEM:mg	BUCCAL	49.4mg BUCCAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROPYLENE GLYCOL - LECITHIN:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	240.07mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:CAPSULE:mg	ORAL	33.86mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:TABLET:mg	ORAL	203.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	315mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:ORAL:CAPSULE:mg	ORAL	50.78mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:SUBLINGUAL:TABLET:mg	SUBLINGUAL	18.7mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC HD 90:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSWEET:ORAL:SOLUTION:mg/5ml	ORAL	52.75mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSWEET:ORAL:SUSPENSION:mg/5ml	ORAL	50mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSWEET:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSWEET K:ORAL:SYRUP:mg/1ml	ORAL	4mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROTEIN HYDROLYSATE:ORAL:TABLET, FILM COATED:mg	ORAL	15mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROTEIN HYDROLYSATE:TOPICAL:LOTION:%w/w	TOPICAL	0.39%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	SCOTCHPAK 1022:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SCOTCHPAK 1022:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	381mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	46%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40-2:TOPICAL:AEROSOL:%w/w	TOPICAL	57.65%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40-2:TOPICAL:GEL:%w/w	TOPICAL	97.5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40B:TOPICAL:AEROSOL:%w/w	TOPICAL	56.09%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40B:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	56.09%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40B:TOPICAL:SOLUTION:%w/w	TOPICAL	54.2%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPIFILM LP-761 BLANC:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPIFILM LP-761 BLANC:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPINEO P 600:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPINEO P 600:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPINEO P 600:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SHELLAC P.V.P. SOLUTION NO. 4:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	87mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SHELLAC P.V.P. SOLUTION NO. 4:ORAL:TABLET:mg	ORAL	5.62mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILASTIC MEDICAL ADHESIVE,SILICONE TYPE A:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	7.5mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:INTRAUTERINE:SUPPOSITORY, EXTENDED RELEASE:mg	INTRAUTERINE	60mg INTRAUTERINE SUPPOSITORY, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:CAPSULE:mg	ORAL	15mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.14mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TOPICAL:LOTION:%w/w	TOPICAL	0.09%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	114.7mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TRANSDERMAL:SYSTEM:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE ADHESIVE 4302:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.08mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	62mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:SUSPENSION:mg	ORAL	5mg ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE/POLYESTER FILM STRIP:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	873mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE/POLYESTER FILM STRIP:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:CAPSULE:mg	ORAL	5.7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.61mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.03mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:GRANULE, EFFERVESCENT:mg	ORAL	0.04mg ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:GRANULE, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	4mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:PASTILLE:mg	ORAL	0.4mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	189mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:SUSPENSION:mg/10ml	ORAL	90mg/10ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	7.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:TABLET, FILM COATED:mg	ORAL	0.18mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.04mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:RECTAL:SOLUTION:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:TOPICAL:CREAM:%w/w	TOPICAL	0.2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:TOPICAL:LOTION:%w/v	TOPICAL	0.01%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.11%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:CAPSULE:mg	ORAL	14.4mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:POWDER, FOR SOLUTION:mg/1ml	ORAL	0.05mg/1ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:TABLET, COATED:mg	ORAL	0.01mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.08mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	1.41mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIMETHICONE EMULSION:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SOAP:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SOAP:TOPICAL:SOAP:%w/w	TOPICAL	95.05%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM ALKYL SULFATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.68%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM CELLULOSE:ORAL:CAPSULE:mg	ORAL	150mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM COCOMONOGLYCERIDE SULFONATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.81%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM POLYACRYLATE:TOPICAL:SYSTEM:mg	TOPICAL	840mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL SPECIAL POLYOL SOLUTION:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL SPECIAL POLYOL SOLUTION:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL-GLYCERIN BLEND:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE:mg	ORAL	430mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	36.4mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	84.8mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:POWDER:mg	ORAL	0.17mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, COATED:mg	ORAL	210mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	179.88mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	130.45mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:WAFER:mg	ORAL	4.8mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:RECTAL:TABLET:mg	RECTAL	55mg RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:TOPICAL:POWDER:mg/mg	TOPICAL	0.1mg/mg TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 7150:ORAL:CAPSULE:mg	ORAL	0.44mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 7150:ORAL:TABLET:mg	ORAL	50mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 825:ORAL:CAPSULE:mg	ORAL	217mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 826:ORAL:CAPSULE:mg	ORAL	237mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 826:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 826:ORAL:TABLET, FILM COATED:mg	ORAL	10mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH 826:SUBLINGUAL:TABLET:mg	SUBLINGUAL	12mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:CAPSULE:mg	ORAL	23mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	10mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.4mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	141.75mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:LOZENGE:mg	ORAL	80mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	75mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEARATES:ORAL:TABLET:mg	ORAL	4.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET C:ORAL:TABLET:mg	ORAL	12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET C:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET:mg	ORAL	860mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	11mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAROYL POLYOXYLGLYCERIDES:ORAL:CAPSULE:mg	ORAL	260mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAROYL POLYOXYLGLYCERIDES:ORAL:TABLET:mg	ORAL	23.34mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAROYL POLYOXYLGLYCERIDES:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR LIQUID TYPE NO. 0:ORAL:SYRUP:ml	ORAL	1.39ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	122.19mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR SPHERES:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SUGAR/STARCH INSERT GRANULES:ORAL:SUSPENSION:mg/5ml	ORAL	2252.4mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNCHRON ORAL CARRIER:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	475mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNCHRON ORAL CARRIER VEHICLE TYPE EM:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	220mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNTHETIC IRON OXIDES:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNTHETIC IRON OXIDES:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNTHETIC IRON OXIDES:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.1mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	TEGACID:TOPICAL:CREAM:%w/w	TOPICAL	16%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TENOX:TOPICAL:CREAM:%w/w	TOPICAL	0.03%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TENOX:TOPICAL:OINTMENT:%w/w	TOPICAL	0.03%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TENOX-2:TOPICAL:OINTMENT:%w/w	TOPICAL	0.03%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TIMING SOLUTION CLEAR N-7:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	26.2mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	VEGETABLE OIL:BUCCAL:GUM, CHEWING:mg	BUCCAL	14.4mg BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:CAPSULE:mg	ORAL	2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:TABLET:mg	ORAL	25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:TOPICAL:CREAM:%w/w	TOPICAL	3.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL GLYCERIDE, HYDROGENATED:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL GLYCERIDE, HYDROGENATED:RECTAL:SUPPOSITORY:mg	RECTAL	870mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, CHEWABLE:mg	ORAL	8mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, COATED:mg	ORAL	2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, FILM COATED:mg	ORAL	12.3mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:RECTAL:SUPPOSITORY:mg	RECTAL	1964.99mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:VAGINAL:CREAM:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:VAGINAL:SUPPOSITORY:mg	VAGINAL	2295mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE SHORTENING:ORAL:CAPSULE:mg	ORAL	10.56mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE SHORTENING:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	WAX:ORAL:TABLET:mg	ORAL	0.02mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
NA	WAX BLEND:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
NA	WECOBEE FS:TOPICAL:CREAM:%w/w	TOPICAL	67.2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
NA	WECOBEE FS:VAGINAL:CREAM:%w/w	VAGINAL	67.2%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
NA	WECOBEE FS:VAGINAL:SUPPOSITORY:mg	VAGINAL	1700mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
NA	XYLITOL 300:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
MA3UYZ6K1H	ACESULFAME:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:DENTAL:SOLUTION:%w/w	DENTAL	0.12%w/w DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:FILM, SOLUBLE:mg	ORAL	1.6mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:POWDER, FOR SOLUTION:mg	ORAL	117mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	45mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, FILM COATED:mg	ORAL	1.75mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.26%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ENDOTRACHEAL:SUSPENSION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INFILTRATION:INJECTION:NA	INFILTRATION		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.35%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:NASAL:SPRAY, METERED:mg/1ml	NASAL	1.2mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.04%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.09%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:ELIXIR:mg/5ml	ORAL	1.07mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:LIQUID:mg/5ml	ORAL	0.13mg/5ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SUSPENSION:ADJ PH	ORAL	ADJ PH ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:PARENTERAL:INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:LIQUID:%w/v	SUBCUTANEOUS	0.2%w/v SUBCUTANEOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:SOLUTION:%w/v	SUBCUTANEOUS	0.06%w/v SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBMUCOSAL:INJECTION, SOLUTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:TOPICAL:SOLUTION:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:TOPICAL:SPONGE:ADJ PH	TOPICAL	ADJ PH TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	0.03%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:VAGINAL:CREAM:%w/w	VAGINAL	0.35%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:VAGINAL:JELLY:%w/w	VAGINAL	1.1%w/w VAGINAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
2E48G1QI9Q	ACETIC ANHYDRIDE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
2E48G1QI9Q	ACETIC ANHYDRIDE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.11mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	7.6mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:TOPICAL:SOLUTION:%w/w	TOPICAL	5.4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
76A0JE0FKJ	ADIPIC ACID:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	1%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
76A0JE0FKJ	ADIPIC ACID:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
89T13OHQ2B	AGAR:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZIF514RVZR	ALBUMIN HUMAN:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	900mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
18B8O9DQA2	ALCLOXA:TOPICAL:CREAM:%w/w	TOPICAL	0.25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:BUCCAL:CONCENTRATE:mg/1ml	BUCCAL	679mg/1ml BUCCAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	200mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:DENTAL:GEL:%w/w	DENTAL	1.8%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:DENTAL:PASTE:%w/w	DENTAL	1.8%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:DENTAL:SOLUTION:%w/w	DENTAL	12.8%w/w DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:LIQUID:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVASCULAR:INJECTION:%v/v	INTRAVASCULAR	100%v/v INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	92%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:LIQUID:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:SOLUTION:%v/v	INTRAVENOUS	5%v/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:SOLUTION, CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVESICAL:SOLUTION:	INTRAVESICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:AEROSOL:mg	NASAL	20mg NASAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:AEROSOL, METERED:mg	NASAL	70mg NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:DROPS:mg/1ml	NASAL	10mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:SOLUTION:mg/1ml	NASAL	10mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:SPRAY:mg/1ml	NASAL	198.8mg/1ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:CONCENTRATE:mg	ORAL	198mg ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:DROPS:mg/1ml	ORAL	210mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:ELIXIR:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	150.68mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RECTAL:GEL:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RECTAL:SUSPENSION:%v/v	RECTAL	0.35%v/v RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RESPIRATORY (INHALATION):AEROSOL, METERED:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	35.75%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	5%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RESPIRATORY (INHALATION):SOLUTION:%w/v	RESPIRATORY (INHALATION)	0.08%w/v RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBCUTANEOUS:INJECTION, SOLUTION:%v/v	SUBCUTANEOUS	6.1%v/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBLINGUAL:SPRAY:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBLINGUAL:SPRAY, METERED:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:AEROSOL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:AEROSOL, SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:GEL, METERED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:LOTION:%w/w	TOPICAL	25%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:POWDER, FOR SOLUTION:%w/w	TOPICAL	40%w/w TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SHAMPOO:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SWAB:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:GEL, METERED:%w/w	TRANSDERMAL	73.5%w/w TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:SOLUTION:%w/v	TRANSDERMAL	49.37%w/v TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:SPRAY:%w/v	TRANSDERMAL	90%w/v TRANSDERMAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:VAGINAL:JELLY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z1LH97KTRM	ALFADEX:INTRACAVITARY:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRACAVITARY	1.29mg INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
03J11K103C	ALGELDRATE:ORAL:TABLET:mg	ORAL	85mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
03J11K103C	ALGELDRATE:ORAL:TABLET, FILM COATED:mg	ORAL	183.75mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
03J11K103C	ALGELDRATE:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:OPHTHALMIC:INSERT, EXTENDED RELEASE:mg	OPHTHALMIC	1mg OPHTHALMIC INSERT, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:CAPSULE:mg	ORAL	80mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, CHEWABLE:mg	ORAL	400mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, COATED:mg	ORAL	60mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	22.25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, FILM COATED:mg	ORAL	52.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
344S277G0Z	ALLANTOIN:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
344S277G0Z	ALLANTOIN:VAGINAL:CREAM:%w/w	VAGINAL	2%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
66YXD4DKO9	ALMOND OIL:TOPICAL:CREAM:%w/w	TOPICAL	2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
80EHD8I43D	ALUMINUM ACETATE:TOPICAL:CREAM:%w/w	TOPICAL	0.23%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
80EHD8I43D	ALUMINUM ACETATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.1%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:ORAL:TABLET:mg	ORAL	50mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
P9BC99461E	ALUMINUM MONOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	0.01%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LMI26O6933	ALUMINUM OXIDE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LMI26O6933	ALUMINUM OXIDE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LMI26O6933	ALUMINUM OXIDE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET:mg	ORAL	19.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, COATED:mg	ORAL	50mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	47mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
IQ2A4DQ696	ALUMINUM SILICATE PENTAHYDRATE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I9PJ0O6294	ALUMINUM STARCH OCTENYLSUCCINATE:TOPICAL:CREAM:%w/w	TOPICAL	10%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	105mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	0.01%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.01%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
34S289N54E	ALUMINUM SULFATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I7T908772F	ALUMINUM SULFATE ANHYDROUS:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.79%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I7T908772F	ALUMINUM SULFATE ANHYDROUS:TOPICAL:CREAM:%w/w	TOPICAL	0.13%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I7T908772F	ALUMINUM SULFATE ANHYDROUS:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:BUCCAL:TROCHE:mg	BUCCAL	0.05mg BUCCAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CAPSULE:mg	ORAL	1.08mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.18mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:ELIXIR:mg	ORAL	1.88mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:SOLUTION:mg/1ml	ORAL	0.11mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:SUSPENSION:mg/1ml	ORAL	0.1mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:SYRUP:mg/1ml	ORAL	0.03mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:TABLET:mg	ORAL	0.48mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:TABLET, COATED:mg	ORAL	0.02mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:TABLET, FILM COATED:mg	ORAL	0.01mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.57%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
75UI7QUZ5J	AMINOBENZOATE SODIUM:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
75UI7QUZ5J	AMINOBENZOATE SODIUM:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LU49E6626Q	AMINOMETHYLPROPANOL:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LU49E6626Q	AMINOMETHYLPROPANOL:TOPICAL:LOTION:%w/w	TOPICAL	0.3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.22%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE:mg	ORAL	0.01mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:SUBLINGUAL:FILM:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:CREAM:%w/w	TOPICAL	5.72%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:GEL:%w/w	TOPICAL	1.2%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:LOTION:ADJ PH	TOPICAL	ADJ PH TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	161mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	25mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RRE756S6Q2	AMMONIUM ACETATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RRE756S6Q2	AMMONIUM ACETATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:SYRUP:mg/5ml	ORAL	131.68mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:TABLET, FILM COATED:mg	ORAL	8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q7AO2R1M0B	AMMONIUM LAURYL SULFATE:TOPICAL:AEROSOL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q7AO2R1M0B	AMMONIUM LAURYL SULFATE:TOPICAL:EMULSION:%w/w	TOPICAL	39.75%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q7AO2R1M0B	AMMONIUM LAURYL SULFATE:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	30%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
10LGE70FSU	AMMONIUM PHOSPHATE, DIBASIC:ORAL:TABLET:mg	ORAL	0.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
10LGE70FSU	AMMONIUM PHOSPHATE, DIBASIC:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
10LGE70FSU	AMMONIUM PHOSPHATE, DIBASIC:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
SU46BAM238	AMMONIUM SULFATE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
SU46BAM238	AMMONIUM SULFATE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	9.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:DENTAL:SOLUTION:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:ORAL:ELIXIR:mg	ORAL	0.03mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:ORAL:SYRUP:mg/5ml	ORAL	2.3mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRACARDIAC:INJECTION:	INTRACARDIAC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:CONCENTRATE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	41.5mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:LIQUID:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:SOLUTION, CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:NASAL:SPRAY:mg/1ml	NASAL	26.03mg/1ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:NASAL:SPRAY, METERED:mg/1ml	NASAL	1.2mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.09%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:ELIXIR:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:LOZENGE:mg	ORAL	9.8mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:RESPIRATORY (INHALATION):SOLUTION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:RESPIRATORY (INHALATION):SUSPENSION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:TABLET, ORALLY DISINTEGRATING:ADJ PH	SUBLINGUAL	ADJ PH SUBLINGUAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:AEROSOL:%w/w	TOPICAL	0.08%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:CLOTH:mg	TOPICAL	4.2mg TOPICAL CLOTH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:OIL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.07%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:SOLUTION:%w/v	TOPICAL	4.35%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:SPRAY:%w/w	TOPICAL	0.01%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TRANSMUCOSAL:LOZENGE:mg	TRANSMUCOSAL	11mg TRANSMUCOSAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:%w/v	INTRAMUSCULAR	3.9%w/v INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRASPINAL:INJECTION:%w/v	INTRASPINAL	8.25%w/v INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:%w/v	INTRAVENOUS	3.9%w/v INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	5%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:ORAL:POWDER:mg	ORAL	0.5mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	7.5%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:BUCCAL:TABLET:mg	BUCCAL	60mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	48.36%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE:mg	ORAL	401mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	301.7mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:PASTILLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, CHEWABLE:mg	ORAL	50mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, COATED:mg	ORAL	333.3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:SUBLINGUAL:POWDER:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:TOPICAL:CREAM:%w/w	TOPICAL	36%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	25mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	25mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	25mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:SUSPENSION:mg/5ml	ORAL	15.69mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	128mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	1%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRABURSAL:INJECTION:%w/v	INTRABURSAL	1%w/v INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.96%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAVENOUS:CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	69.9mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:GRANULE, EFFERVESCENT:mg	ORAL	935mg ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	400mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	48mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:TABLET, CHEWABLE:mg	ORAL	72.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	15mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:RESPIRATORY (INHALATION):SUSPENSION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.96%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.94%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:TOPICAL:LOTION:%w/w	TOPICAL	0.08%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
21C2F5E8RE	ANISE:ORAL:ELIXIR:mg/5ml	ORAL	0.15mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
21C2F5E8RE	ANISE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:DENTAL:PASTE, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:DENTAL:POWDER, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:DROPS:mg/1ml	ORAL	0.4mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:ELIXIR:ml/5ml	ORAL	0.15ml/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:PASTILLE:mg	ORAL	16mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:SOLUTION:mg	ORAL	1.4mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:SUSPENSION:ml/5ml	ORAL	1ml/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T3CHA1B51H	ANTIPYRINE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
R40P36GDK6	APAFLURANE:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	98.02%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
DRG3KJZ1TJ	APRICOT KERNEL OIL PEG-6 ESTERS:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
DRG3KJZ1TJ	APRICOT KERNEL OIL PEG-6 ESTERS:VAGINAL:CREAM:%w/w	VAGINAL	2.94%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	780mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.29%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:POWDER, FOR SOLUTION:%w/v	INTRAVENOUS	7.07%w/v INTRAVENOUS POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INFILTRATION:INJECTION, SOLUTION:%w/v	INFILTRATION	0.2%w/v INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRACAVITARY:INJECTION:mg	INTRACAVITARY	5mg INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.2%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	2mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CAPSULE:mg	ORAL	7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CONCENTRATE:mg/1ml	ORAL	6mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	2.35mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:RECTAL:SUPPOSITORY:mg	RECTAL	3mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.1%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	0.11%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.04%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	0.04%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:ORAL:CAPSULE:mg	ORAL	12mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:ORAL:TABLET:mg	ORAL	7.14mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:RECTAL:SUPPOSITORY:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:TOPICAL:CREAM:%w/w	TOPICAL	0.02%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:TOPICAL:SYSTEM:mg	TOPICAL	0.04mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:BUCCAL:SYSTEM:mg	BUCCAL	1.1mg BUCCAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:GRANULE, EFFERVESCENT:mg	ORAL	30mg ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER:mg	ORAL	450mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR SOLUTION:mg	ORAL	233mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:SYRUP:mg/5ml	ORAL	0.63mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
30KYC7MIAI	ASPARTIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8P5F881OCY	BALSAM PERU:RECTAL:SUPPOSITORY:mg	RECTAL	100mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:INTRAUTERINE:SUPPOSITORY, EXTENDED RELEASE:mg	INTRAUTERINE	10mg INTRAUTERINE SUPPOSITORY, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:SUBCUTANEOUS:IMPLANT:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
98HPY76U4W	BEEF TALLOW:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	12.4mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:DENTAL:POWDER, DENTIFRICE:mg/mg	DENTAL	0.05mg/mg DENTAL POWDER, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:CAPSULE:ADJ PH	ORAL	ADJ PH ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:SUSPENSION:mg/5ml	ORAL	65mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:TABLET:mg	ORAL	355mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:TABLET, COATED:mg	ORAL	1.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:CREAM:%w/w	TOPICAL	4.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:LOTION:%w/w	TOPICAL	5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:POWDER:mg/mg	TOPICAL	0.67mg/mg TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	3.25%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	9.86mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:VAGINAL:SUPPOSITORY:mg	VAGINAL	288.1mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
TA269SD04T	BENZALDEHYDE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
TA269SD04T	BENZALDEHYDE:ORAL:SUSPENSION:mg/1ml	ORAL	0.6mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:AURICULAR (OTIC):SOLUTION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.01%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRALESIONAL:INJECTION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:LIQUID:mg/1ml	NASAL	0.2mg/1ml NASAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SOLUTION:mg/100ml	NASAL	40.46mg/100ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SPRAY, METERED:mg/1ml	NASAL	0.7mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	2%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.03%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.02%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.02%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.02%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:CLOTH:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:LOTION:%w/w	TOPICAL	0.1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.03%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.02%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SOLUTION/ DROPS:%w/v	TOPICAL	0.01%w/v TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SUSPENSION/ DROPS:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:INTRAVENOUS:LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.02%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	0.5mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	0.02%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
U3RSY48JW5	BENZOCAINE:TOPICAL:OINTMENT:%w/w	TOPICAL	1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
IRY12B2TQ6	BENZODODECINIUM BROMIDE:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:BUCCAL:MOUTHWASH:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	5%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.2%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:IRRIGATION:SOLUTION:%w/v	IRRIGATION	0.02%w/v IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:CONCENTRATE:mg/5ml	ORAL	12.5mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:ELIXIR:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:LIQUID:mg/1ml	ORAL	2mg/1ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SUSPENSION:mg	ORAL	15mg ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:RECTAL:GEL:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:RECTAL:SUSPENSION:%w/w	RECTAL	0.1%w/w RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:GEL:%w/w	TOPICAL	0.1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:LOTION:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	0.1%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	0.1%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:CREAM:%w/w	VAGINAL	0.25%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:SUPPOSITORY:mg	VAGINAL	2mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
GK21SBA74R	BENZOIN RESIN:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
L7J6A1NE81	BENZOIN, (+/-)-:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
L7J6A1NE81	BENZOIN, (+/-)-:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.9%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ENDOTRACHEAL:INJECTION:	ENDOTRACHEAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:EPIDURAL:INJECTION:%w/v	EPIDURAL	1%w/v EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTERIAL:INJECTION:%w/v	INTRA-ARTERIAL	0.9%w/v INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTION, SOLUTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRABURSAL:INJECTION:%w/v	INTRABURSAL	1%w/v INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRACAVITARY:INJECTION:ml	INTRACAVITARY	0.01ml INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRACAVITARY:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRACAVITARY	8.4mg INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:INJECTION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, EMULSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	144mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	144mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	1.04%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:NASAL:SPRAY, METERED:mg/1ml	NASAL	5mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.23mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:SOLUTION:mg/1ml	ORAL	50mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:TABLET:mg	ORAL	1.06mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	2.31mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	1.25mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:RECTAL:GEL:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:RECTAL:SUPPOSITORY:mg	RECTAL	129mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SOFT TISSUE:INJECTION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCONJUNCTIVAL:INJECTION:	SUBCONJUNCTIVAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCUTANEOUS:INJECTION, EMULSION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.95%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:LOTION:%w/w	TOPICAL	2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:OINTMENT:%w/w	TOPICAL	2.2%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:SHAMPOO:%w/w	TOPICAL	1.25%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:SOLUTION:%w/w	TOPICAL	2%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	1%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:CREAM:%w/w	VAGINAL	1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
83H19HW7K6	BENZYL CHLORIDE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
01YAE03M7J	BETA CAROTENE:ORAL:EMULSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
01YAE03M7J	BETA CAROTENE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:ORAL:TABLET:mg	ORAL	133.33mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:ORAL:TABLET, FILM COATED:mg	ORAL	41.25mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
P2Z71CIK5H	BETANAPHTHOL:ORAL:CAPSULE:mg	ORAL	0.3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
M41L2IN55T	BISMUTH SUBCARBONATE:ORAL:TABLET:mg	ORAL	4.35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
M41L2IN55T	BISMUTH SUBCARBONATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.04mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
9755T40D11	BLACK CURRANT:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.05%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.6%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	7.36mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	0.53%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.32%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	1%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.3%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.5%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%w/w	OPHTHALMIC	0.3%w/w OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.3%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	1%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:EMULSION:%w/w	TOPICAL	1.3%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:SHAMPOO:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:SOLUTION:%w/v	TOPICAL	1.24%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:SUSPENSION/ DROPS:%w/v	TOPICAL	0.3%w/v TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:VAGINAL:JELLY:%w/w	VAGINAL	1%w/w VAGINAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1N032N7MFO	BROWN IRON OXIDE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1N032N7MFO	BROWN IRON OXIDE:ORAL:TABLET:mg	ORAL	0.79mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1N032N7MFO	BROWN IRON OXIDE:ORAL:TABLET, FILM COATED:mg	ORAL	0.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6LV4FOR43R	BUTANE:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6LV4FOR43R	BUTANE:TOPICAL:AEROSOL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6LV4FOR43R	BUTANE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	27%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:CAPSULE:mg	ORAL	0.02mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.01mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET:mg	ORAL	0.01mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.05mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:TOPICAL:SOLUTION:%w/w	TOPICAL	0.08%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:TOPICAL:SWAB:%w/w	TOPICAL	0.08%w/w TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
389H2R62BD	BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER (125000 MW):TOPICAL:SOLUTION:%w/w	TOPICAL	15%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
DJN2FGG8Z3	BUTYL METHACRYLATE AND METHYL METHACRYLATE COPOLYMER (3:1; 150000 MW):TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6Y0AI5605C	BUTYL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	3.68%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6Y0AI5605C	BUTYL STEARATE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:INTRAVENOUS:INJECTION, SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:NASAL:SOLUTION:mg/100ml	NASAL	20mg/100ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CAPSULE, GELATIN COATED:mg	ORAL	0.07mg ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CONCENTRATE:mg/1ml	ORAL	0.08mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:SYRUP:mg/5ml	ORAL	0.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET, FILM COATED:mg	ORAL	0.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:RECTAL:SUPPOSITORY:mg	RECTAL	0.21mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:SUBLINGUAL:FILM:mg	SUBLINGUAL	0.08mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:CREAM:%w/w	TOPICAL	5.2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.01%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:VAGINAL:CREAM:%w/w	VAGINAL	0.03%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:VAGINAL:OINTMENT:%w/w	VAGINAL	0.02%w/w VAGINAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:VAGINAL:SUPPOSITORY:mg	VAGINAL	1mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	0.02mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:INJECTION, SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:NASAL:SPRAY, METERED:mg/1ml	NASAL	0.1mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.1mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:FILM, SOLUBLE:mg	ORAL	0.06mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:SOLUTION:mg/1ml	ORAL	0.19mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	0.1mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.24mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, FOR SUSPENSION:mg	ORAL	0.1mg ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:RECTAL:SUPPOSITORY:mg	RECTAL	0.21mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.13mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:AEROSOL:%w/w	TOPICAL	0.1%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.1%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.2%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:GEL, METERED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.1%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SOAP:%w/w	TOPICAL	0.02%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.09%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.02%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SWAB:%w/w	TOPICAL	0.5%w/w TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.05%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:VAGINAL:CREAM:%w/w	VAGINAL	0.05%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3XUS85K0RA	BUTYLENE GLYCOL:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3XUS85K0RA	BUTYLENE GLYCOL:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	8.12mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.02%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SYRUP:mg/1ml	ORAL	28.4mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, COATED:mg	ORAL	0.08mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.01mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:RECTAL:SOLUTION:%w/v	RECTAL	0.01%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:CREAM:%w/w	TOPICAL	0.4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:LIQUID:%w/w	TOPICAL	0.02%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:OINTMENT:%w/w	TOPICAL	0.18%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
GC844VRD7E	C12-15 ALKYL LACTATE:TOPICAL:SOLUTION:%w/w	TOPICAL	10%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3G6A5W338E	CAFFEINE:NASAL:SPRAY, METERED:mg/1ml	NASAL	10mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3G6A5W338E	CAFFEINE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	2%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3G6A5W338E	CAFFEINE:ORAL:GRANULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SY7Q814VUP	CALCIUM:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SY7Q814VUP	CALCIUM:ORAL:TABLET:mg	ORAL	85.04mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:SOLUTION:mg/5ml	ORAL	3mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.38%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:DENTAL:POWDER, DENTIFRICE:mg/mg	DENTAL	0.5mg/mg DENTAL POWDER, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	4.02%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:CAPSULE:mg	ORAL	349.9mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	4mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, COATED:mg	ORAL	64.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	8.4mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	229.7mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:RESPIRATORY (INHALATION):SOLUTION:%w/v	RESPIRATORY (INHALATION)	4.02%w/v RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INFILTRATION:INJECTION:mg	INFILTRATION	0.33mg INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRA-ARTERIAL:INJECTION, SOLUTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	4%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.01%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAOCULAR:SOLUTION:mg	INTRAOCULAR	0.48mg INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAPERITONEAL:SOLUTION:%w/v	INTRAPERITONEAL	0.03%w/v INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRATHECAL:INJECTION, SOLUTION:	INTRATHECAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:%w/v	INTRAVENOUS	0.03%w/v INTRAVENOUS INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	4%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.05%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.02%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:ORAL:CONCENTRATE:mg/1ml	ORAL	0.08mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:RESPIRATORY (INHALATION):CAPSULE:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
OFM21057LP	CALCIUM CHLORIDE ANHYDROUS:INTRA-ARTERIAL:INJECTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
OFM21057LP	CALCIUM CHLORIDE ANHYDROUS:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
MLM29U2X85	CALCIUM CITRATE:ORAL:POWDER:mg	ORAL	429mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
MLM29U2X85	CALCIUM CITRATE:ORAL:TABLET:mg	ORAL	98.95mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
MLM29U2X85	CALCIUM CITRATE:ORAL:TABLET, FILM COATED:mg	ORAL	309mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	3.7mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:ORAL:SUSPENSION:ADJ PH	ORAL	ADJ PH ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:ORAL:TABLET:mg	ORAL	35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	45.93%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE:DENTAL:POWDER, DENTIFRICE:mg/mg	DENTAL	0.11mg/mg DENTAL POWDER, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE:ORAL:TABLET:mg	ORAL	183.94mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE:ORAL:TABLET, COATED:mg	ORAL	93.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	352.63mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE:ORAL:TABLET, FILM COATED:mg	ORAL	362mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
701EKV9RMN	CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET:mg	ORAL	17mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8F049NKY49	CALCIUM POLYCARBOPHIL:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
X69NU20D19	CALCIUM PYROPHOSPHATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	39%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
X69NU20D19	CALCIUM PYROPHOSPHATE:ORAL:TABLET:mg	ORAL	298.04mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6AP9J91K4V	CALCIUM SACCHARATE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.45%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6AP9J91K4V	CALCIUM SACCHARATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6AP9J91K4V	CALCIUM SACCHARATE:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET:mg	ORAL	146.13mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, COATED:mg	ORAL	155mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	15mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:BUCCAL:TABLET:mg	BUCCAL	1.42mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:CAPSULE:mg	ORAL	21.1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	91.9mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, COATED:mg	ORAL	12.2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, FILM COATED:mg	ORAL	16mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	14mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:CAPSULE:mg	ORAL	141.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.66mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:TABLET, COATED:mg	ORAL	170mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	127mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	235mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:CAPSULE:mg	ORAL	50mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	250mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	26.68mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, COATED:mg	ORAL	214.24mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	87.2mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	260mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1M6415C70M	CALDIAMIDE SODIUM:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.02%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5TJD82A1ET	CAMPHOR (SYNTHETIC):NASAL:JELLY:mg	NASAL	65mg NASAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5TJD82A1ET	CAMPHOR (SYNTHETIC):OPHTHALMIC:DROPS:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K304VI98I3	CANADA BALSAM:TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, FILM COATED:mg	ORAL	0.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.58mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
J4BY50FL78	CAPRYLIC/CAPRIC/SUCCINIC TRIGLYCERIDE:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
00BT03FSO2	CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
00BT03FSO2	CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
00BT03FSO2	CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8:ORAL:SOLUTION:mg/1ml	ORAL	61.2mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UW86K581WY	CAPSICUM OLEORESIN:ORAL:SYRUP:mg/5ml	ORAL	0.05mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
EOL5G26Q9F	CAPTAN:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	0.15%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:LIQUID:mg	ORAL	5.3mg ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SUSPENSION:mg/5ml	ORAL	111.12mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SYRUP:mg/5ml	ORAL	207mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:RECTAL:SOLUTION:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:TOPICAL:CREAM:%w/w	TOPICAL	0.26%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
71DD5V995L	CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:EMULSION:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
71DD5V995L	CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
71DD5V995L	CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:EMULSION:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	38.9mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.3%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1N11AG4X4L	CARBOMER COPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL, METERED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOMER HOMOPOLYMER:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	195mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOMER HOMOPOLYMER:TOPICAL:DISC:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOMER HOMOPOLYMER:TOPICAL:GEL:%w/w	TOPICAL	0.7%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOMER HOMOPOLYMER:TOPICAL:LOTION:%w/w	TOPICAL	0.53%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOMER HOMOPOLYMER:TOPICAL:SYSTEM:mg	TOPICAL	10mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.48%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:SUSPENSION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.45%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:%w/w	TOPICAL	0.3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:SUSPENSION/ DROPS:%w/v	TOPICAL	0.4%w/v TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):VAGINAL:GEL:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.45%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.4%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):RECTAL:ENEMA:%w/v	RECTAL	0.24%w/v RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:EMULSION:%w/w	TOPICAL	0.5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:GEL:%w/w	TOPICAL	0.95%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:GEL, METERED:%w/w	TOPICAL	1%w/w TOPICAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:OINTMENT:%w/w	TOPICAL	0.5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TRANSDERMAL:GEL, METERED:%w/w	TRANSDERMAL	1%w/w TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:GEL:%w/w	OPHTHALMIC	4%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:EMULSION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:OINTMENT, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:GEL, METERED:%w/w	TRANSDERMAL	1%w/w TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	5mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:DROPS:mg/1ml	ORAL	10mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:SUSPENSION:mg/5ml	ORAL	50.07mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:TABLET:mg	ORAL	45mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:VAGINAL:JELLY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	13.3mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET, FILM COATED:mg	ORAL	241.84mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:BUCCAL:TABLET:mg	BUCCAL	4mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:DENTAL:GEL:%w/w	DENTAL	0.4%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:DENTAL:PASTE:%w/w	DENTAL	16.63%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	1.2%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ENTERAL:SUSPENSION:	ENTERAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRA-ARTICULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRABURSAL:INJECTION:%w/v	INTRABURSAL	0.76%w/v INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.75%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAMUSCULAR:POWDER, FOR SUSPENSION:%w/v	INTRAMUSCULAR	0.7%w/v INTRAMUSCULAR POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	0.1%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.5%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:CAPSULE:mg	ORAL	160mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	4.2mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:GRANULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	15.63mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION/ DROPS:mg/2.5ml	ORAL	12.85mg/2.5ml ORAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SYRUP:mg	ORAL	26.5mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, CHEWABLE:mg	ORAL	24.75mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, COATED:mg	ORAL	3.2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, FILM COATED:mg	ORAL	50mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.75%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	16mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:TOPICAL:SOLUTION:%w/w	TOPICAL	0.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	0.2%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:VAGINAL:CREAM:%w/w	VAGINAL	0.75%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0F4M8SIS5K	CARBOXYMETHYLCELLULOSE SODIUM 12:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0F4M8SIS5K	CARBOXYMETHYLCELLULOSE SODIUM 12:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET:mg	ORAL	167.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, CHEWABLE:mg	ORAL	31.13mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, COATED:mg	ORAL	207.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	230mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	140mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:mg	ORAL	0.11mg ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:DENTAL:PASTE:%w/w	DENTAL	0.3%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:NASAL:POWDER:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	15mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:SUSPENSION:mg/5ml	ORAL	6mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:RESPIRATORY (INHALATION):POWDER:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	33mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C4SQ0541D	CARRAGEENAN CALCIUM:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7CY8BVL34N	CARRAGEENAN SODIUM:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:NASAL:GEL:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:NASAL:SPRAY:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	5%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:CAPSULE:mg	ORAL	1.04mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, COATED:mg	ORAL	0.9mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.01mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	23.27mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, FILM COATED:mg	ORAL	15.29mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.6mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:TOPICAL:OINTMENT:%w/w	TOPICAL	14.9%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:TOPICAL:SOLUTION:%w/w	TOPICAL	1.38%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	28.2mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	9.42mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, COATED:mg	ORAL	11.15mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	70mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, FILM COATED:mg	ORAL	15.6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET:mg	ORAL	27.39mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, CHEWABLE:mg	ORAL	6.86mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	44.6mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
44AIH82TSC	CELLULOSE, OXIDIZED:ORAL:TABLET:mg	ORAL	200mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
44AIH82TSC	CELLULOSE, OXIDIZED:ORAL:TABLET, COATED:mg	ORAL	20mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q1LS2UJO3A	CERESIN:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q1LS2UJO3A	CERESIN:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7V4MR24V5P	CETEARETH-12:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	5%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7V4MR24V5P	CETEARETH-12:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
867H4YOZ8Z	CETEARETH-15:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1R9DCZ5FOX	CETEARETH-30:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1R9DCZ5FOX	CETEARETH-30:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1R9DCZ5FOX	CETEARETH-30:TOPICAL:LOTION:%w/w	TOPICAL	2.3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9M64UO4C25	CETEARYL ETHYLHEXANOATE:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
LF9X1PN3XJ	CETETH-10:TOPICAL:LOTION:%w/w	TOPICAL	2.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7H8VAM7778	CETETH-2:TOPICAL:CREAM:%w/w	TOPICAL	2.59%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7H8VAM7778	CETETH-2:TOPICAL:LOTION:%w/w	TOPICAL	0.8%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:CREAM:%w/w	TOPICAL	6%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	4%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:LOTION:%w/w	TOPICAL	2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:SOLUTION:%w/w	TOPICAL	2%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:VAGINAL:TAMPON:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
495CTZ441V	CETETH-23:TOPICAL:CREAM:%w/w	TOPICAL	2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	9.43mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	62mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	8%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:OINTMENT:%w/w	TOPICAL	1.2%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:SPRAY:%w/w	TOPICAL	1%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.5%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:VAGINAL:CREAM:%w/w	VAGINAL	12%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	1%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, COATED:mg	ORAL	0.25mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	59mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:AEROSOL:%w/w	TOPICAL	1.16%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	4%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:OINTMENT:%w/w	TOPICAL	7%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.01%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	0.75%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:VAGINAL:CREAM:%w/w	VAGINAL	4%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:VAGINAL:SUPPOSITORY:mg	VAGINAL	0.03mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:CREAM:%w/w	TOPICAL	10.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:CREAM:%w/w	VAGINAL	3%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:CREAM:%w/w	TOPICAL	0.32%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:SOLUTION:%w/w	TOPICAL	0.05%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:VAGINAL:CREAM:%w/w	VAGINAL	3.3%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:ORAL:CAPSULE:mg	ORAL	1.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.02mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:RESPIRATORY (INHALATION):AEROSOL, METERED:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:RESPIRATORY (INHALATION):AEROSOL, SPRAY:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
BUC5I9595W	CHERRY:ORAL:TABLET:mg	ORAL	0.45mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
BUC5I9595W	CHERRY:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.57%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAMUSCULAR:SUSPENSION:mg	INTRAMUSCULAR	3.5mg INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NASAL:DROPS:mg	NASAL	500mg NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NASAL:SOLUTION:mg/1ml	NASAL	5.25mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.5%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	0.65%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1.1%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:PARENTERAL:INJECTION:%w/v	PARENTERAL	0.5%w/v PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:RESPIRATORY (INHALATION):INHALANT:mg	RESPIRATORY (INHALATION)	3mg RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	0.5%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.5%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.53%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:TOPICAL:LIQUID:%w/w	TOPICAL	0.5%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.53%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:TOPICAL:SOLUTION:%w/w	TOPICAL	0.3%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
36W53O7109	CHLOROCRESOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
36W53O7109	CHLOROCRESOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0F32U78V2Q	CHLOROXYLENOL:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.1%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0F32U78V2Q	CHLOROXYLENOL:TOPICAL:CREAM:%w/w	TOPICAL	0.15%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:EPIDURAL:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	EPIDURAL	0.33%w/v EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INFILTRATION:INJECTABLE, LIPOSOMAL:%w/v	INFILTRATION	0.47%w/v INFILTRATION INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTABLE, LIPOSOMAL:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	52mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	INTRAVENOUS	0.32%w/v INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:TOPICAL:LOTION:%w/w	TOPICAL	1.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:TOPICAL:OINTMENT:%w/w	TOPICAL	5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:VAGINAL:CREAM:%w/w	VAGINAL	0.3%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5UE7I54O43	CHOLETH-24:TOPICAL:EMULSION:%w/w	TOPICAL	5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
OQS23HUA1X	CHONDRUS CRISPUS:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SR60A3XG0F	CINNAMALDEHYDE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SR60A3XG0F	CINNAMALDEHYDE:ORAL:TABLET:mg	ORAL	2.1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5S29HWU6QB	CINNAMON:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5S29HWU6QB	CINNAMON:ORAL:ELIXIR:mg/5ml	ORAL	10.5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:DENTAL:PASTE, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:DENTAL:POWDER, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:ELIXIR:mg/5ml	ORAL	0.58mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:PASTILLE:mg	ORAL	4mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:SUSPENSION:mg/5ml	ORAL	0.2mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:SYRUP:mg/5ml	ORAL	0.05mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.2%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:AURICULAR (OTIC):SOLUTION/ DROPS:%w/w	AURICULAR (OTIC)	0.04%w/w AURICULAR (OTIC) SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:BUCCAL:SOLUTION:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:BUCCAL:TABLET:mg	BUCCAL	30mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:EPIDURAL:INJECTION:%w/v	EPIDURAL	0.02%w/v EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INFILTRATION:INJECTION:%w/v	INFILTRATION	0.02%w/v INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRA-ARTICULAR:INJECTION, SOLUTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRACARDIAC:INJECTION:%w/v	INTRACARDIAC	1.05%w/v INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:SOLUTION:%w/v	INTRAMUSCULAR	0.05%w/v INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAOCULAR	0.03%w/v INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAOCULAR:SOLUTION:	INTRAOCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	2068mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:POWDER, FOR SOLUTION:%w/v	INTRAVENOUS	0.09%w/v INTRAVENOUS POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:SOLUTION, CONCENTRATE:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IONTOPHORESIS:SOLUTION:%w/v	IONTOPHORESIS	0.02%w/v IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	0.2mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IRRIGATION:INJECTION, SOLUTION, CONCENTRATE:%w/v	IRRIGATION	0.03%w/v IRRIGATION INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SOLUTION:mg/1ml	NASAL	2.8mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.03%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CONCENTRATE:mg/1ml	ORAL	5.3mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:ELIXIR:mg/5ml	ORAL	100mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:LOZENGE:mg	ORAL	9.8mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, EXTENDED RELEASE:mg	ORAL	140.8mg ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SYRUP:mg/5ml	ORAL	722mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET:mg	ORAL	914mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, CHEWABLE:mg	ORAL	7mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	1mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, EFFERVESCENT:mg	ORAL	460mg ORAL TABLET, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	40mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TROCHE:mg	ORAL	12mg ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:PARENTERAL:INJECTION:	PARENTERAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:PERIDURAL:INJECTION:NA	PERIDURAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:PERINEURAL:INJECTION:%w/v	PERINEURAL	0.02%w/v PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RESPIRATORY (INHALATION):INHALANT:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	0.13%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RESPIRATORY (INHALATION):SOLUTION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RESPIRATORY (INHALATION):SUSPENSION:%w/v	RESPIRATORY (INHALATION)	0.03%w/v RESPIRATORY (INHALATION) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	1.26%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:AEROSOL:%w/w	TOPICAL	0.11%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.11%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.05%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:EMULSION:%w/w	TOPICAL	0.11%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:LOTION:%w/w	TOPICAL	0.85%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:POWDER, FOR SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SHAMPOO:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	0.25%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SOAP:%w/w	TOPICAL	0.5%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SOLUTION/ DROPS:%w/v	TOPICAL	0.01%w/v TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SWAB:%w/w	TOPICAL	0.05%w/w TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SYSTEM:mg	TOPICAL	0.2mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	1.38mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:VAGINAL:CREAM:%w/w	VAGINAL	0.49%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:VAGINAL:DOUCHE:%w/w	VAGINAL	0.07%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AJ56JP5TFP	CITRUS SINENSIS FLOWER OIL:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
578389D6D0	CLOVE OIL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	2.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
578389D6D0	CLOVE OIL:ORAL:ELIXIR:mg/5ml	ORAL	0.42mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
578389D6D0	CLOVE OIL:ORAL:SUSPENSION:mg/5ml	ORAL	0.1mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	3.5%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SOLUTION:%w/v	TOPICAL	2.5%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SPONGE:%w/w	TOPICAL	2%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SUSPENSION:%w/w	TOPICAL	4%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
C80684146D	COCO MONOETHANOLAMIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	4%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9108TZ9KG	COCOA:ORAL:SUSPENSION:mg/5ml	ORAL	246.66mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
512OYT1CRR	COCOA BUTTER:RECTAL:SUPPOSITORY:mg	RECTAL	2280mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
03DH2IZ3FY	COCO-BETAINE:TOPICAL:SHAMPOO:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
40U37V505D	COCONUT ACID:TOPICAL:SHAMPOO:%w/w	TOPICAL	3%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
40U37V505D	COCONUT ACID:TOPICAL:SOAP:%w/w	TOPICAL	7%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
40U37V505D	COCONUT ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	0.7%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	23.6%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:OINTMENT:%w/w	TOPICAL	14.75%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:SOAP:%w/w	TOPICAL	4.6%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:SOLUTION:%w/w	TOPICAL	15.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8D9H4QU99H	COCOYL CAPRYLOCAPRATE:TOPICAL:GEL:%w/w	TOPICAL	2.5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
JFH385Y744	COFFEE BEAN:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PQM9SA369U	COLA NUT:ORAL:CONCENTRATE:mg/1ml	ORAL	247.2mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PQM9SA369U	COLA NUT:ORAL:SOLUTION:ml/15ml	ORAL	0.3ml/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PQM9SA369U	COLA NUT:RECTAL:SOLUTION:%v/v	RECTAL	2%v/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	4.38mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7626GC95E5	CORIANDER OIL:ORAL:DROPS:mg/1ml	ORAL	0.15mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7626GC95E5	CORIANDER OIL:ORAL:ELIXIR:mg	ORAL	0.03mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7626GC95E5	CORIANDER OIL:ORAL:LIQUID:mg	ORAL	2.5mg ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1DAF35W3S2	CORN GLYCERIDES:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1DAF35W3S2	CORN GLYCERIDES:ORAL:SOLUTION:mg/1ml	ORAL	318.85mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:CAPSULE:mg	ORAL	918mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:SUSPENSION:ml/5ml	ORAL	2.5ml/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET, COATED:mg	ORAL	10mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.03mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.7mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:BUCCAL:TROCHE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	28.5mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:ELIXIR:mg/1ml	ORAL	400mg/1ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SOLUTION:mg/5ml	ORAL	750mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SUSPENSION:mg/5ml	ORAL	2500mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SUSPENSION, EXTENDED RELEASE:mg/5ml	ORAL	1500mg/5ml ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SYRUP:mg	ORAL	600mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:TABLET:mg	ORAL	14.07mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:TABLET, COATED:mg	ORAL	17mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:TROCHE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:NASAL:SPRAY, METERED:mg/0.1ml	NASAL	1.33mg/0.1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:ORAL:TABLET:mg	ORAL	0.16mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.5%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.8%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.8%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.8%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	0.8%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.8%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.5%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.2%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.8%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
029TFK992N	CROSCARMELLOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	1%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	65.6mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	11.25mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, DELAYED RELEASE PARTICLES:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	1.4mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	3%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	25.1mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:GRANULE, FOR SOLUTION:mg/120ml	ORAL	36.3mg/120ml ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:SUSPENSION, EXTENDED RELEASE:mg	ORAL	186.8mg ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:WAFER:mg	ORAL	97mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:SUBCUTANEOUS:PELLET:mg	SUBCUTANEOUS	2mg SUBCUTANEOUS PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TOPICAL:EMULSION:%w/w	TOPICAL	1%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:FILM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	1%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:VAGINAL:SUPPOSITORY:mg	VAGINAL	116.1mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
LRX7AJ16DT	CUPRIC SULFATE:AURICULAR (OTIC):SOLUTION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
LRX7AJ16DT	CUPRIC SULFATE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
P6YC3EG204	CYANOCOBALAMIN:ORAL:SOLUTION:mg/1000ml	ORAL	60mg/1000ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	5.26%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:CREAM:%w/w	TOPICAL	13%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	7.6%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:SOLUTION:%w/v	TOPICAL	11.57%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0THT5PCI0R	CYCLOMETHICONE 5:TOPICAL:AEROSOL:%w/w	TOPICAL	2.5%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0THT5PCI0R	CYCLOMETHICONE 5:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0THT5PCI0R	CYCLOMETHICONE 5:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K848JZ4886	CYSTEINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.02%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K848JZ4886	CYSTEINE:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	0.01%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	1.5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	1mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
A9U1687S1S	CYSTEINE HYDROCHLORIDE ANHYDROUS:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:TABLET:mg	ORAL	0.03mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.09%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:CAPSULE:mg	ORAL	0.02mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.38mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	1.67mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	1.43mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:CAPSULE:mg	ORAL	1.31mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.54mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, COATED PELLETS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.2mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	0.7mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:TOPICAL:AEROSOL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:CAPSULE:mg	ORAL	0.1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, COATED:mg	ORAL	1.16mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.22mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, FILM COATED:mg	ORAL	0.26mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:DENTAL:SOLUTION:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.01mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CONCENTRATE:mg/1ml	ORAL	0.02mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:ELIXIR:mg/5ml	ORAL	27.5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SUSPENSION:mg/5ml	ORAL	0.13mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SYRUP:mg	ORAL	0.1mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:TABLET:mg	ORAL	0.24mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:TOPICAL:SHAMPOO:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OE8ZA0KN9Z	D&C RED NO. 36:ORAL:TABLET:mg	ORAL	48.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
K4XZD9W99K	D&C RED NO. 6 BARIUM LAKE:ORAL:TABLET:mg	ORAL	0.38mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:mg	ORAL	0.4mg ORAL TABLET, CHEWABLE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.01mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:DENTAL:GEL:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:DENTAL:PASTE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE:mg	ORAL	20mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.01mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	1.51mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CONCENTRATE:mg/1ml	ORAL	0.03mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:ELIXIR:mg/15ml	ORAL	0.3mg/15ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:GUM, CHEWING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:POWDER:mg	ORAL	6mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET:mg	ORAL	80mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, COATED:mg	ORAL	2.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	1.9mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, FILM COATED:mg	ORAL	120mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:RECTAL:SOLUTION:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:RECTAL:SUPPOSITORY:mg	RECTAL	0.11mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.23mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:GEL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:SHAMPOO:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:SOAP:%w/w	TOPICAL	1.4%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:CAPSULE:mg	ORAL	1.2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.3mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.24mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:SOLUTION:mg/5ml	ORAL	0.09mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, COATED:mg	ORAL	3.68mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.05mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.8mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, FOR SUSPENSION:mg	ORAL	0.13mg ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	2.08mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.18mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CQ3XH3DET6	D&C YELLOW NO. 10 ALUMINUM LAKE:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2KAG279R6R	DEHYDROACETIC ACID:TOPICAL:LOTION:%w/w	TOPICAL	0.1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2KAG279R6R	DEHYDROACETIC ACID:TOPICAL:SHAMPOO:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4YK5Z54AT2	DENATONIUM BENZOATE:TOPICAL:GEL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4YK5Z54AT2	DENATONIUM BENZOATE:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4YK5Z54AT2	DENATONIUM BENZOATE:TOPICAL:SWAB:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
JC2Q67KRW7	DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
K3R6ZDH4DU	DEXTRAN 40:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	300mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:LOZENGE:mg	ORAL	598.8mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:TRANSMUCOSAL:LOZENGE:mg	TRANSMUCOSAL	1840mg TRANSMUCOSAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:BUCCAL:LOZENGE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	5%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	1600mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRASPINAL:INJECTION:mg	INTRASPINAL	75mg INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRATHECAL:INJECTION, SOLUTION:	INTRATHECAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	1450mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAVENOUS:INJECTION, SOLUTION:mg	INTRAVENOUS	51.7mg INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAVENOUS:POWDER, FOR SOLUTION:%w/v	INTRAVENOUS	5.02%w/v INTRAVENOUS POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	5.05%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:NASAL:SPRAY, METERED:mg	NASAL	50mg NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:CONCENTRATE:mg	ORAL	400mg ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:PASTILLE:mg	ORAL	826mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:SOLUTION:mg/5ml	ORAL	2489mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:SYRUP:mg	ORAL	620mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:TABLET:mg	ORAL	183.66mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:TABLET, CHEWABLE:mg	ORAL	642.76mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:TABLET, COATED:mg	ORAL	132mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	103.95mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:ORAL:TROCHE:mg	ORAL	903.5mg ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	115.78mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE:VAGINAL:POWDER:mg	VAGINAL	430mg VAGINAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAMUSCULAR:INJECTION, EMULSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:SUBCUTANEOUS:INJECTION, EMULSION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:SOLUTION:mg/1ml	ORAL	240mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, COATED:mg	ORAL	0.63mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2.48mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, FILM COATED:mg	ORAL	12mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:CAPSULE:mg	ORAL	3.4mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	5mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET:mg	ORAL	88mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET, CHEWABLE:mg	ORAL	2mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET, COATED:mg	ORAL	7.2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:TOPICAL:SOAP:%w/w	TOPICAL	0.27%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:URETERAL:SOLUTION:ADJ PH	URETERAL	ADJ PH URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:CREAM:%w/w	TOPICAL	0.25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:OINTMENT:%w/w	TOPICAL	0.1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	51%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:CAPSULE:mg	ORAL	400mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, CHEWABLE:mg	ORAL	53mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, COATED:mg	ORAL	488.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	258.45mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.6%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.6%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:CAPSULE:mg	ORAL	30mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:SYRUP:mg/5ml	ORAL	22mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	13.6mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:GRANULE, DELAYED RELEASE:mg	ORAL	43.2mg ORAL GRANULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1NKX3648J9	DICHLOROBENZYL ALCOHOL:TOPICAL:CREAM:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:INTRAPLEURAL:AEROSOL, METERED:%w/v	INTRAPLEURAL	26%w/v INTRAPLEURAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:NASAL:AEROSOL, METERED:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:RECTAL:AEROSOL, METERED:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	98.7%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	31.8%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	8%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:AEROSOL, POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:AEROSOL, SPRAY:%w/w	TOPICAL	26%w/w TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	20%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:RECTAL:AEROSOL, METERED:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	51.12%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	67.2%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:TOPICAL:AEROSOL, FOAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	85%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:VAGINAL:AEROSOL, SPRAY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
AZE05TDV2V	DIETHANOLAMINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	1.5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
AZE05TDV2V	DIETHANOLAMINE:TOPICAL:CREAM:%w/w	TOPICAL	0.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	6.8mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	12mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, COATED:mg	ORAL	2.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
I41B9FJK6V	DIETHYL SEBACATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
I41B9FJK6V	DIETHYL SEBACATE:TOPICAL:SOLUTION:%w/w	TOPICAL	24%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
94YQ11Y95F	DIETHYLENE GLYCOL MONO AND DIPALMITOSTEARATE:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:OINTMENT:%w/w	TOPICAL	5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	5%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
DO250MG0W6	DIHYDROXYALUMINUM AMINOACETATE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
DO250MG0W6	DIHYDROXYALUMINUM AMINOACETATE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
84H8Z9550J	DIHYDROXYALUMINUM SODIUM CARBONATE:ORAL:TABLET:mg	ORAL	7.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
84H8Z9550J	DIHYDROXYALUMINUM SODIUM CARBONATE:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:GEL:%w/w	TOPICAL	1.5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:SOLUTION:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	5%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:SOLUTION:%w/v	TOPICAL	10.88%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	1.5%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
3LH1P5MUK0	DIISOPROPYLBENZOTHIAZYL-2-SULFENAMIDE:ORAL:TABLET:mg	ORAL	105mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
3LH1P5MUK0	DIISOPROPYLBENZOTHIAZYL-2-SULFENAMIDE:ORAL:TABLET, CHEWABLE:mg	ORAL	151.98mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
RO266O364U	DIMETHICONE 100:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
RO266O364U	DIMETHICONE 100:TOPICAL:GEL:%w/w	TOPICAL	0.1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H8YMB5QY0D	DIMETHICONE 20:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:ORAL:CAPSULE:mg	ORAL	3.7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.11mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:CLOTH:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:SOLUTION:%w/w	TOPICAL	0.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	1.14mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	164mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	47.31mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
S0859MSI8I	DIMETHOXANE:TOPICAL:EMULSION:%w/w	TOPICAL	0.08%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
SA6A6V432S	DIMETHYL ISOSORBIDE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	5.44%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
SA6A6V432S	DIMETHYL ISOSORBIDE:TOPICAL:CREAM:%w/w	TOPICAL	15%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	104mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:TOPICAL:LOTION:%w/w	TOPICAL	45.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:CAPSULE:mg	ORAL	4.52mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, CHEWABLE:mg	ORAL	4.57mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
B5TNV5E10B	DINOSEB-AMMONIUM:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
VA9U6BR3SB	DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL-:INFILTRATION:INJECTABLE, LIPOSOMAL:%w/v	INFILTRATION	0.09%w/v INFILTRATION INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
VA9U6BR3SB	DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL-:INTRAVENOUS:INJECTION, SUSPENSION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:BUCCAL:SYSTEM:mg	BUCCAL	29.9mg BUCCAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CZ1032CEKR	DISODIUM CITRATE SESQUIHYDRATE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.18%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
18L9G3U51M	DISODIUM COCOAMPHODIACETATE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	5%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6FO62KCQ7A	DISODIUM HYDROGEN CITRATE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.09%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
D6DH1DTN7E	DISODIUM LAURETH SULFOSUCCINATE:TOPICAL:GEL:%w/w	TOPICAL	0.04%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
D6DH1DTN7E	DISODIUM LAURETH SULFOSUCCINATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	15%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P160Q81342	DISODIUM LAURYL SULFOSUCCINATE:TOPICAL:GEL:%w/w	TOPICAL	0.04%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P160Q81342	DISODIUM LAURYL SULFOSUCCINATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	15%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
EAG959U971	DISTEAROYLPHOSPHATIDYLCHOLINE, DL-:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:%w/v	INTRAVENOUS	2.27%w/v INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
EAG959U971	DISTEAROYLPHOSPHATIDYLCHOLINE, DL-:INTRAVENOUS:INJECTION, SUSPENSION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4271ZA8WXO	DISTEAROYLPHOSPHATIDYLGLYCEROL, DL-:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:%w/v	INTRAVENOUS	0.66%w/v INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
WE369X5600	DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID:ENDOSINUSIAL:IMPLANT:mg	ENDOSINUSIAL	1.35mg ENDOSINUSIAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
WE369X5600	DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID:INTRAVITREAL:IMPLANT:mg	INTRAVITREAL	116mg INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
WE369X5600	DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID:INTRAVITREAL:INJECTION:mg	INTRAVITREAL	116mg INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
WE369X5600	DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
58X445TH30	DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
58X445TH30	DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
BYR0546TOW	DMDM HYDANTOIN:TOPICAL:LOTION:%w/w	TOPICAL	0.4%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9G1OE216XY	DOCOSANOL:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	1.1%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9G1OE216XY	DOCOSANOL:TOPICAL:SOLUTION:%w/w	TOPICAL	1.1%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.02%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:CAPSULE:mg	ORAL	8.2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:SUSPENSION, EXTENDED RELEASE:mg	ORAL	0.77mg ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET, COATED:mg	ORAL	1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:TOPICAL:GEL:%w/w	TOPICAL	0.3%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:TOPICAL:SHAMPOO:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:CAPSULE:mg	ORAL	85mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.14mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INFILTRATION:INJECTION, SOLUTION:%w/v	INFILTRATION	0.01%w/v INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRA-ARTERIAL:INJECTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRA-ARTERIAL:INJECTION, SOLUTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.05%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRATHECAL:INJECTION:mg	INTRATHECAL	2.16mg INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVASCULAR:INJECTION:mg	INTRAVASCULAR	100mg INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVASCULAR:INJECTION, SOLUTION:	INTRAVASCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVESICAL:SOLUTION:mg	INTRAVESICAL	0.11mg INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:CONCENTRATE:mg/1ml	ORAL	0.25mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:ELIXIR:mg/5ml	ORAL	5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:POWDER, FOR SOLUTION:mg	ORAL	0.22mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:TABLET, FILM COATED:mg	ORAL	0.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.78mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	5mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.06%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:TOPICAL:SOLUTION:%w/v	TOPICAL	0.01%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:URETHRAL:SOLUTION:%w/v	URETHRAL	0.01%w/v URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8U5D034955	EDETATE CALCIUM DISODIUM ANHYDROUS:INTRA-ARTERIAL:INJECTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8U5D034955	EDETATE CALCIUM DISODIUM ANHYDROUS:INTRAVASCULAR:INJECTION, SOLUTION:%w/v	INTRAVASCULAR	0.05%w/v INTRAVASCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8U5D034955	EDETATE CALCIUM DISODIUM ANHYDROUS:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	0.05%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.1%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.01%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INFILTRATION:INJECTION:mg	INFILTRATION	0.1mg INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.05%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRABURSAL:INJECTION:%w/v	INTRABURSAL	0.01%w/v INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRACARDIAC:INJECTION:	INTRACARDIAC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.05%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	10%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVASCULAR:INJECTION:mg	INTRAVASCULAR	0.48mg INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	10%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, EMULSION:mg	INTRAVENOUS	0.5mg INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	0.4mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	0.03%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	0.05%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	0.1mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:DROPS:mg/1ml	NASAL	0.1mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:LIQUID:mg/1ml	NASAL	2mg/1ml NASAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SOLUTION:mg/100ml	NASAL	100mg/100ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:DROPS:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.3%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:GEL:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.13%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.01%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:ELIXIR:mg/5ml	ORAL	1.3mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:LIQUID:mg/1ml	ORAL	0.5mg/1ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	3mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, COATED:mg	ORAL	0.21mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, FILM COATED:mg	ORAL	4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RECTAL:ENEMA:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RECTAL:SOLUTION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SOLUTION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SPRAY:%w/w	RESPIRATORY (INHALATION)	0.05%w/w RESPIRATORY (INHALATION) SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SUSPENSION:%w/v	RESPIRATORY (INHALATION)	0.01%w/v RESPIRATORY (INHALATION) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.05%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.05%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:EMULSION:%w/w	TOPICAL	0.11%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:OINTMENT:%w/w	TOPICAL	0.01%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SHAMPOO:%w/w	TOPICAL	1%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	1%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.06%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:VAGINAL:GEL:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.01%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:ORAL:SOLUTION:mg	ORAL	0.5mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:TOPICAL:CREAM:%w/w	TOPICAL	0.02%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:VAGINAL:CREAM:%w/w	VAGINAL	0.05%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.01%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.01%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.04%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:OPHTHALMIC:EMULSION:%w/w	OPHTHALMIC	0.02%w/w OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:ORAL:CAPSULE:mg	ORAL	1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:LOTION:%w/w	TOPICAL	0.17%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:SHAMPOO:%w/w	TOPICAL	1.33%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:SOAP:%w/w	TOPICAL	0.12%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:SOLUTION:%w/w	TOPICAL	0.3%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:SPONGE:%w/w	TOPICAL	0.14%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
420IP921MB	EDETATE TRISODIUM:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.02%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.02%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:ORAL:TABLET, FILM COATED:mg	ORAL	0.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:RECTAL:SUPPOSITORY:mg	RECTAL	1.7mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:SUBMUCOSAL:INJECTION, SOLUTION:%w/v	SUBMUCOSAL	0.03%w/v SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:CREAM:%w/w	TOPICAL	0.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:GEL:%w/w	TOPICAL	0.1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	0.5%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.06%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:EMULSION:%w/v	INTRAVENOUS	1.2%w/v INTRAVENOUS EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	1.8%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	48.75mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4HI65O1DUA	ENTSUFON:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6867H5FR4	ENTSUFON SODIUM:TOPICAL:EMULSION:%w/w	TOPICAL	40.3%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6867H5FR4	ENTSUFON SODIUM:TOPICAL:SHAMPOO:%w/w	TOPICAL	54%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6867H5FR4	ENTSUFON SODIUM:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
311332OII1	ERYTHORBIC ACID:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8TL7LH93FM	ERYTHROSINE SODIUM ANHYDROUS:ORAL:CAPSULE:mg	ORAL	0.01mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8TL7LH93FM	ERYTHROSINE SODIUM ANHYDROUS:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	382.26mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:TOPICAL:SOLUTION:%w/w	TOPICAL	31%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	0.05mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
XRK36F13ZZ	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 600000 MW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	27.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE, COATED PELLETS:mg	ORAL	93.36mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	187.3mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, COATED:mg	ORAL	66mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	96.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	30mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NT5GK8OOD	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NT5GK8OOD	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NT5GK8OOD	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
UFD2LZ005D	ETHYL BUTYRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
UFD2LZ005D	ETHYL BUTYRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:ELIXIR:mg/15ml	ORAL	0.6mg/15ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:POWDER, FOR SUSPENSION:mg/140ml	ORAL	10mg/140ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6995S49749	ETHYL MYRISTATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	1%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Z2Z439864Y	ETHYL OLEATE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Z2Z439864Y	ETHYL OLEATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	15mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V38JK4Z93O	ETHYL VANILLATE:ORAL:CAPSULE:mg	ORAL	0.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:CAPSULE:mg	ORAL	0.64mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:SUSPENSION:mg/5ml	ORAL	0.08mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:TABLET, CHEWABLE:mg	ORAL	0.14mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:CAPSULE:mg	ORAL	12.32mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET, COATED:mg	ORAL	20mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	53.8mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET, FILM COATED:mg	ORAL	83mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	52.5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	17.46mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:CAPSULE:mg	ORAL	39.39mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	35.28mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	80.4mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
47MLB0F1MV	ETHYLCELLULOSE (100 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
47MLB0F1MV	ETHYLCELLULOSE (100 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:CAPSULE:mg	ORAL	32.2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:CAPSULE, COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:GRANULE:mg	ORAL	0.01mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6I475159RA	ETHYLCELLULOSE (50 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6I475159RA	ETHYLCELLULOSE (50 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6I475159RA	ETHYLCELLULOSE (50 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6I475159RA	ETHYLCELLULOSE (50 MPA.S):TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:CAPSULE:mg	ORAL	62.13mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MX37N1DUF3	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MX37N1DUF3	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MX37N1DUF3	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A:ORAL:TABLET:mg	ORAL	12.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MX37N1DUF3	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MX37N1DUF3	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:CAPSULE:mg	ORAL	11.1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
HZJ2V81RYU	ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
91GW059KN7	ETHYLENE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
FC72KVT52F	ETHYLENE GLYCOL:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	1%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
IDK7C2HS09	ETHYLENE GLYCOL MONOETHYL ETHER:ORAL:CAPSULE:mg	ORAL	0.01mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
JJH7GNN18P	ETHYLENE OXIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	2.7%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
60V9STC53F	ETHYLENEDIAMINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.39%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
60V9STC53F	ETHYLENEDIAMINE:ORAL:SOLUTION:mg/5ml	ORAL	18.5mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
60V9STC53F	ETHYLENEDIAMINE:TOPICAL:CREAM:%w/w	TOPICAL	0.18%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
91WQV43244	ETHYLENEDIAMINE DIHYDROCHLORIDE:TOPICAL:CREAM:%w/w	TOPICAL	0.25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8ILA5X28VS	ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE):SUBCUTANEOUS:IMPLANT:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8ILA5X28VS	ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE):VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8ILA5X28VS	ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE):VAGINAL:RING:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4OKC630HS6	ETHYLENE-VINYL ACETATE COPOLYMER (9% VINYLACETATE):VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4OKC630HS6	ETHYLENE-VINYL ACETATE COPOLYMER (9% VINYLACETATE):VAGINAL:RING:mg	VAGINAL	250.1mg VAGINAL RING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
B7I80BVV5E	ETHYLHEXYL HYDROXYSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	12%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:GRANULE, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Z0D00IVA10	ETHYLPARABEN SODIUM:ORAL:CAPSULE:mg	ORAL	1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	2.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:DENTAL:SOLUTION:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:NASAL:DROPS:mg/1ml	NASAL	0.2mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:NASAL:JELLY:mg	NASAL	68.5mg NASAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:NASAL:SOLUTION:mg/1ml	NASAL	0.2mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.02%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
RV6J6604TK	EUCALYPTOL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
2R04ONI662	EUCALYPTUS OIL:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
08F8S9O3I5	EXT. D&C YELLOW NO. 7:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.3mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
08F8S9O3I5	EXT. D&C YELLOW NO. 7:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3R47K3TBD	FD&C BLUE NO. 1:BUCCAL:CONCENTRATE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:BUCCAL:MOUTHWASH:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:DENTAL:PASTE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:DENTAL:PASTE, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:DENTAL:SOLUTION:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE:mg	ORAL	26.3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, COATED PELLETS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, DELAYED RELEASE PELLETS:mg	ORAL	0.01mg ORAL CAPSULE, DELAYED RELEASE PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.06mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:FILM, SOLUBLE:mg	ORAL	0.04mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	0.04mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	1mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SOLUTION:mg/15ml	ORAL	1.13mg/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SYRUP:mg/5ml	ORAL	0.05mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET:mg	ORAL	27.53mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, COATED:mg	ORAL	0.52mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.04mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, FILM COATED:mg	ORAL	0.16mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:RECTAL:SOLUTION:%w/v	RECTAL	0.01%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:SUBLINGUAL:FILM:mg	SUBLINGUAL	0.07mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.03mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:CREAM:%w/w	TOPICAL	0.01%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:LIQUID:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.75%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SOAP:%w/w	TOPICAL	0.01%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SOLUTION:%w/w	TOPICAL	0.01%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:VAGINAL:DOUCHE:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:CAPSULE:mg	ORAL	0.38mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	4mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.02mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:SYRUP:mg	ORAL	0.01mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET, COATED:mg	ORAL	0.14mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.03mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:mg	ORAL	8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1 ALUMINUM LAKE:TOPICAL:SOAP:%w/w	TOPICAL	0.01%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:BUCCAL:TABLET:mg	BUCCAL	0.01mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.22mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, COATED:mg	ORAL	24.12mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.2mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2.78mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	3.5mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.05mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, COATED:mg	ORAL	0.75mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.48mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:ORAL:TROCHE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2 ALUMINUM LAKE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:DENTAL:GEL:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE:mg	ORAL	40mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, COATED PELLETS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.16mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.02mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:SOLUTION:mg/5ml	ORAL	0.25mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:SYRUP:mg/5ml	ORAL	3.75mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:TABLET, COATED:mg	ORAL	0.01mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:RECTAL:SUPPOSITORY:mg	RECTAL	0.02mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.09%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE:mg	ORAL	11.69mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.09mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.39mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:ELIXIR:mg/5ml	ORAL	0.04mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	0.75mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:SUSPENSION:mg/5ml	ORAL	1mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:SUSPENSION/ DROPS:mg/2.5ml	ORAL	0.13mg/2.5ml ORAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:SYRUP:mg/5ml	ORAL	0.15mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET:mg	ORAL	2.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, COATED:mg	ORAL	0.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.07mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, FILM COATED:mg	ORAL	0.02mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:BUCCAL:TABLET:mg	BUCCAL	0.01mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:DENTAL:SOLUTION:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, COATED PELLETS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, DELAYED RELEASE PELLETS:mg	ORAL	0.02mg ORAL CAPSULE, DELAYED RELEASE PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.34mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.07mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CONCENTRATE:mg/1ml	ORAL	0.04mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:ELIXIR:mg/5ml	ORAL	12.5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:LIQUID:mg/10ml	ORAL	0.06mg/10ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	0.33mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SUSPENSION:mg/5ml	ORAL	100mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, CHEWABLE:mg	ORAL	40mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, COATED:mg	ORAL	0.1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.45mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2.22mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, FILM COATED:mg	ORAL	2.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:SUBLINGUAL:TABLET:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:TOPICAL:SHAMPOO:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:BUCCAL:CONCENTRATE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:BUCCAL:LOZENGE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:BUCCAL:TABLET:mg	BUCCAL	0.11mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE:mg	ORAL	652mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.26mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:ELIXIR:mg	ORAL	0.15mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SOLUTION:mg/1ml	ORAL	1mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SYRUP:mg	ORAL	0.1mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET:mg	ORAL	180mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, CHEWABLE:mg	ORAL	4.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, COATED:mg	ORAL	7.93mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2.03mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, FILM COATED:mg	ORAL	1.68mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.76mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.11mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:OINTMENT:%w/w	TOPICAL	0.01%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:SOLUTION:%w/w	TOPICAL	0.06%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:VAGINAL:CREAM:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:CAPSULE:mg	ORAL	0.09mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	33mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:TABLET, CHEWABLE:mg	ORAL	1mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:TABLET, COATED:mg	ORAL	0.14mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:mg	ORAL	10mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	1.2mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
JQ6BLH9FR7	FD&C YELLOW NO. 5 ALUMINUM LAKE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.03mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	0.01mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:BUCCAL:TABLET:mg	BUCCAL	1mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, COATED:mg	ORAL	0.03mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, COATED PELLETS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.02mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	4.59mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	0.18mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CONCENTRATE:mg/5ml	ORAL	0.03mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:DROPS:mg/1ml	ORAL	0.2mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:ELIXIR:mg/5ml	ORAL	5.4mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:LIQUID:mg/1ml	ORAL	0.2mg/1ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER:mg	ORAL	20mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SOLUTION:mg/15ml	ORAL	75.3mg/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SUSPENSION, EXTENDED RELEASE:mg/5ml	ORAL	0.12mg/5ml ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SYRUP:mg/5ml	ORAL	4mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET:mg	ORAL	60.02mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, CHEWABLE:mg	ORAL	0.41mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, COATED:mg	ORAL	3.17mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, FILM COATED:mg	ORAL	1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:RECTAL:SOLUTION:%w/v	RECTAL	0.5%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:SUBLINGUAL:FILM:mg	SUBLINGUAL	0.03mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:GEL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:SOAP:%w/w	TOPICAL	0.2%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:SPONGE:%w/w	TOPICAL	0.01%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:BUCCAL:TABLET:mg	BUCCAL	0.4mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, COATED:mg	ORAL	0.12mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	2mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:SUSPENSION, EXTENDED RELEASE:mg	ORAL	2.7mg ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, COATED:mg	ORAL	1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	3.6mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	0.15mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:BUCCAL:FILM:mg	BUCCAL	0.27mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:BUCCAL:TABLET:mg	BUCCAL	1mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, COATED:mg	ORAL	0.01mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, FILM COATED:mg	ORAL	3.02mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.17mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	0.04mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, COATED:mg	ORAL	0.11mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.49mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET:mg	ORAL	3.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, FILM COATED:mg	ORAL	0.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	1.23mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
G7036X8B5H	FERROUS OXIDE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
G7036X8B5H	FERROUS OXIDE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
G7036X8B5H	FERROUS OXIDE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
T0H3L6C7I5	FORMALDEHYDE SOLUTION:TOPICAL:CREAM:%w/w	TOPICAL	0.28%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
T0H3L6C7I5	FORMALDEHYDE SOLUTION:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.25%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
T0H3L6C7I5	FORMALDEHYDE SOLUTION:TOPICAL:SOAP:%w/w	TOPICAL	0.1%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
T0H3L6C7I5	FORMALDEHYDE SOLUTION:TOPICAL:SOLUTION:%w/w	TOPICAL	0.2%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
0YIW783RG1	FORMIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	6%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	50mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	2625mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SUSPENSION:mg/1ml	ORAL	20mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SYRUP:mg/5ml	ORAL	1732.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:TABLET:mg	ORAL	64.92mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:RECTAL:SOLUTION:%w/v	RECTAL	0.67%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:POWDER, FOR SOLUTION:mg/1ml	ORAL	2mg/1ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:SYRUP:mg/5ml	ORAL	0.75mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
X2RN3Q8DNE	GALACTOSE:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
X2RN3Q8DNE	GALACTOSE:ORAL:SOLUTION:mg/15ml	ORAL	2200mg/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
X2RN3Q8DNE	GALACTOSE:ORAL:TABLET:mg	ORAL	0.67mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
X2RN3Q8DNE	GALACTOSE:RECTAL:SOLUTION:%w/v	RECTAL	14.67%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2C22T7DYYR	GALACTOSE MONOHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2C22T7DYYR	GALACTOSE MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	4.5mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:DENTAL:PASTE:%w/w	DENTAL	16.8%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRACAVITARY:INJECTION:ml	INTRACAVITARY	0.05ml INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	16%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	14mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAMUSCULAR:INJECTION, SUSPENSION:mg	INTRAMUSCULAR	1.3mg INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	14mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:INTRAVENOUS:SOLUTION:mg	INTRAVENOUS	34.8mg INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:NASAL:DROPS:mg/1ml	NASAL	50mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	65mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:PASTILLE:mg	ORAL	143mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:POWDER:mg	ORAL	100mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:SOLUTION:mg	ORAL	34.8mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, COATED:mg	ORAL	42.12mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	19mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:WAFER:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:PERIODONTAL:TABLET:mg	PERIODONTAL	3.44mg PERIODONTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:RESPIRATORY (INHALATION):CAPSULE:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	100mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	16%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	14mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:SUBLINGUAL:TABLET, ORALLY DISINTEGRATING:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
VP36V95O3T	GENTISIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
VP36V95O3T	GENTISIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
C5529G5JPQ	GINGER:ORAL:ELIXIR:mg/5ml	ORAL	10mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
C5529G5JPQ	GINGER:ORAL:SYRUP:ml/5ml	ORAL	0.05ml/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
3D49LE7HM2	GLUCEPTATE SODIUM:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	75mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
3D49LE7HM2	GLUCEPTATE SODIUM:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	200mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R4R8J0Q44B	GLUCONIC ACID:ORAL:TABLET, COATED:mg	ORAL	35.3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:TOPICAL:CLOTH:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:TOPICAL:SOLUTION:%w/w	TOPICAL	0.3%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:TOPICAL:SPONGE:ADJ PH	TOPICAL	ADJ PH TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
M0C2SP444T	GLUTAMIC ACID HYDROCHLORIDE:ORAL:TABLET:mg	ORAL	30mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
T3C89M417N	GLUTARAL:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.05%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	63.64%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:AURICULAR (OTIC):SOLUTION/ DROPS:	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:AURICULAR (OTIC):SUSPENSION:%w/w	AURICULAR (OTIC)	0.05%w/w AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	100mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:BUCCAL:SYSTEM:mg	BUCCAL	66mg BUCCAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:DENTAL:PASTE:%w/w	DENTAL	20%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	18%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:DENTAL:SOLUTION:%w/v	DENTAL	15%w/v DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRADERMAL:INJECTION:%w/v	INTRADERMAL	1.6%w/v INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	15%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:EMULSION:%w/v	INTRAVENOUS	2.2%w/v INTRAVENOUS EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	225mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	15%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	168.1mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:DROPS:mg/1ml	NASAL	10mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:SOLUTION:mg/1ml	NASAL	25mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:SPRAY:mg/1ml	NASAL	22.3mg/1ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	2.3%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.88%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	6%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	2.25%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	2.5%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	2.5%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, COATED:mg	ORAL	14.21mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	132.32mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, GELATIN COATED:mg	ORAL	3.37mg ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:DROPS:mg/1ml	ORAL	300mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:ELIXIR:mg/1ml	ORAL	500mg/1ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	200mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, COATED:mg	ORAL	1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, FILM COATED:mg	ORAL	1.55mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:PERIODONTAL:TABLET:mg	PERIODONTAL	0.53mg PERIODONTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:RECTAL:SUPPOSITORY:mg	RECTAL	128mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	5%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	15%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	1.6%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:AEROSOL:%w/w	TOPICAL	3%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2.11%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:CLOTH:mg/mg	TOPICAL	0.05mg/mg TOPICAL CLOTH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:JELLY:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:LIQUID:%w/w	TOPICAL	2.5%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SHAMPOO:%w/w	TOPICAL	5%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SOAP:%w/w	TOPICAL	0.76%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SPONGE:%w/w	TOPICAL	2%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SUSPENSION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	306.2mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:CREAM:%w/w	VAGINAL	5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:DOUCHE:%w/w	VAGINAL	1%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:JELLY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:SUPPOSITORY:mg	VAGINAL	227.9mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
258491E1RZ	GLYCERYL 1-STEARATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
258491E1RZ	GLYCERYL 1-STEARATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
258491E1RZ	GLYCERYL 1-STEARATE:TOPICAL:OINTMENT:%w/w	TOPICAL	3%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	3.5mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	0.08mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	5.6mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	39.2mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	4mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
HYE7O27HAO	GLYCERYL ISOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	2.7%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
HYE7O27HAO	GLYCERYL ISOSTEARATE:VAGINAL:CREAM:%w/w	VAGINAL	2.7%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Y98611C087	GLYCERYL LAURATE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Y98611C087	GLYCERYL LAURATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	2.48mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Y98611C087	GLYCERYL LAURATE:VAGINAL:SUPPOSITORY:mg	VAGINAL	300mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:CAPSULE:mg	ORAL	765mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:CAPSULE, GELATIN COATED:mg	ORAL	62.2mg ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	139mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:SOLUTION:mg/1ml	ORAL	30mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:TABLET:mg	ORAL	1.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:CAPSULE:mg	ORAL	400mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:SOLUTION:mg/1ml	ORAL	349.1mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
G7515SW10N	GLYCERYL MONOCAPRYLOCAPRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4987GT719I	GLYCERYL MONOCITRATE:TOPICAL:CREAM:%w/w	TOPICAL	0.05%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4763AXI84L	GLYCERYL MONOLINOLEATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
C4YAD5F5G6	GLYCERYL MONOOLEATE:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.5%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE:mg	ORAL	13.75mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	32.4mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:EMULSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET:mg	ORAL	33.34mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	264.3mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:RECTAL:SUPPOSITORY:mg	RECTAL	35mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.23mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	3.27%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:LIQUID:%w/w	TOPICAL	1%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:LOTION:%w/w	TOPICAL	9%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:OINTMENT:%w/w	TOPICAL	5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:SUSPENSION:%w/w	TOPICAL	1.25%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	3%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:VAGINAL:CREAM:%w/w	VAGINAL	17%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	3.5%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TOPICAL:GEL:%w/w	TOPICAL	1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TOPICAL:SPRAY:%w/w	TOPICAL	0.95%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	18.8mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
6Y2XJ05B35	GLYCERYL PALMITATE:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
6Y2XJ05B35	GLYCERYL PALMITATE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:INTRADERMAL:INJECTION:mg	INTRADERMAL	16mg INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:ORAL:SUSPENSION:mg/5ml	ORAL	150mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:ORAL:TABLET:mg	ORAL	18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:TOPICAL:AEROSOL:%w/w	TOPICAL	2.55%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	2.78%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:TOPICAL:EMULSION:%w/w	TOPICAL	2.55%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
ZUE0CEL42O	GLYCERYL RICINOLEATE:ORAL:TABLET:mg	ORAL	11.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
ZUE0CEL42O	GLYCERYL RICINOLEATE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	1%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
FCZ5MH785I	GLYCERYL STEARATE SE:TOPICAL:CREAM:%w/w	TOPICAL	4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
FCZ5MH785I	GLYCERYL STEARATE SE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
RD25J5V947	GLYCERYL STEARATE/PEG-100 STEARATE:ORAL:TABLET:mg	ORAL	1.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
RD25J5V947	GLYCERYL STEARATE/PEG-100 STEARATE:ORAL:TABLET, COATED:mg	ORAL	1.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
RD25J5V947	GLYCERYL STEARATE/PEG-100 STEARATE:RECTAL:SUPPOSITORY:mg	RECTAL	36mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
RD25J5V947	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
RD25J5V947	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	7.08%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
RD25J5V947	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:LOTION:%w/w	TOPICAL	6.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
P6OCJ2551R	GLYCERYL TRISTEARATE:ORAL:CAPSULE:mg	ORAL	225mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
P6OCJ2551R	GLYCERYL TRISTEARATE:ORAL:TABLET, CHEWABLE:mg	ORAL	2.3mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.34%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRADERMAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRADERMAL	0.5mg INTRADERMAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	40mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:%w/v	INTRAVENOUS	0.38%w/v INTRAVENOUS INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	200mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTION, EMULSION:mg	INTRAVENOUS	200mg INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	3.76mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	200mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.42%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:POWDER, FOR SOLUTION:mg	ORAL	0.09mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:SOLUTION:mg	ORAL	50mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:TABLET:mg	ORAL	163.31mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:TABLET, CHEWABLE:mg	ORAL	200mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:RESPIRATORY (INHALATION):POWDER:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	0.5mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	10mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
225ZLC74HX	GLYCINE HYDROCHLORIDE:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
225ZLC74HX	GLYCINE HYDROCHLORIDE:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.05%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
YHX98F77PB	GLYCOL CETEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
0324G66D0E	GLYCOL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
0324G66D0E	GLYCOL STEARATE:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	5%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
JQ9EK2H6BG	GRAPEFRUIT JUICE:ORAL:SYRUP:mg/5ml	ORAL	7.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:BUCCAL:TABLET:mg	BUCCAL	1.1mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.2%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:CAPSULE:mg	ORAL	3.3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	12.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:SUSPENSION:mg/5ml	ORAL	4.93mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, FILM COATED:mg	ORAL	35.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4L2574620F	GUINEA GREEN B:ORAL:TABLET:mg	ORAL	0.12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4L2574620F	GUINEA GREEN B:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NT00Y05A2V	HAMAMELIS VIRGINIANA TOP WATER:TOPICAL:CREAM:%w/w	TOPICAL	50.98%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8334LX7S21	HARD FAT:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8334LX7S21	HARD FAT:RECTAL:SUPPOSITORY:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:CREAM:%w/w	TOPICAL	12%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:OINTMENT:%w/w	TOPICAL	12%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:SOLUTION:%w/w	TOPICAL	0.3%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:DENTAL:PASTE:%w/w	DENTAL	4%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:CAPSULE:mg	ORAL	10mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	4.53mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET:mg	ORAL	50mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET, COATED:mg	ORAL	25mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.64mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:CREAM:%w/w	TOPICAL	54.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:GEL:%w/w	TOPICAL	26%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:LOTION:%w/w	TOPICAL	1.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:OINTMENT:%w/w	TOPICAL	94%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:PASTE:%w/w	TOPICAL	2.5%w/w TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:TAPE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TRANSDERMAL:SYSTEM:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:VAGINAL:JELLY:%w/w	VAGINAL	42.6%w/w VAGINAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	4.29mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.09%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	INTRAVENOUS	0.16%w/v INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:ORAL:CAPSULE:mg	ORAL	0.76mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:ORAL:SUSPENSION:mg/1ml	ORAL	5mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	3.88mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T44ZYB1BAV	HORNSTEDTIA COSTATA SEED:ORAL:ELIXIR:mg/5ml	ORAL	2.5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:INTRAVITREAL:INJECTION, SUSPENSION:	INTRAVITREAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:TOPICAL:LOTION:%w/w	TOPICAL	0.01%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.37%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.04%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:DENTAL:INJECTION:ADJ PH	DENTAL	ADJ PH DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:DENTAL:SOLUTION:ADJ PH	DENTAL	ADJ PH DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ENDOTRACHEAL:INJECTION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ENDOTRACHEAL:POWDER, FOR SUSPENSION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:INJECTION, SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EXTRACORPOREAL:INJECTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EXTRACORPOREAL:SOLUTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INFILTRATION:INJECTION:%w/v	INFILTRATION	0.37%w/v INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INFILTRATION:INJECTION, SOLUTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTERSTITIAL:INJECTION:ADJ PH	INTERSTITIAL	ADJ PH INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-AMNIOTIC:INJECTION:ADJ PH	INTRA-AMNIOTIC	ADJ PH INTRA-AMNIOTIC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:INJECTION, SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTICULAR:INJECTION, SUSPENSION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACARDIAC:INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACARDIAC:INJECTION, SOLUTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAUDAL:INJECTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAUDAL:INJECTION, SOLUTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAVITARY:INJECTION:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAVITARY:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRADERMAL:INJECTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRADERMAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRALESIONAL:INJECTION, SUSPENSION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, EMULSION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	1.1%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION, CONCENTRATE:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, SUSPENSION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:LIQUID:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:mg	INTRAMUSCULAR	5mg INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:ADJ PH	INTRAOCULAR	ADJ PH INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAOCULAR:SOLUTION:ADJ PH	INTRAOCULAR	ADJ PH INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAPERITONEAL:INJECTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAPERITONEAL:SOLUTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASPINAL:INJECTION:ADJ PH	INTRASPINAL	ADJ PH INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASYNOVIAL:INJECTION, SUSPENSION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:INJECTION, SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATUMOR:INJECTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATUMOR:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATYMPANIC:SUSPENSION:%w/w	INTRATYMPANIC	0.14%w/w INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVASCULAR:INJECTION, SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVASCULAR:SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTABLE, LIPOSOMAL:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, EMULSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:%w/v	INTRAVENOUS	0.18%w/v INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	4.17mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	160mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.7%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:POWDER:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:POWDER, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:SOLUTION:mg	INTRAVENOUS	18.25mg INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:SOLUTION, CONCENTRATE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVESICAL:INJECTION, SOLUTION:	INTRAVESICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVITREAL:INJECTION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVITREAL:INJECTION, SUSPENSION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IONTOPHORESIS:SOLUTION:ADJ PH	IONTOPHORESIS	ADJ PH IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:DROPS:ml	NASAL	10ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:LIQUID:ADJ PH	NASAL	ADJ PH NASAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SOLUTION:mg/100ml	NASAL	247mg/100ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SPRAY:ml	NASAL	10ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SPRAY, METERED:ADJ PH	NASAL	ADJ PH NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SUSPENSION:ADJ PH	NASAL	ADJ PH NASAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:EMULSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:GEL:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.31%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SUSPENSION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:CAPSULE, LIQUID FILLED:ADJ PH	ORAL	ADJ PH ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:CONCENTRATE:mg/1ml	ORAL	2.17mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:LIQUID:mg/1ml	ORAL	4.46mg/1ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SUSPENSION:mg	ORAL	100mg ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:ADJ PH	ORAL	ADJ PH ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SYRUP:mg/1ml	ORAL	2.03mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:TABLET:mg	ORAL	2.32mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:TABLET, FILM COATED:ADJ PH	ORAL	ADJ PH ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:INJECTION, SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PERIDURAL:INJECTION:ADJ PH	PERIDURAL	ADJ PH PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PERINEURAL:INJECTION:ADJ PH	PERINEURAL	ADJ PH PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RECTAL:SOLUTION:ADJ PH	RECTAL	ADJ PH RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.7%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	1.5%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):SOLUTION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):SPRAY:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RETROBULBAR:INJECTION:ADJ PH	RETROBULBAR	ADJ PH RETROBULBAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SOFT TISSUE:INJECTION, SUSPENSION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBARACHNOID:INJECTION, SOLUTION:ADJ PH	SUBARACHNOID	ADJ PH SUBARACHNOID INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCONJUNCTIVAL:INJECTION:ADJ PH	SUBCONJUNCTIVAL	ADJ PH SUBCONJUNCTIVAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, EMULSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.61%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION, CONCENTRATE:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, SUSPENSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SUSPENSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SUSPENSION, EXTENDED RELEASE:mg	SUBCUTANEOUS	5mg SUBCUTANEOUS SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBMUCOSAL:INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBMUCOSAL:INJECTION, SOLUTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:AEROSOL, FOAM:ADJ PH	TOPICAL	ADJ PH TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:CREAM:%w/w	TOPICAL	2.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:EMULSION:ADJ PH	TOPICAL	ADJ PH TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:GEL:%w/w	TOPICAL	0.5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:JELLY:ADJ PH	TOPICAL	ADJ PH TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:LOTION:ADJ PH	TOPICAL	ADJ PH TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SHAMPOO:%w/w	TOPICAL	4%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SOLUTION:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SOLUTION/ DROPS:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SPONGE:ADJ PH	TOPICAL	ADJ PH TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SUSPENSION/ DROPS:ADJ PH	TOPICAL	ADJ PH TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.02%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:URETERAL:SOLUTION:ADJ PH	URETERAL	ADJ PH URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:URETHRAL:INJECTION:ADJ PH	URETHRAL	ADJ PH URETHRAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:URETHRAL:SOLUTION:ADJ PH	URETHRAL	ADJ PH URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
BBX060AN9V	HYDROGEN PEROXIDE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
BBX060AN9V	HYDROGEN PEROXIDE:TOPICAL:SOLUTION:%w/w	TOPICAL	0.16%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
BBX060AN9V	HYDROGEN PEROXIDE:TOPICAL:SPONGE:%w/w	TOPICAL	0.2%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:CAPSULE:mg	ORAL	405mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	3.1mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	410.82mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.6mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:TOPICAL:LIQUID:%w/w	TOPICAL	0.24%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:TOPICAL:SUSPENSION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
JY81OXM1OM	HYDROGENATED COCONUT OIL:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:CAPSULE:mg	ORAL	21.78mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	58mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, COATED:mg	ORAL	0.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	4mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
257THB963H	HYDROGENATED PALM OIL:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.15%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	213mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:ORAL:TABLET:mg	ORAL	0.21mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:TOPICAL:CREAM:%w/w	TOPICAL	1.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:TABLET:mg	ORAL	13.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:TABLET, COATED:mg	ORAL	3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QHQ97HF0PY	HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QHQ97HF0PY	HYDROGENATED SOYBEAN PHOSPHATIDYLCHOLINE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	INTRAVENOUS	0.96%w/v INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
27F77DSJ5V	HYDROGENATED STARCH HYDROLYSATE:ORAL:SOLUTION:mg/1ml	ORAL	300mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
27F77DSJ5V	HYDROGENATED STARCH HYDROLYSATE:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.25%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.35%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:ORAL:SYRUP:mg/5ml	ORAL	7.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:ORAL:TABLET, CHEWABLE:mg	ORAL	11.8mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
T4V6TWG28D	HYDROXYETHYL CELLULOSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	20mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R33S7TK2EP	HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%):TOPICAL:SOLUTION:%w/v	TOPICAL	0.6%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:SYRUP:mg/5ml	ORAL	100mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	150mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:TABLET, FILM COATED:mg	ORAL	1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10.7mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):AURICULAR (OTIC):SUSPENSION:%w/w	AURICULAR (OTIC)	0.2%w/w AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):NASAL:SPRAY:mg/0.2ml	NASAL	0.1mg/0.2ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.25%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:SYRUP:mg/5ml	ORAL	2mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:TABLET:mg	ORAL	22.96mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:TABLET, CHEWABLE:mg	ORAL	5.9mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	85.5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):TOPICAL:GEL:%w/w	TOPICAL	1.75%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):TOPICAL:LOTION:%w/v	TOPICAL	0.2%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):TOPICAL:SOLUTION:%w/v	TOPICAL	0.21%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):TOPICAL:SUSPENSION:%w/w	TOPICAL	0.69%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
12VCE9HR9E	HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%):ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
12VCE9HR9E	HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
12VCE9HR9E	HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%):TOPICAL:SPRAY:%w/w	TOPICAL	0.05%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1.6%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.48%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):ORAL:CAPSULE:mg	ORAL	2.98mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):ORAL:SOLUTION:mg/1ml	ORAL	3.5mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	140mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZYD53NBL45	HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%):TOPICAL:SOLUTION:%w/v	TOPICAL	0.26%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
X70SE62ZAR	HYDROXYETHYL CELLULOSE (5000 MPA.S AT 1%):OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.52%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
X70SE62ZAR	HYDROXYETHYL CELLULOSE (5000 MPA.S AT 1%):TOPICAL:SOLUTION:%w/v	TOPICAL	0.52%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2Q40985DRM	HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%):ORAL:SOLUTION:mg/5ml	ORAL	22.5mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2Q40985DRM	HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%):ORAL:SYRUP:mg/5ml	ORAL	8mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2Q40985DRM	HYDROXYETHYL CELLULOSE (6500 MPA.S AT 2%):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZDN57Z154K	HYDROXYETHYL ETHYLCELLULOSE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.48%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZDN57Z154K	HYDROXYETHYL ETHYLCELLULOSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	40.63mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RWW266YE9I	HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RWW266YE9I	HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	0.6%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.6mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:TABLET, FILM COATED:mg	ORAL	30mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
P6BYU725IU	HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
P6BYU725IU	HYDROXYPROPYL .GAMMA.-CYCLODEXTRIN:TOPICAL:SOLUTION:%w/v	TOPICAL	1.5%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	20%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:ORAL:CAPSULE:mg	ORAL	0.6mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0A7M0N7SPE	HYDROXYPROPYL CELLULOSE (160000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0A7M0N7SPE	HYDROXYPROPYL CELLULOSE (160000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:CAPSULE, COATED PELLETS:mg	ORAL	41.4mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, COATED:mg	ORAL	13.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, FILM COATED:mg	ORAL	131.67mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	187.6mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	39.2mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):SUBLINGUAL:TABLET:mg	SUBLINGUAL	1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TOPICAL:LOTION, AUGMENTED:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TOPICAL:SOLUTION:%w/v	TOPICAL	0.1%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	19mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KZQ570MOA5	HYDROXYPROPYL CELLULOSE (20000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KZQ570MOA5	HYDROXYPROPYL CELLULOSE (20000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KZQ570MOA5	HYDROXYPROPYL CELLULOSE (20000 WAMW):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KZQ570MOA5	HYDROXYPROPYL CELLULOSE (20000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KZQ570MOA5	HYDROXYPROPYL CELLULOSE (20000 WAMW):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KZQ570MOA5	HYDROXYPROPYL CELLULOSE (20000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VQ8ZWO78F6	HYDROXYPROPYL CELLULOSE (430000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VQ8ZWO78F6	HYDROXYPROPYL CELLULOSE (430000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VQ8ZWO78F6	HYDROXYPROPYL CELLULOSE (430000 WAMW):TOPICAL:LOTION, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VQ8ZWO78F6	HYDROXYPROPYL CELLULOSE (430000 WAMW):TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8VAB711C5E	HYDROXYPROPYL CELLULOSE (45000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8VAB711C5E	HYDROXYPROPYL CELLULOSE (45000 WAMW):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8VAB711C5E	HYDROXYPROPYL CELLULOSE (45000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1L0RPI3ASP	HYDROXYPROPYL CELLULOSE (650000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0MGW7Q3QG4	HYMETELLOSE (50 MPA.S):ORAL:TABLET:mg	ORAL	24mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.5%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.12%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	3.32mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:GRANULE, DELAYED RELEASE:mg	ORAL	17.2mg ORAL GRANULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:GRANULE, FOR SUSPENSION:mg	ORAL	1.7mg ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	65mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:SOLUTION:mg/1ml	ORAL	3.7mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, CHEWABLE:mg	ORAL	11.8mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	221mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:RECTAL:GEL:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:TOPICAL:CREAM:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:TOPICAL:JELLY:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:TOPICAL:LOTION:%w/w	TOPICAL	0.1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:TOPICAL:SHAMPOO:%w/w	TOPICAL	3%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:TOPICAL:SOLUTION:%w/v	TOPICAL	4%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE:VAGINAL:INSERT:mg	VAGINAL	54.21mg VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):TOPICAL:LOTION:%w/w	TOPICAL	0.1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
L4RXU2VPD6	HYPROMELLOSE 2208 (1500 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:CAPSULE:mg	ORAL	80.25mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET:mg	ORAL	323.28mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
LJY3MA129D	HYPROMELLOSE 2208 (200000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
58779NIC8P	HYPROMELLOSE 2208 (4 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
58779NIC8P	HYPROMELLOSE 2208 (4 MPA.S):SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):TOPICAL:JELLY:%w/v	TOPICAL	2.3%w/v TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):TOPICAL:LOTION:%w/w	TOPICAL	0.1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):URETHRAL:JELLY:%w/v	URETHRAL	2.3%w/v URETHRAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6531BH494O	HYPROMELLOSE 2906 (4 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6531BH494O	HYPROMELLOSE 2906 (4 MPA.S):ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6531BH494O	HYPROMELLOSE 2906 (4 MPA.S):RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	45.67mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:GRANULE, DELAYED RELEASE:mg	ORAL	33.2mg ORAL GRANULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:TABLET:mg	ORAL	50mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
612E703ZUQ	HYPROMELLOSE 2906 (50 MPA.S):ORAL:TABLET:mg	ORAL	1.88mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
612E703ZUQ	HYPROMELLOSE 2906 (50 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0HO1H52958	HYPROMELLOSE 2910 (10000 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0HO1H52958	HYPROMELLOSE 2910 (10000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0HO1H52958	HYPROMELLOSE 2910 (10000 MPA.S):VAGINAL:GEL:%w/w	VAGINAL	3.5%w/w VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, COATED:mg	ORAL	7.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):OPHTHALMIC:GEL:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.6%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET:mg	ORAL	54mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, COATED:mg	ORAL	245mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, DELAYED RELEASE:mg	ORAL	127.29mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):TOPICAL:JELLY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):TOPICAL:SHAMPOO:%w/w	TOPICAL	1.2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):NASAL:POWDER:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):NASAL:SPRAY:mg/1ml	NASAL	1mg/1ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):NASAL:SPRAY, METERED:mg/1ml	NASAL	1mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):SUBLINGUAL:FILM:mg	SUBLINGUAL	4.68mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:FILM, SOLUBLE:mg	ORAL	33.5mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6N003M473W	HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6N003M473W	HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MPA.S):ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36BGF0E889	HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36BGF0E889	HYPROMELLOSE ACETATE SUCCINATE 12070923 (3 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
24P2YXD2PW	HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
24P2YXD2PW	HYPROMELLOSE ACETATE SUCCINATE 16070722 (3 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A7ZHS2RJ34	HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A7ZHS2RJ34	HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A7ZHS2RJ34	HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A7ZHS2RJ34	HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A7ZHS2RJ34	HYPROMELLOSE ACETATE SUCCINATE, UNSPECIFIED:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	29mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8LDD2V82F5	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8LDD2V82F5	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:CAPSULE:mg	ORAL	63.92mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2NX48Z0A9G	ICODEXTRIN:ORAL:TABLET:mg	ORAL	8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2NX48Z0A9G	ICODEXTRIN:ORAL:TABLET, COATED:mg	ORAL	10mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2NX48Z0A9G	ICODEXTRIN:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	9.25mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2NX48Z0A9G	ICODEXTRIN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2NX48Z0A9G	ICODEXTRIN:TOPICAL:CREAM:%w/w	TOPICAL	0.03%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2NX48Z0A9G	ICODEXTRIN:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2NX48Z0A9G	ICODEXTRIN:TOPICAL:SHAMPOO:%w/w	TOPICAL	5%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:CREAM:%w/w	TOPICAL	0.4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.4%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
D3741U8K7L	INDIGOTINDISULFONATE SODIUM:ORAL:CAPSULE:mg	ORAL	0.68mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
D3741U8K7L	INDIGOTINDISULFONATE SODIUM:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.04mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ED959S6ACY	INVERT SUGAR:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ED959S6ACY	INVERT SUGAR:ORAL:SOLUTION:ml/5ml	ORAL	3.06ml/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ED959S6ACY	INVERT SUGAR:ORAL:SYRUP:mg/5ml	ORAL	2560mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
E1UOL152H7	IRON:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:TOPICAL:AEROSOL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	18%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:TOPICAL:AEROSOL, SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
04Y7590D77	ISOLEUCINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.9%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
04Y7590D77	ISOLEUCINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.21%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
S870P55O2W	ISOMALT:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
S870P55O2W	ISOMALT:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
S870P55O2W	ISOMALT:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
S870P55O2W	ISOMALT:ORAL:TROCHE:mg	ORAL	1718.71mg ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
S870P55O2W	ISOMALT:SUBLINGUAL:POWDER:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:LOTION, AUGMENTED:%w/w	TOPICAL	30%w/w TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:OIL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SOLUTION:%w/v	TOPICAL	40%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SPONGE:%w/w	TOPICAL	4%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SWAB:%w/w	TOPICAL	43.9%w/w TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
C67IXB9Y7T	ISOPROPYL ISOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:AURICULAR (OTIC):OIL:%v/v	AURICULAR (OTIC)	3.85%v/v AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:AURICULAR (OTIC):SUSPENSION:%w/w	AURICULAR (OTIC)	0.02%w/w AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:AEROSOL:%w/w	TOPICAL	9.3%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:AEROSOL, SPRAY:%w/w	TOPICAL	6.89%w/w TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	8%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:GEL:%w/w	TOPICAL	10%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:LOTION:%w/w	TOPICAL	5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:OIL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:OINTMENT:%w/w	TOPICAL	35%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:FILM:mg	TRANSDERMAL	58.08mg TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	20.4mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:GEL, METERED:%w/w	TRANSDERMAL	1%w/w TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:VAGINAL:CREAM:%w/w	VAGINAL	1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:VAGINAL:SUPPOSITORY:mg	VAGINAL	0.01mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:AEROSOL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:AEROSOL, SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:GEL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:LOTION:%w/w	TOPICAL	5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TRANSDERMAL:FILM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	187.5mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
X33R8U0062	ISOSTEARIC ACID:TOPICAL:CREAM:%w/w	TOPICAL	25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
X33R8U0062	ISOSTEARIC ACID:TOPICAL:GEL:%w/w	TOPICAL	0.2%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
X33R8U0062	ISOSTEARIC ACID:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.5%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
VR5Y7PDT5W	ISOTONIC SODIUM CHLORIDE SOLUTION:EPIDURAL:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	EPIDURAL	0.57%w/v EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
VR5Y7PDT5W	ISOTONIC SODIUM CHLORIDE SOLUTION:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.6%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
VR5Y7PDT5W	ISOTONIC SODIUM CHLORIDE SOLUTION:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.9%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
VR5Y7PDT5W	ISOTONIC SODIUM CHLORIDE SOLUTION:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
24H4NWX5CO	KAOLIN:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	14.61mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	21mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:SYRUP:mg/1ml	ORAL	10mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET:mg	ORAL	150mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, COATED:mg	ORAL	52.44mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	18.5mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	66mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:TOPICAL:POWDER:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
73W9IQY50Q	KARAYA GUM:BUCCAL:SYSTEM:mg	BUCCAL	68.1mg BUCCAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
IDP0HWP8PJ	KOLLICOAT SR 30D:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
IDP0HWP8PJ	KOLLICOAT SR 30D:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	22.28mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
S34RY76LK6	KOLLIDON SR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
33X04XA5AT	LACTIC ACID:AURICULAR (OTIC):SOLUTION/ DROPS:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:INTRACARDIAC:INJECTION:%w/v	INTRACARDIAC	0.01%w/v INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	1.16%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:INTRAMUSCULAR:SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	44mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:ORAL:CONCENTRATE:mg/5ml	ORAL	50mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:ORAL:TABLET:ADJ PH	ORAL	ADJ PH ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:AEROSOL:%w/w	TOPICAL	1.05%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	1.05%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:LOTION:%w/w	TOPICAL	5.7%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:OINTMENT:ADJ PH	TOPICAL	ADJ PH TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	7.22%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.7%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:VAGINAL:CREAM:%w/w	VAGINAL	0.81%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:INTRAMUSCULAR:INJECTION, SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	5.64%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:ORAL:LIQUID:mg/5ml	ORAL	10mg/5ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:SUBCUTANEOUS:PELLET, IMPLANTABLE:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:TOPICAL:CREAM:ADJ PH	TOPICAL	ADJ PH TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:TOPICAL:SOLUTION:%w/w	TOPICAL	7.4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:VAGINAL:JELLY:%w/w	VAGINAL	3.1%w/w VAGINAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.4%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.3%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:TOPICAL:CREAM:%w/w	TOPICAL	0.01%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
UH2K6W1Y64	LACTITOL MONOHYDRATE:ORAL:CAPSULE:mg	ORAL	235mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
65R938S4DV	LACTOBIONIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
65R938S4DV	LACTOBIONIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:BUCCAL:TABLET:mg	BUCCAL	296.7mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:INTRACAVITARY:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRACAVITARY	193.8mg INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	203.5mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	133mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	203.5mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	133mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.45%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:CAPSULE:mg	ORAL	530mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	135.2mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	231.84mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	120mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	512.5mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:SOLUTION:mg/15ml	ORAL	1682mg/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET:mg	ORAL	2500mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, COATED:mg	ORAL	332.05mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, EFFERVESCENT:mg	ORAL	96.5mg ORAL TABLET, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	400mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, FILM COATED:mg	ORAL	590mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:RECTAL:SOLUTION:%w/v	RECTAL	8%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:RECTAL:TABLET:mg	RECTAL	20mg RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:RESPIRATORY (INHALATION):CAPSULE:mg	RESPIRATORY (INHALATION)	44.4mg RESPIRATORY (INHALATION) CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	90mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	133mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	675mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:VAGINAL:CREAM:%w/w	VAGINAL	3%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:VAGINAL:POWDER:mg	VAGINAL	430mg VAGINAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRACAVITARY:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRACAVITARY	47.5mg INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	900mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	750mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:%w/v	INTRAVENOUS	9.5%w/v INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	690mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	536.4mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:GRANULE, FOR SOLUTION:mg/120ml	ORAL	1691.8mg/120ml ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:INHALANT:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:RESPIRATORY (INHALATION):POWDER:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	49mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	107mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:VAGINAL:CREAM:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:NASAL:SPRAY:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	3%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:RECTAL:OINTMENT:%w/w	RECTAL	14%w/w RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:EMULSION:%w/w	TOPICAL	0.25%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:LOTION:%w/w	TOPICAL	1.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:OINTMENT:%w/w	TOPICAL	10%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:SHAMPOO:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:VAGINAL:CREAM:%w/w	VAGINAL	2%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	10%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:CREAM:%w/w	TOPICAL	6%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
OVV5IIJ58F	LANOLIN OIL:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	3%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
OVV5IIJ58F	LANOLIN OIL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1J05Z83K3M	LANOSTEROL:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
4F6FC4MI8W	LAURAMINE OXIDE:TOPICAL:SOLUTION:%w/v	TOPICAL	3.5%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
4F6FC4MI8W	LAURAMINE OXIDE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
D4D38LT1L5	LAURETH-2:TOPICAL:SHAMPOO:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:AEROSOL:%w/w	TOPICAL	0.45%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	1.08%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:EMULSION:%w/w	TOPICAL	0.45%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:CREAM:%w/w	TOPICAL	1.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:LOTION:%w/w	TOPICAL	1.3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:SOLUTION:%w/v	TOPICAL	5.22%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:EMULSION:%w/w	TOPICAL	15%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:LOTION:%w/v	TOPICAL	0.6%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	20%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	4%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SPONGE:%w/w	TOPICAL	5%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.48%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
KB1BQB7R06	LAURIC/MYRISTIC DIETHANOLOLAMIDE:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
KB1BQB7R06	LAURIC/MYRISTIC DIETHANOLOLAMIDE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
H5ZC52369M	LAUROYL PEG-32 GLYCERIDES:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
H5ZC52369M	LAUROYL PEG-32 GLYCERIDES:ORAL:TABLET:mg	ORAL	0.15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
G5SU0BFK7O	LAURYL LACTATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	12mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
DIQ16UC154	LAURYL SULFATE:ORAL:CAPSULE:mg	ORAL	0.15mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
DIQ16UC154	LAURYL SULFATE:ORAL:TABLET, FILM COATED:mg	ORAL	2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
ZBP1YXW0H8	LAVENDER OIL:NASAL:INHALANT:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
ZBP1YXW0H8	LAVENDER OIL:TOPICAL:GEL:%w/w	TOPICAL	0.1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:CAPSULE:mg	ORAL	20mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:TABLET, FILM COATED:mg	ORAL	0.33mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.1%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:VAGINAL:CREAM:%w/w	VAGINAL	1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL, COLD PRESSED:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.7%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL, COLD PRESSED:ORAL:CAPSULE:mg	ORAL	8.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL, COLD PRESSED:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL, COLD PRESSED:TOPICAL:GEL:%w/w	TOPICAL	0.05%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	1.1%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.27%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:ORAL:TABLET:mg	ORAL	4.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:SUBLINGUAL:SPRAY:mg/1ml	SUBLINGUAL	0.05mg/1ml SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:TOPICAL:LOTION:%w/w	TOPICAL	0.08%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
RYX5QG61EI	LEVULINIC ACID:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	16.5mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
RYX5QG61EI	LEVULINIC ACID:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	20mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K414AX1M5S	LIGHT GREEN CF YELLOWISH:ORAL:CAPSULE:mg	ORAL	40mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K414AX1M5S	LIGHT GREEN CF YELLOWISH:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3F7BHA64Z0	LIGHT GREEN SF YELLOWISH:ORAL:TABLET:mg	ORAL	0.05mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3F7BHA64Z0	LIGHT GREEN SF YELLOWISH:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.59mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:AURICULAR (OTIC):OIL:%v/v	AURICULAR (OTIC)	43.44%v/v AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:DENTAL:PASTE:%w/w	DENTAL	45.8%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:CAPSULE:mg	ORAL	0.8mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:PASTILLE:mg	ORAL	3.6mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET:mg	ORAL	7.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET, COATED:mg	ORAL	4.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET, FILM COATED:mg	ORAL	2.49mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	25%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:EMULSION:%w/w	TOPICAL	5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:OIL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:SOLUTION/ DROPS:%w/v	TOPICAL	36.95%w/v TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	162mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:VAGINAL:SUPPOSITORY:mg	VAGINAL	1464.9mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
C7X2M0VVNH	LIME (CALCIUM OXIDE):ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
C7X2M0VVNH	LIME (CALCIUM OXIDE):ORAL:SOLUTION, CONCENTRATE:ml/1ml	ORAL	0.1ml/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
UZH29XGA8G	LIME OIL, COLD PRESSED:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
UZH29XGA8G	LIME OIL, COLD PRESSED:SUBLINGUAL:TABLET:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GFD7C86Q1W	LIMONENE, (+)-:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GFD7C86Q1W	LIMONENE, (+)-:TOPICAL:GEL:%w/w	TOPICAL	0.5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GFD7C86Q1W	LIMONENE, (+)-:TOPICAL:LOTION:%v/v	TOPICAL	10%v/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6ZAE7X688J	LIQUID PETROLEUM:TOPICAL:LIQUID:%w/w	TOPICAL	5%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6ZAE7X688J	LIQUID PETROLEUM:TOPICAL:OINTMENT:%w/w	TOPICAL	97.48%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
V4716MY704	LOCUST BEAN GUM:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	74.25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BMJ7J4127K	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BMJ7J4127K	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BMJ7J4127K	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	40mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	16.25mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, DELAYED RELEASE PARTICLES:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, FILM COATED:mg	ORAL	50mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
U466TXA0AK	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL: 140000 MW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
R67D5N7LRS	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL; 120000 MW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
R67D5N7LRS	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K3Z4F929H6	LYSINE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K3Z4F929H6	LYSINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.61%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K3Z4F929H6	LYSINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.22%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
TTL6G7LIWZ	LYSINE ACETATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	7.56mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
TTL6G7LIWZ	LYSINE ACETATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.31%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
JNJ23Q2COM	LYSINE HYDROCHLORIDE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F7625B974U	LYSINE MONOHYDRATE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.8%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7LVU907546	MAGNESIUM ALUMINOMETASILICATE TYPE IA:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7LVU907546	MAGNESIUM ALUMINOMETASILICATE TYPE IA:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:CONCENTRATE:mg/5ml	ORAL	410mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	12.5mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:LIQUID:mg/5ml	ORAL	82mg/5ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:SUSPENSION:mg/5ml	ORAL	5000mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:SUSPENSION/ DROPS:mg/2.5ml	ORAL	4.15mg/2.5ml ORAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:SYRUP:mg/1ml	ORAL	100mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:TABLET:mg	ORAL	60mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:TABLET, CHEWABLE:mg	ORAL	12mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:CREAM:%w/w	TOPICAL	1.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	3%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:LOTION:%w/w	TOPICAL	1.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	1.25%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:VAGINAL:OINTMENT:%w/w	VAGINAL	5.39%w/w VAGINAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XLI9KNX1FT	MAGNESIUM ALUMINUM SILICATE TYPE IC:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
II0CAA4909	MAGNESIUM ALUMINUM SILICATE TYPE IIA:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE:mg	ORAL	22.4mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	22.4mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, CHEWABLE:mg	ORAL	100mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, COATED:mg	ORAL	28.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	250mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	11.22mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION:%w/w	AURICULAR (OTIC)	0.06%w/w AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAOCULAR:SOLUTION:mg	INTRAOCULAR	0.3mg INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAPERITONEAL:SOLUTION:%w/v	INTRAPERITONEAL	0.01%w/v INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRATHECAL:INJECTION, SOLUTION:	INTRATHECAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.03%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.01%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.03%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	6.7mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	0.01mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET, FILM COATED:mg	ORAL	43.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
77CBG3UN78	MAGNESIUM NITRATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
77CBG3UN78	MAGNESIUM NITRATE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	25.74mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:CAPSULE:mg	ORAL	40mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, CHEWABLE:mg	ORAL	30mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, COATED:mg	ORAL	29.03mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, FILM COATED:mg	ORAL	33.7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:WAFER:mg	ORAL	22mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:TOPICAL:SOAP:%w/w	TOPICAL	0.33%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:BUCCAL:TABLET:mg	BUCCAL	17.5mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INTRAVITREAL:IMPLANT:NA	INTRAVITREAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INTRAVITREAL:SYSTEM:mg	INTRAVITREAL	0.02mg INTRAVITREAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE:mg	ORAL	256.4mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.15mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:INHALANT:mg	ORAL	0.08mg ORAL INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	32.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:SUSPENSION:mg/5ml	ORAL	57.56mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:WAFER:mg	ORAL	66mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	0.13mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	0.5mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	17.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TOPICAL:POWDER:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TRANSMUCOSAL:LOZENGE:mg	TRANSMUCOSAL	25mg TRANSMUCOSAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:VAGINAL:RING:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE:ORAL:TABLET:mg	ORAL	2.9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE:ORAL:TABLET, FILM COATED:mg	ORAL	14mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE:TOPICAL:SOAP:%w/w	TOPICAL	0.2%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
ML30MJ2U7I	MAGNESIUM SULFATE ANHYDROUS:ORAL:CAPSULE:mg	ORAL	29.8mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, CHEWABLE:mg	ORAL	76.89mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, COATED:mg	ORAL	20mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:ORAL:CAPSULE:mg	ORAL	2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:ORAL:SYRUP:mg/5ml	ORAL	1.73mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:LIQUID:ADJ PH	ORAL	ADJ PH ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:POWDER:mg	ORAL	232mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
J3TZF807X5	MALIC ACID, L-:ORAL:SOLUTION:mg/10ml	ORAL	34mg/10ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
J3TZF807X5	MALIC ACID, L-:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SUSPENSION:mg/120ml	ORAL	39600mg/120ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:FILM, SOLUBLE:mg	ORAL	3.2mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, CHEWABLE:mg	ORAL	292mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, COATED:mg	ORAL	5.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A9RD92BS4	MALTOL:ORAL:CONCENTRATE:mg/1ml	ORAL	0.1mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A9RD92BS4	MALTOL:ORAL:SOLUTION:mg	ORAL	0.1mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
66Y63L379N	MALTOSE ANHYDROUS:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DM477EE40D	MALTOSE MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DM477EE40D	MALTOSE MONOHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:BUCCAL:TABLET:mg	BUCCAL	180.19mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	106.6mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	300mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:POWDER, FOR SUSPENSION:%w/v	INTRAMUSCULAR	6.75%w/v INTRAMUSCULAR POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	980.4mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, SUSPENSION:%w/v	INTRAVENOUS	2.5%w/v INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	4.4%w/v INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:NASAL:SPRAY:mg	NASAL	41.5mg NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	5%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	4.7%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%w/w	OPHTHALMIC	4.35%w/w OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	4.6%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SUSPENSION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	3.3%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SUSPENSION, EXTENDED RELEASE:mg	ORAL	2464.6mg ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, COATED:mg	ORAL	177.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:WAFER:mg	ORAL	642mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:PARENTERAL:INJECTION:%w/v	PARENTERAL	4.4%w/v PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:PARENTERAL:INJECTION, POWDER, FOR SOLUTION:mg	PARENTERAL	200mg PARENTERAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:PARENTERAL:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	PARENTERAL	7.5%w/v PARENTERAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:RESPIRATORY (INHALATION):POWDER:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	35mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION, POWDER, FOR SUSPENSION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:SOLUTION:%w/v	SUBCUTANEOUS	1.59%w/v SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBLINGUAL:TABLET, ORALLY DISINTEGRATING:mg	SUBLINGUAL	10.25mg SUBLINGUAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBMUCOSAL:INJECTION, SOLUTION:%w/v	SUBMUCOSAL	2.94%w/v SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TOPICAL:SUSPENSION/ DROPS:%w/v	TOPICAL	0.3%w/v TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	1.1%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	3390mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.37mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:SUBCUTANEOUS:INJECTION, SUSPENSION, EXTENDED RELEASE:mg	SUBCUTANEOUS	990.3mg SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:SUBLINGUAL:POWDER:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:SUBLINGUAL:SPRAY, METERED:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	10.87%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	8%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:LOTION:%w/w	TOPICAL	7%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:OINTMENT:%w/w	TOPICAL	20%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	144.76mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	154mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	0.15mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	4.7%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:DENTAL:SOLUTION:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:NASAL:DROPS:mg	NASAL	40.32mg NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:NASAL:INHALANT:mg	NASAL	32mg NASAL INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:NASAL:JELLY:mg	NASAL	32.5mg NASAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:OPHTHALMIC:DROPS:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:CAPSULE:mg	ORAL	0.87mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:CONCENTRATE:mg/5ml	ORAL	0.05mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:SOLUTION:mg/1ml	ORAL	0.5mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	0.5mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:SYRUP:mg/5ml	ORAL	7.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:TABLET:mg	ORAL	0.58mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	14mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.02%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	0.02%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:TOPICAL:CREAM:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:TOPICAL:GEL:%w/w	TOPICAL	0.1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:TOPICAL:LOTION:%w/w	TOPICAL	0.05%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:TOPICAL:SOAP:%w/w	TOPICAL	0.75%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL:TOPICAL:SOLUTION:%w/v	TOPICAL	0.08%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRADERMAL:INJECTION:%w/v	INTRADERMAL	0.16%w/v INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.1%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.3%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.3%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.22%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.16%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:SOLUTION:%w/v	SUBCUTANEOUS	0.1%w/v SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7SPF5O5BW8	METANIL YELLOW:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7SPF5O5BW8	METANIL YELLOW:TOPICAL:SOAP:%w/w	TOPICAL	0.01%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MTK99R3UV0	METAPHOSPHORIC ACID:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.13%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MTK99R3UV0	METAPHOSPHORIC ACID:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	15mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, COATED PELLETS:mg	ORAL	93.36mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET:mg	ORAL	13.65mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10.08mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE:mg	ORAL	116.1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	4.32mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	80.7mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:INTRATHECAL:INJECTION:%w/v	INTRATHECAL	0.01%w/v INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.16%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.15%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.15%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.15%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A6R43525YO	METHYL CHLORIDE:ORAL:TABLET:mg	ORAL	69.82mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6PT9KLV9IO	METHYL ETHYL KETONE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	61mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
N0MWT4C7WH	METHYL GLUCETH-10:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	5%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
J3QD0LD11P	METHYL GLUCETH-20:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V1YW10H14D	METHYL GLUCOSE SESQUISTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	3.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V1YW10H14D	METHYL GLUCOSE SESQUISTEARATE:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8IPS6BI6KW	METHYL LAURATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8IPS6BI6KW	METHYL LAURATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	17.6mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8IPS6BI6KW	METHYL LAURATE:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.25%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	1.1%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:DENTAL:POWDER, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:ORAL:CAPSULE:mg	ORAL	16mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:TOPICAL:GEL:%w/w	TOPICAL	0.05%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:TOPICAL:POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:VAGINAL:DOUCHE:%w/w	VAGINAL	0.05%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8D4NXF3ZH7	METHYL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8D4NXF3ZH7	METHYL STEARATE:VAGINAL:CREAM:%w/w	VAGINAL	1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:BUCCAL:TABLET:mg	BUCCAL	4mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.1%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.1%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:NASAL:JELLY:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.12%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.16%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:CAPSULE:mg	ORAL	13.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	59.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:SUSPENSION:mg/10ml	ORAL	1000mg/10ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:TABLET, CHEWABLE:mg	ORAL	50mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:TABLET, COATED:mg	ORAL	138.3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	96mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:ORAL:TABLET, FILM COATED:mg	ORAL	21mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	4mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.11%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:TOPICAL:CREAM:%w/w	TOPICAL	1.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:TOPICAL:JELLY:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:TOPICAL:LOTION:%w/w	TOPICAL	1.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z944H5SN0H	METHYLCELLULOSE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
P0NTE48364	METHYLCELLULOSE (1500 MPA.S):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
O0GN6F9B2Y	METHYLCELLULOSE (400 MPA.S):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
O0GN6F9B2Y	METHYLCELLULOSE (400 MPA.S):ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
O0GN6F9B2Y	METHYLCELLULOSE (400 MPA.S):ORAL:TABLET:mg	ORAL	33mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MRJ667KA5E	METHYLCELLULOSE (4000 MPA.S):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MRJ667KA5E	METHYLCELLULOSE (4000 MPA.S):TOPICAL:CREAM:%w/w	TOPICAL	0.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DEL7T5QRPN	METHYLCHLOROISOTHIAZOLINONE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DEL7T5QRPN	METHYLCHLOROISOTHIAZOLINONE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
15O9QS218W	METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE MIXTURE:TOPICAL:CREAM:%w/w	TOPICAL	0.05%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T42P99266K	METHYLENE BLUE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.06%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	0.01%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.05%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:EPIDURAL:INJECTION:mg	EPIDURAL	1mg EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:EPIDURAL:INJECTION, SOLUTION:%w/v	EPIDURAL	5%w/v EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INFILTRATION:INJECTION:	INFILTRATION		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.24%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRADERMAL:INJECTION:mg	INTRADERMAL	1mg INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.15%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	3.6mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION, SUSPENSION:%w/v	INTRAMUSCULAR	0.14%w/v INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:SOLUTION:%w/v	INTRAMUSCULAR	0.13%w/v INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	15mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	5%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	0.13%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IONTOPHORESIS:SOLUTION:%w/v	IONTOPHORESIS	0.1%w/v IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IRRIGATION:SOLUTION:%w/v	IRRIGATION	2%w/v IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:NASAL:DROPS:mg	NASAL	26mg NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:NASAL:JELLY:mg	NASAL	250mg NASAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:NASAL:SOLUTION:mg	NASAL	250mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.86mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:DROPS:mg/1ml	ORAL	1mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:ELIXIR:mg	ORAL	800mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:GRANULE, FOR SUSPENSION:mg/5ml	ORAL	8mg/5ml ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	1mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION:mg/5ml	ORAL	1000mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET:mg	ORAL	1.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, CHEWABLE:mg	ORAL	1.28mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, COATED:mg	ORAL	0.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.17mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, FILM COATED:mg	ORAL	0.23mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PARENTERAL:INJECTION:	PARENTERAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PARENTERAL:INJECTION, SOLUTION:%w/v	PARENTERAL	5%w/v PARENTERAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PERIDURAL:INJECTION:mg	PERIDURAL	1mg PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PERINEURAL:INJECTION:	PERINEURAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:ENEMA:%w/v	RECTAL	0.18%w/v RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:SOLUTION:%w/v	RECTAL	0.13%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.03%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.15%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.16%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.16%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.16%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:EMULSION:%w/w	TOPICAL	0.2%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:JELLY:%w/v	TOPICAL	0.07%w/v TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.15%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	0.15%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SPRAY:%w/w	TOPICAL	0.2%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.3%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:URETHRAL:JELLY:%w/v	URETHRAL	0.07%w/v URETHRAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	0.1%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:GEL:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:TABLET:mg	ORAL	0.19mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.3mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
JR9CE63FPM	METHYLPYRROLIDONE:PERIODONTAL:SYSTEM:mg/mg	PERIODONTAL	0.63mg/mg PERIODONTAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
JR9CE63FPM	METHYLPYRROLIDONE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
JR9CE63FPM	METHYLPYRROLIDONE:SUBCUTANEOUS:INJECTION, SUSPENSION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:INTRAVITREAL:IMPLANT:mg	INTRAVITREAL	1.66mg INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE, DELAYED RELEASE:mg	ORAL	789.6mg ORAL GRANULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DELAYED RELEASE PARTICLES:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	43.2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	6mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:TOPICAL:CREAM:%w/w	TOPICAL	0.45%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:TOPICAL:GEL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:VAGINAL:CREAM:%w/w	VAGINAL	0.45%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
871QYF3I7B	MILK PROTEIN CONCENTRATE:BUCCAL:TABLET:mg	BUCCAL	27.43mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:AURICULAR (OTIC):OINTMENT:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.5%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:DENTAL:PASTE:%w/w	DENTAL	95%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	59.5%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	50mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET:mg	ORAL	113.75mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, COATED:mg	ORAL	1.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	5.67mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	23.63%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:GEL:%w/w	TOPICAL	2.5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:OIL:%v/v	TOPICAL	43.29%v/v TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:PASTE:%w/w	TOPICAL	47.5%w/w TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SOAP:%w/w	TOPICAL	0.82%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SUSPENSION:%w/w	TOPICAL	82%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SYSTEM:mg	TOPICAL	654.36mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TRANSDERMAL:FILM:mg	TRANSDERMAL	11.42mg TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	34mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	6.09mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:VAGINAL:CREAM:%w/w	VAGINAL	15%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:VAGINAL:SUPPOSITORY:mg	VAGINAL	30mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.02%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRA-ARTICULAR:INJECTION, SUSPENSION:%w/v	INTRA-ARTICULAR	0.02%w/v INTRA-ARTICULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.02%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRALESIONAL:INJECTION, SUSPENSION:%w/v	INTRALESIONAL	0.02%w/v INTRALESIONAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.02%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SUSPENSION:%w/v	INTRAMUSCULAR	0.02%w/v INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRASYNOVIAL:INJECTION, SUSPENSION:%w/v	INTRASYNOVIAL	0.02%w/v INTRASYNOVIAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.02%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:SOFT TISSUE:INJECTION, SUSPENSION:%w/v	SOFT TISSUE	0.02%w/v SOFT TISSUE INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
461P5CJN6T	MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE):ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
461P5CJN6T	MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE):ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.2%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.3%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.3%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	68mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	1.36%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:INTRAVESICAL:INJECTION, SOLUTION:mg	INTRAVESICAL	29.2mg INTRAVESICAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:NASAL:SOLUTION:mg	NASAL	680mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.2%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.44%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	17mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:ORAL:SUSPENSION:mg/5ml	ORAL	50mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:ORAL:TABLET:mg	ORAL	25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J9FJ0HL51	MONOBASIC POTASSIUM PHOSPHATE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:GRANULE, EFFERVESCENT:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:TABLET:mg	ORAL	50mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
W81N5U6R6U	MONOSODIUM GLUTAMATE:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	0.2mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
YWW937R1QR	MONOSTEARYL CITRATE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.75%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INFILTRATION:INJECTION, SOLUTION:NA	INFILTRATION		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAMUSCULAR:SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.5%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
N2TH4S4KUD	MONTAN WAX:ORAL:TABLET:mg	ORAL	0.06mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
N2TH4S4KUD	MONTAN WAX:ORAL:TABLET, COATED:mg	ORAL	0.05mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
N2TH4S4KUD	MONTAN WAX:ORAL:TABLET, FILM COATED:mg	ORAL	0.03mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0I3V7S25AW	MYRISTIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0I3V7S25AW	MYRISTIC ACID:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	2%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2.5%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	1.05%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
1D822OC34X	MYRISTYL LACTATE:TOPICAL:LOTION:%w/w	TOPICAL	0.8%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	30.91%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:NASAL:SPRAY:ml	NASAL	0.01ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
IIE41SBQ9L	N-ACETYL-D-ALANINE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
SZT789770M	NAPHTHOL BLUE BLACK:ORAL:TABLET:mg	ORAL	0.83mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DI107E57B4	N-DODECYL .BETA.-D-MALTOSIDE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
VJ597D52EX	NEOTAME:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	2.5%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	2.5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.86%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	0.8%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:TOPICAL:CREAM:ADJ PH	TOPICAL	ADJ PH TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:TOPICAL:SOLUTION:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:VAGINAL:CREAM:ADJ PH	VAGINAL	ADJ PH VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
9E0S3UM200	NONCRYSTALLIZING SORBITOL SOLUTION:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
9E0S3UM200	NONCRYSTALLIZING SORBITOL SOLUTION:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
9E0S3UM200	NONCRYSTALLIZING SORBITOL SOLUTION:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
9E0S3UM200	NONCRYSTALLIZING SORBITOL SOLUTION:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
4867M0AEJI	NONOXYNOL-40:TOPICAL:LIQUID:%w/w	TOPICAL	3%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
4867M0AEJI	NONOXYNOL-40:VAGINAL:DOUCHE:%w/w	VAGINAL	0.25%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
48Q180SH9T	NONOXYNOL-9:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.13%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
48Q180SH9T	NONOXYNOL-9:TOPICAL:CLOTH:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:NASAL:AEROSOL:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:ORAL:AEROSOL, METERED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:RESPIRATORY (INHALATION):AEROSOL, METERED:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
5I112077IN	N-PHENYL-1-NAPTHYLAMINE:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	0.01%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Z1CLM48948	NUTMEG OIL:ORAL:ELIXIR:mg/5ml	ORAL	4.5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Z1CLM48948	NUTMEG OIL:RESPIRATORY (INHALATION):LIQUID:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
4X49Y0596W	OCTISALATE:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4X49Y0596W	OCTISALATE:TRANSDERMAL:SOLUTION:%w/v	TRANSDERMAL	5%w/v TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4X49Y0596W	OCTISALATE:TRANSDERMAL:SPRAY:%w/v	TRANSDERMAL	8.5%w/v TRANSDERMAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
9T1C662FKS	OCTOXYNOL-40:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
9T1C662FKS	OCTOXYNOL-40:OPHTHALMIC:SOLUTION/ DROPS:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:GEL:%w/w	TOPICAL	0.12%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:LOTION:%w/w	TOPICAL	0.12%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:SPONGE:%w/w	TOPICAL	5%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:GEL:%w/w	TOPICAL	10%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.01%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TRANSDERMAL:FILM:mg	TRANSDERMAL	32.44mg TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	253.4mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	4.05mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:VAGINAL:CREAM:%w/w	VAGINAL	13.5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	0.03%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, COATED:mg	ORAL	0.72mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, FILM COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.01%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:CREAM:%w/w	TOPICAL	25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:GEL, METERED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	7.4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	22mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7L6R1SQ6M0	OLETH-2:AURICULAR (OTIC):OIL:	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7L6R1SQ6M0	OLETH-2:TOPICAL:OIL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
YTH167I2AG	OLETH-20:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.6%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:CREAM:%w/w	TOPICAL	10%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:OINTMENT:%w/w	TOPICAL	5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	7.45mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	1.5%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	6.12mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3X3L452Y85	OLEYL OLEATE:TOPICAL:OINTMENT:%w/w	TOPICAL	2.55%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3X3L452Y85	OLEYL OLEATE:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	30mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:ORAL:SOLUTION:mg/1ml	ORAL	425mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:TOPICAL:SOLUTION:%w/w	TOPICAL	0.6%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
M4565XE42N	OPACODE NS-78-17821 WB BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
M4565XE42N	OPACODE NS-78-17821 WB BLACK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
M4565XE42N	OPACODE NS-78-17821 WB BLACK:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.03mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
M4565XE42N	OPACODE NS-78-17821 WB BLACK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.03mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NSP54SZ9YB	OPACODE S-1-1666 RED:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NSP54SZ9YB	OPACODE S-1-1666 RED:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NSP54SZ9YB	OPACODE S-1-1666 RED:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4AJX4M6SSA	OPACODE S-1-17822 BLACK:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4AJX4M6SSA	OPACODE S-1-17822 BLACK:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.04mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3Z4GL78VFW	OPACODE S-1-17823 BLACK:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3Z4GL78VFW	OPACODE S-1-17823 BLACK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3Z4GL78VFW	OPACODE S-1-17823 BLACK:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
WNX8Q9P6UC	OPACODE S-1-8115 BLACK:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
WNX8Q9P6UC	OPACODE S-1-8115 BLACK:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.03mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4LK0LJX5WB	OPADRY 03B14436 PINK:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4LK0LJX5WB	OPADRY 03B14436 PINK:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	14mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
R2M5KK65A9	OPADRY 03B28796 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
R2M5KK65A9	OPADRY 03B28796 WHITE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
R2M5KK65A9	OPADRY 03B28796 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
R2M5KK65A9	OPADRY 03B28796 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
M67GSV4XEH	OPADRY 03B57519 GREY:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
M67GSV4XEH	OPADRY 03B57519 GREY:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	12.07mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
H82AGY7EQQ	OPADRY 03F82726 YELLOW:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
H82AGY7EQQ	OPADRY 03F82726 YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
TMJ4Z2Z4QW	OPADRY 04F58804 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
TMJ4Z2Z4QW	OPADRY 04F58804 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
TMJ4Z2Z4QW	OPADRY 04F58804 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4RW65XL9NG	OPADRY 12B58900 WHITE:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
PLA64J57K9	OPADRY 85F19250 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
PLA64J57K9	OPADRY 85F19250 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
DWT35JJC4S	OPADRY AMB 80W68912 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
DWT35JJC4S	OPADRY AMB 80W68912 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
DWT35JJC4S	OPADRY AMB 80W68912 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
DWT35JJC4S	OPADRY AMB 80W68912 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B53ZH89YAO	OPADRY II 33G11938 GREEN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
VTB5DCJ7N6	OPADRY II 85F18378 WHITE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
VTB5DCJ7N6	OPADRY II 85F18378 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
VTB5DCJ7N6	OPADRY II 85F18378 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
VTB5DCJ7N6	OPADRY II 85F18378 WHITE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
VTB5DCJ7N6	OPADRY II 85F18378 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UM45RMS9QT	OPADRY II 85F18422 WHITE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UM45RMS9QT	OPADRY II 85F18422 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UM45RMS9QT	OPADRY II 85F18422 WHITE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UM45RMS9QT	OPADRY II 85F18422 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UM45RMS9QT	OPADRY II 85F18422 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
A2E86PPP6D	OPADRY II RED 85G94101:ORAL:TABLET:mg	ORAL	4.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
A2E86PPP6D	OPADRY II RED 85G94101:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:CAPSULE:mg	ORAL	4.44mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B38S8YKT74	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	18.15mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
RX96DK7VVX	OPADRY II Y-30-18037 WHITE:ORAL:TABLET:mg	ORAL	38mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
RX96DK7VVX	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	33mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
RX96DK7VVX	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
RX96DK7VVX	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	26mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
WCE543V7AA	OPADRY OY-S-29019 CLEAR:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
WCE543V7AA	OPADRY OY-S-29019 CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
PLG7GLN7QI	OPADRY YS-1-12726A YELLOW:ORAL:TABLET:mg	ORAL	4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
PLG7GLN7QI	OPADRY YS-1-12726A YELLOW:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	16.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
PLG7GLN7QI	OPADRY YS-1-12726A YELLOW:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UP4CT4IW2C	OPADRY YS-1-17274A BEIGE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, COATED:mg	ORAL	4.45mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, FILM COATED:mg	ORAL	1.1mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4PQ7L4V6AQ	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UI8UMA9Q6F	OPADRY YS-1-7040 WHITE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UI8UMA9Q6F	OPADRY YS-1-7040 WHITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UI8UMA9Q6F	OPADRY YS-1-7040 WHITE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
UI8UMA9Q6F	OPADRY YS-1-7040 WHITE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5A9KE2L9L3	ORANGE JUICE:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
L8B7EWV9I7	ORANGE OIL TERPENELESS:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
L8B7EWV9I7	ORANGE OIL TERPENELESS:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL, COLD PRESSED:ORAL:ELIXIR:mg	ORAL	0.24mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL, COLD PRESSED:ORAL:LIQUID:mg	ORAL	50mg ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL, COLD PRESSED:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL, COLD PRESSED:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL, COLD PRESSED:ORAL:TABLET, CHEWABLE:mg	ORAL	3.7mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL, COLD PRESSED:SUBLINGUAL:TABLET:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
TI9T76XD44	ORANGE PEEL:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5T9Z06LCV4	O-TOLYL BIGUANIDE:TOPICAL:SOAP:%w/w	TOPICAL	0.02%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5T9Z06LCV4	O-TOLYL BIGUANIDE:TOPICAL:SOLUTION:%w/w	TOPICAL	0.01%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5QUO05548Z	PALM OIL:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2V16EO95H1	PALMITIC ACID:INTRAVENOUS:INJECTION, SUSPENSION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2V16EO95H1	PALMITIC ACID:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q8Y7S3B85M	PALMITOSTEARIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	50mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET:mg	ORAL	0.7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, COATED:mg	ORAL	0.07mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.2mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:RECTAL:OINTMENT:%w/w	RECTAL	5%w/w RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	94.93%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:SOAP:%w/w	TOPICAL	0.4%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:AURICULAR (OTIC):OIL:	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:ORAL:CAPSULE:mg	ORAL	313.8mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	10%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:TOPICAL:OIL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:VAGINAL:CREAM:%w/w	VAGINAL	9%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:DENTAL:PASTE:	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:NASAL:SPRAY:mg	NASAL	10mg NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	5.45mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47EQO8LE7H	PECTIN, CITRUS:DENTAL:PASTE:%w/w	DENTAL	16.6%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47EQO8LE7H	PECTIN, CITRUS:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47EQO8LE7H	PECTIN, CITRUS:ORAL:TABLET:mg	ORAL	0.35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9H0AO7T794	PEG/PPG-18/18 DIMETHICONE:TOPICAL:GEL:%w/w	TOPICAL	1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9H0AO7T794	PEG/PPG-18/18 DIMETHICONE:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6SG11EPD3Z	PEG/PPG-4/30 COPOLYMER:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.5%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:VAGINAL:CREAM:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6941286E4I	PEG-120 GLYCERYL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6941286E4I	PEG-120 GLYCERYL STEARATE:VAGINAL:CREAM:%w/w	VAGINAL	2%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YM0K64F20V	PEG-120 METHYL GLUCOSE DIOLEATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	1.8%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0345752X7U	PEG-20 METHYL GLUCOSE SESQUISTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	3.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0345752X7U	PEG-20 METHYL GLUCOSE SESQUISTEARATE:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0345752X7U	PEG-20 METHYL GLUCOSE SESQUISTEARATE:TOPICAL:LOTION:%w/w	TOPICAL	3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
X958PZJ9ON	PEG-20 SORBITAN ISOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	6%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
X21KPH4633	PEG-25 PROPYLENE GLYCOL STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	2.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4ERD2076EF	PEG-40 CASTOR OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
JL4CCU7I1G	PEG-40 SORBITAN DIISOSTEARATE:DENTAL:SOLUTION:%w/v	DENTAL	0.8%w/v DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
JL4CCU7I1G	PEG-40 SORBITAN DIISOSTEARATE:ORAL:LIQUID:mg/15ml	ORAL	100mg/15ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:ORAL:SOLUTION:mg/1ml	ORAL	300mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:VAGINAL:CREAM:%w/w	VAGINAL	3%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:VAGINAL:SUPPOSITORY:mg	VAGINAL	30mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0E2639OTJY	PEG-6 ISOSTEARATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
02NG325BQG	PEG-60 HYDROGENATED CASTOR OIL:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	20%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
02NG325BQG	PEG-60 HYDROGENATED CASTOR OIL:TOPICAL:CREAM:%w/w	TOPICAL	1.9%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
02NG325BQG	PEG-60 HYDROGENATED CASTOR OIL:TOPICAL:GEL:%w/w	TOPICAL	1.9%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
993L8OB0ER	PEG-7 LINOLEOYL GLYCERIDES:ORAL:CAPSULE:mg	ORAL	300mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
09179OX7TB	PEG-75 LANOLIN:TOPICAL:AEROSOL:%w/w	TOPICAL	1.5%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
09179OX7TB	PEG-75 LANOLIN:TOPICAL:EMULSION:%w/w	TOPICAL	1.5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
09179OX7TB	PEG-75 LANOLIN:TOPICAL:SOLUTION:%w/w	TOPICAL	1%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
762O8IWA10	PEG-8 LAURATE:TOPICAL:LOTION:%w/v	TOPICAL	0.5%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
762O8IWA10	PEG-8 LAURATE:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.63%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:ORAL:CONCENTRATE:mg/5ml	ORAL	25mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:VAGINAL:CREAM:%w/w	VAGINAL	20%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:VAGINAL:SUPPOSITORY:mg	VAGINAL	200mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OK17S3S98K	PENTADECALACTONE:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	8%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
961TOZ5L7T	PENTASODIUM PENTETATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	5mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
961TOZ5L7T	PENTASODIUM PENTETATE:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7A314HQM0I	PENTETIC ACID:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	2mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	49.3%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:DENTAL:POWDER, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:DENTAL:SOLUTION:%v/v	DENTAL	0.04%v/v DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:CONCENTRATE:mg	ORAL	0.05mg ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:ELIXIR:mg/1ml	ORAL	0.04mg/1ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:GUM, CHEWING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SOLUTION:mg/1ml	ORAL	3.5mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SUSPENSION:mg/1ml	ORAL	100mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SYRUP:ml/5ml	ORAL	0.6ml/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:POWDER:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:SPRAY, METERED:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.15mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:TOPICAL:OINTMENT:%w/w	TOPICAL	0.2%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:AURICULAR (OTIC):OINTMENT:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	88.4%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.07mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:ORAL:TABLET:mg	ORAL	3.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.18mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:RECTAL:OINTMENT:%w/w	RECTAL	75%w/w RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:RESPIRATORY (INHALATION):LIQUID:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	7.9%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	26%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:EMULSION:%w/w	TOPICAL	7.8%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:LOTION:%w/w	TOPICAL	25%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:OINTMENT, AUGMENTED:%w/w	TOPICAL	81.94%w/w TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:SOAP:%w/w	TOPICAL	0.85%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:VAGINAL:CAPSULE:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:VAGINAL:OINTMENT:%w/w	VAGINAL	88.49%w/w VAGINAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:VAGINAL:SUPPOSITORY:mg	VAGINAL	27mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0EWG668W17	PHENAZOPYRIDINE HYDROCHLORIDE:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.5%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRADERMAL:INJECTION:%w/v	INTRADERMAL	0.25%w/v INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.5%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	2mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	0.5%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	2mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	0.5%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	2mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.55%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.07%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:LIQUID:%w/v	SUBCUTANEOUS	0.5%w/v SUBCUTANEOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:VAGINAL:DOUCHE:%w/w	VAGINAL	0.14%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:AEROSOL:%w/w	TOPICAL	1.05%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47E5O17Y3R	PHENYLALANINE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	7.26mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47E5O17Y3R	PHENYLALANINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.17%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.25%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:INTRA-ARTICULAR:SUSPENSION:mg	INTRA-ARTICULAR	5mg INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:INTRAMUSCULAR:SUSPENSION:mg	INTRAMUSCULAR	5mg INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.25%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:RESPIRATORY (INHALATION):INHALANT:mg	RESPIRATORY (INHALATION)	277.1mg RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:VAGINAL:CREAM:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:NASAL:DROPS:mg	NASAL	20mg NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:NASAL:SOLUTION:mg/1ml	NASAL	0.02mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:TOPICAL:CREAM:%w/w	TOPICAL	0.01%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.02%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:VAGINAL:CREAM:%w/w	VAGINAL	0.01%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:NASAL:SOLUTION:mg	NASAL	2mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:ORAL:SOLUTION:mg/1ml	ORAL	0.03mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:ORAL:SYRUP:mg/1ml	ORAL	0.01mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:DENTAL:PASTE, DENTIFRICE:ADJ PH	DENTAL	ADJ PH DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	2.11%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:SYRUP:mg/5ml	ORAL	6.4mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET:mg	ORAL	0.04mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.19mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.02%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:GEL:ADJ PH	TOPICAL	ADJ PH TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:LOTION, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:OINTMENT:ADJ PH	TOPICAL	ADJ PH TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:SOLUTION:%w/w	TOPICAL	0.23%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:SPONGE:ADJ PH	TOPICAL	ADJ PH TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:VAGINAL:AEROSOL, FOAM:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:VAGINAL:CREAM:%w/w	VAGINAL	0.56%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5EXL5H740Y	PINE NEEDLE OIL (PINUS SYLVESTRIS):TOPICAL:LOTION:%w/w	TOPICAL	0.25%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2A88ZO081O	PINEAPPLE:ORAL:CONCENTRATE:mg/1ml	ORAL	1mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2A88ZO081O	PINEAPPLE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1RTM4PAL0V	PIPERAZINE:ORAL:TABLET:mg	ORAL	0.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U3HKX3SA66	PLASACRYL T20:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U3HKX3SA66	PLASACRYL T20:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET:mg	ORAL	45.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, CHEWABLE:mg	ORAL	21mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, COATED:mg	ORAL	5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6716Z5YR3G	POLIDRONIUM CHLORIDE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1S66E28KXA	POLOXAMER 124:ORAL:SUSPENSION:mg/1ml	ORAL	0.09mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1S66E28KXA	POLOXAMER 124:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1S66E28KXA	POLOXAMER 124:TOPICAL:LOTION:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
JX0HIX6OAG	POLOXAMER 182:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:INTRAMUSCULAR:POWDER, FOR SUSPENSION:%w/v	INTRAMUSCULAR	0.2%w/v INTRAMUSCULAR POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	6mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	2.2mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:GRANULE, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, COATED:mg	ORAL	3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:PERIODONTAL:GEL:mg	PERIODONTAL	55mg PERIODONTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
IS93EQR73R	POLOXAMER 331:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	1000mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
IS93EQR73R	POLOXAMER 331:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	26.43mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
IS93EQR73R	POLOXAMER 331:ORAL:SUSPENSION:mg/5ml	ORAL	12.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:INTRATYMPANIC:SUSPENSION:%w/w	INTRATYMPANIC	15.1%w/w INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.2%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.2%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:OPHTHALMIC:SUSPENSION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	0.01mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:SOLUTION:mg/5ml	ORAL	50mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:TABLET, FILM COATED:mg	ORAL	106.7mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:PERIODONTAL:GEL:mg	PERIODONTAL	155mg PERIODONTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
99Q3C7L77T	POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW):ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9G2MAD7J6W	POLYACRYLIC ACID (250000 MW):TOPICAL:SYSTEM:mg	TOPICAL	196mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9G2MAD7J6W	POLYACRYLIC ACID (250000 MW):TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1NA5AO9GH7	POLYBUTENE (1400 MW):TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1NA5AO9GH7	POLYBUTENE (1400 MW):TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	17.87mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.38%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.9%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.86%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:TOPICAL:GEL:%w/w	TOPICAL	2%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, COATED:mg	ORAL	7.67mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:ORAL:CONCENTRATE:mg/1ml	ORAL	100mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:ORAL:SOLUTION:mg/5ml	ORAL	1000mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:ORAL:TABLET, FILM COATED:mg	ORAL	1.52mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:RECTAL:SUPPOSITORY:mg	RECTAL	1658mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TOPICAL:AEROSOL, FOAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TOPICAL:CREAM:%w/w	TOPICAL	0.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.5%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:TABLET:mg	ORAL	0.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:TABLET, FILM COATED:mg	ORAL	0.13mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:URETHRAL:SUPPOSITORY:mg	URETHRAL	9.75mg URETHRAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1600:DENTAL:GEL:%w/w	DENTAL	5%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1600:DENTAL:PASTE:%w/w	DENTAL	4.96%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1600:ORAL:TABLET:mg	ORAL	1.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1600:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1600:RECTAL:SUPPOSITORY:mg/mg	RECTAL	0.3mg/mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1600:TOPICAL:SOLUTION:%w/w	TOPICAL	29.7%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	9.98%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:ORAL:SOLUTION:mg/1ml	ORAL	200mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:TOPICAL:OINTMENT:%w/w	TOPICAL	39%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.01mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	97.43%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAMUSCULAR:INJECTION:%v/v	INTRAMUSCULAR	50%v/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAMUSCULAR:SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	44.22%w/v INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:LIQUID:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:TOPICAL:CREAM:%w/w	TOPICAL	4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:TOPICAL:SOLUTION:%w/w	TOPICAL	29.7%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SA1B764746	POLYETHYLENE GLYCOL 3000:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SA1B764746	POLYETHYLENE GLYCOL 3000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	3%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAVENOUS:INJECTION:ml	INTRAVENOUS	0.5ml INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:NASAL:SOLUTION:mg/100ml	NASAL	40000mg/100ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:SUSPENSION:mg/1ml	ORAL	45mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, CHEWABLE:mg	ORAL	15mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, COATED:mg	ORAL	0.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	8.5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.09mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:RECTAL:SUPPOSITORY:mg	RECTAL	1425.96mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	2.88%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	2.88%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FVS1AZD90Y	POLYETHYLENE GLYCOL 3500:ORAL:TABLET:mg	ORAL	3.05mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	20.3%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAMUSCULAR:INJECTION, SOLUTION:%v/v	INTRAMUSCULAR	18%v/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:NASAL:SPRAY, METERED:mg/1ml	NASAL	200mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CONCENTRATE:mg/1ml	ORAL	600mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:FILM, SOLUBLE:mg	ORAL	4.76mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SOLUTION, CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	45mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:RECTAL:SUPPOSITORY:mg/mg	RECTAL	0.25mg/mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:AEROSOL, POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:CREAM:%w/w	TOPICAL	7.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:EMULSION:%w/w	TOPICAL	1.2%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:LIQUID:%w/w	TOPICAL	1%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:LOTION:%w/w	TOPICAL	5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:SWAB:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:VAGINAL:SUPPOSITORY:mg	VAGINAL	30mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:DENTAL:OINTMENT:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	3%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	3%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	3%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAVENOUS:INJECTION, SUSPENSION:%w/v	INTRAVENOUS	0.49%w/v INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	1.28mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	10.72mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:SYRUP:mg/5ml	ORAL	370mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, COATED:mg	ORAL	2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:RECTAL:SUPPOSITORY:mg	RECTAL	1269mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:SUBLINGUAL:TABLET:mg	SUBLINGUAL	2.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:TOPICAL:OINTMENT:%w/w	TOPICAL	45%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:VAGINAL:CREAM:%w/w	VAGINAL	0.5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TVH7653921	POLYETHYLENE GLYCOL 4500:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TVH7653921	POLYETHYLENE GLYCOL 4500:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	5%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:SOLUTION:mg/5ml	ORAL	650mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET:mg	ORAL	6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:TOPICAL:SOLUTION:%w/w	TOPICAL	0.3%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:BUCCAL:TABLET:mg	BUCCAL	70mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, COATED:mg	ORAL	106mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:RECTAL:SUPPOSITORY:mg	RECTAL	128mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:SUBLINGUAL:TABLET:mg	SUBLINGUAL	70mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:VAGINAL:INSERT:mg	VAGINAL	0.06mg VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
UH6KR4953D	POLYETHYLENE GLYCOL 800:ORAL:TABLET:mg	ORAL	3.48mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	2%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, CHEWABLE:mg	ORAL	6.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, COATED:mg	ORAL	0.21mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, FILM COATED:mg	ORAL	49mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	14mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:RECTAL:SUPPOSITORY:mg	RECTAL	52mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
UEP843BRCQ	POLYETHYLENE GLYCOL 900:TOPICAL:SOLUTION:%w/w	TOPICAL	0.95%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ENK4Y6S66X	POLYETHYLENE GLYCOL MONOMETHYL ETHER 350:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
V46Y6OJ5QB	POLYETHYLENE OXIDE 100000:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
V46Y6OJ5QB	POLYETHYLENE OXIDE 100000:ORAL:TABLET:mg	ORAL	192.66mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
V46Y6OJ5QB	POLYETHYLENE OXIDE 100000:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	96.33mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
V46Y6OJ5QB	POLYETHYLENE OXIDE 100000:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HZ58M6D839	POLYETHYLENE OXIDE 1000000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HZ58M6D839	POLYETHYLENE OXIDE 1000000:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	336mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
11628IH70O	POLYETHYLENE OXIDE 200000:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
11628IH70O	POLYETHYLENE OXIDE 200000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
11628IH70O	POLYETHYLENE OXIDE 200000:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5K3991GVWI	POLYETHYLENE OXIDE 2000000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RU64142H6P	POLYETHYLENE OXIDE 4000000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3IG9032SAH	POLYETHYLENE OXIDE 5000000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2126FD486L	POLYETHYLENE OXIDE 600000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G3MS6M810Y	POLYETHYLENE OXIDE 7000000:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G3MS6M810Y	POLYETHYLENE OXIDE 7000000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
16P9295IIL	POLYETHYLENE OXIDE 900000:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
16P9295IIL	POLYETHYLENE OXIDE 900000:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:ORAL:SOLUTION:mg/1ml	ORAL	310mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:TOPICAL:CREAM:%w/w	TOPICAL	2.7%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:VAGINAL:CREAM:%w/w	VAGINAL	2.7%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FLT10CH37X	POLYISOBUTYLENE (1100000 MW):TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FLT10CH37X	POLYISOBUTYLENE (1100000 MW):TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	69mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FLT10CH37X	POLYISOBUTYLENE (1100000 MW):TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TQ77WR8A02	POLYISOBUTYLENE (55000 MW):TRANSDERMAL:FILM:mg	TRANSDERMAL	238.44mg TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TQ77WR8A02	POLYISOBUTYLENE (55000 MW):TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	29.8mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
459TN2L5F5	POLYLACTIDE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
459TN2L5F5	POLYLACTIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	264.8mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
459TN2L5F5	POLYLACTIDE:PERIODONTAL:SYSTEM:mg/mg	PERIODONTAL	0.37mg/mg PERIODONTAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9J7G894K2M	POLYLACTIDE (14000 MW):INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
71YMM1X75O	POLYOXYL 15 HYDROXYSTEARATE:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	4.4%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
71YMM1X75O	POLYOXYL 15 HYDROXYSTEARATE:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.25%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:AEROSOL:%w/w	TOPICAL	5.5%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:GEL:%w/w	TOPICAL	2%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:SPRAY:%w/w	TOPICAL	2.42%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAMUSCULAR:INJECTION, EMULSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	52.75%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVESICAL:SOLUTION:	INTRAVESICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	5%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:SOLUTION:mg/1ml	ORAL	515mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:SUSPENSION:mg/1ml	ORAL	0.4mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	5.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:SUBCUTANEOUS:INJECTION, EMULSION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:TOPICAL:CREAM:%w/w	TOPICAL	4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:DENTAL:SOLUTION:%w/w	DENTAL	1%w/w DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.53%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:CAPSULE, COATED:mg	ORAL	101.25mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:SOLUTION:mg/1ml	ORAL	450mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	1%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	7%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:CAPSULE:mg	ORAL	7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:GRANULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:TABLET:mg	ORAL	8.48mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:TABLET, FILM COATED:mg	ORAL	2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2.83%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	8.8%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:LOTION:%w/w	TOPICAL	3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
S4G2J0Y0LG	POLYPROPYLENE GLYCOL 11 STEARYL ETHER:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	5%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
S4G2J0Y0LG	POLYPROPYLENE GLYCOL 11 STEARYL ETHER:TOPICAL:SUSPENSION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1II18XLS1L	POLYPROPYLENE GLYCOL 15 STEARYL ETHER:TOPICAL:GEL:%w/w	TOPICAL	2%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1II18XLS1L	POLYPROPYLENE GLYCOL 15 STEARYL ETHER:TOPICAL:OINTMENT:%w/w	TOPICAL	15%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1II18XLS1L	POLYPROPYLENE GLYCOL 15 STEARYL ETHER:TOPICAL:SUSPENSION:%w/w	TOPICAL	16%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0L414VCS5Y	POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW):TOPICAL:SHAMPOO:%w/w	TOPICAL	1%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.1%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	1.62%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:NASAL:SPRAY, METERED:mg/1ml	NASAL	25mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	1.3mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET, FILM COATED:mg	ORAL	0.35mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:INJECTION, SOLUTION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	3.7%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:CLOTH:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:EMULSION:%w/w	TOPICAL	2%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:GEL:%w/w	TOPICAL	5%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:LOTION:%w/w	TOPICAL	7.8%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:SHAMPOO:%w/w	TOPICAL	8%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:SOAP:%w/w	TOPICAL	0.02%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:SOLUTION:%w/w	TOPICAL	15%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	3%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:VAGINAL:TAMPON:mg	VAGINAL	64.8mg VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:ORAL:DROPS:ml	ORAL	0.02ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:ORAL:ELIXIR:mg/5ml	ORAL	0.05mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:LIQUID:%w/w	TOPICAL	2%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:LOTION:%w/w	TOPICAL	2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:ORAL:EMULSION:mg/1ml	ORAL	20mg/1ml ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:ORAL:SUSPENSION:mg/5ml	ORAL	25mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:RECTAL:SUPPOSITORY:mg/mg	RECTAL	0.05mg/mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:AEROSOL:%w/w	TOPICAL	0.42%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	3%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:LOTION:%w/w	TOPICAL	5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:OINTMENT:%w/w	TOPICAL	2%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:SHAMPOO:%w/w	TOPICAL	14.55%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.85%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:CREAM:%w/w	VAGINAL	5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:SUPPOSITORY:mg	VAGINAL	0.03mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	0.02%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.2%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):SOLUTION/ DROPS:	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	1%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRABURSAL:INJECTION:%w/v	INTRABURSAL	0.04%w/v INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRALESIONAL:INJECTION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	4%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	5%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	0.2%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	53mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, SUSPENSION:%w/v	INTRAVENOUS	0.5%w/v INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:LIQUID:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.02%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:NASAL:SPRAY:mg	NASAL	0.01mg NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:NASAL:SPRAY, METERED:mg/1ml	NASAL	0.1mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:EMULSION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.25%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.15%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE:mg	ORAL	418.37mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, COATED:mg	ORAL	0.04mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	2mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CONCENTRATE:mg/1ml	ORAL	1mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:ELIXIR:mg/15ml	ORAL	2.5mg/15ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:POWDER:mg	ORAL	66mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, CHEWABLE:mg	ORAL	0.02mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, FILM COATED:mg	ORAL	24mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	8mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:ENEMA:%w/v	RECTAL	0.01%w/v RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:SOLUTION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:SUPPOSITORY:mg	RECTAL	72.15mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RESPIRATORY (INHALATION):SUSPENSION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SOFT TISSUE:INJECTION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.3%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.3%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.08mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.98%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:EMULSION:%w/w	TOPICAL	2.5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:LOTION:%w/w	TOPICAL	15%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:OINTMENT:%w/w	TOPICAL	0.1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	3%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:VAGINAL:CREAM:%w/w	VAGINAL	0.4%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:VAGINAL:SUPPOSITORY:mg	VAGINAL	28mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:CAPSULE:mg	ORAL	12mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	32mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:SUSPENSION, EXTENDED RELEASE:mg/5ml	ORAL	92.9mg/5ml ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET:mg	ORAL	7mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	6.5mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	8.07mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	16mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	37.4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.05%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:INTRAVITREAL:IMPLANT:mg	INTRAVITREAL	0.12mg INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	1.4%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.4%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	1.4%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	1.4%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:CAPSULE:mg	ORAL	1.67mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, COATED:mg	ORAL	0.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, FILM COATED:mg	ORAL	20mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:TOPICAL:SOLUTION:%w/v	TOPICAL	1.4%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	0.5%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:VAGINAL:CREAM:%w/w	VAGINAL	0.5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C1MS7RRZ6L	POLYVINYL ALCOHOL (94000 MW):ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C1MS7RRZ6L	POLYVINYL ALCOHOL (94000 MW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
23ZQ42JZZH	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW):ORAL:TABLET:mg	ORAL	5.37mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
23ZQ42JZZH	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW):ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
23ZQ42JZZH	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I5O20161WH	POLYVINYL ALCOHOL/POLYVINYL ACETATE COPOLYMER (8:1; 18000 MW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
M911911U02	POTASSIUM ACETATE:RECTAL:ENEMA:%w/v	RECTAL	0.41%w/v RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1L24V9R23S	POTASSIUM ALUM:VAGINAL:POWDER:mg	VAGINAL	14mg VAGINAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1L24V9R23S	POTASSIUM ALUM:VAGINAL:SUPPOSITORY:mg	VAGINAL	17.2mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:BUCCAL:TABLET:mg	BUCCAL	8mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:TABLET:mg	ORAL	12.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	8mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NPT6P8P3UU	POTASSIUM BITARTRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NPT6P8P3UU	POTASSIUM BITARTRATE:VAGINAL:DOUCHE:%w/w	VAGINAL	10%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:ORAL:CAPSULE:mg	ORAL	27.69mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:ORAL:SOLUTION:mg/1ml	ORAL	6.2mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:TOPICAL:SOLUTION:%w/w	TOPICAL	15%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INFILTRATION:INJECTION:mg	INFILTRATION	0.3mg INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	0.4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAOCULAR:SOLUTION:mg	INTRAOCULAR	0.75mg INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRATHECAL:INJECTION, SOLUTION:	INTRATHECAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.44%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.08%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:IRRIGATION:SOLUTION:%w/v	IRRIGATION	0.04%w/v IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:NASAL:POWDER:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.22%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.14%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.03%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:CAPSULE:mg	ORAL	62mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:POWDER:mg	ORAL	0.18mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	0.18mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:TOPICAL:AEROSOL:%w/w	TOPICAL	0.26%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:INTRAVASCULAR:SOLUTION:NA	INTRAVASCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.07mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:PASTILLE:ADJ PH	ORAL	ADJ PH ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:AEROSOL, FOAM:ADJ PH	TOPICAL	ADJ PH TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:CREAM:%w/w	TOPICAL	0.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:SOLUTION:%w/w	TOPICAL	14.02%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:VAGINAL:CREAM:%w/w	VAGINAL	0.5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.11%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	0.6mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.05%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:ORAL:TABLET, COATED:mg	ORAL	0.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:RECTAL:ENEMA:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
01DMT14Z63	POTASSIUM METAPHOSPHATE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:NASAL:SPRAY, METERED:mg/1ml	NASAL	1.2mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.47%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.47%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:SOLUTION:mg/15ml	ORAL	1000mg/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:SYRUP:mg/1ml	ORAL	2mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.2mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:RECTAL:SOLUTION:%w/v	RECTAL	6.67%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.2%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:CREAM:%w/w	TOPICAL	0.25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:LOTION:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1K573LC5TV	POTASSIUM SULFATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.2%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1.8%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	1.8%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.6%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	10.03mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:POWDER, FOR SOLUTION:mg	ORAL	4.5mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	35mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:SOLUTION:mg/5ml	ORAL	250mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, CHEWABLE:mg	ORAL	18mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, COATED:mg	ORAL	49.2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, FILM COATED:mg	ORAL	240mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	17mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, FOR SUSPENSION:mg	ORAL	2mg ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	15.03mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:ORAL:TROCHE:mg	ORAL	30mg ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	6mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	6mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE:TRANSDERMAL:SOLUTION:%w/v	TRANSDERMAL	2%w/v TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTION, SUSPENSION:%w/v	INTRAVENOUS	0.08%w/v INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:SOLUTION, CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	20mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E54VE15114	POVIDONE K15:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C67P1734QJ	POVIDONE K17:ORAL:CAPSULE:mg	ORAL	130mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C67P1734QJ	POVIDONE K17:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.5%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C67P1734QJ	POVIDONE K17:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.5%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	10mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:GRANULE, FOR SUSPENSION:mg	ORAL	0.27mg ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:SOLUTION:mg/5ml	ORAL	500mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, CHEWABLE:mg	ORAL	0.45mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.59%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.6%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:GRANULE, EFFERVESCENT:mg	ORAL	40mg ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DELAYED RELEASE PARTICLES:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	45mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	1.9%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TOPICAL:SOLUTION:%w/v	TOPICAL	4%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:AURICULAR (OTIC):SOLUTION/ DROPS:	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.3%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	1.2%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	1.5%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, COATED:mg	ORAL	9.77mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:TRANSDERMAL:SOLUTION:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	20mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:BUCCAL:TABLET:mg	BUCCAL	4.5mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:DENTAL:PASTE, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:EXTRACORPOREAL:DISC:NA	EXTRACORPOREAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:CAPSULE:mg	ORAL	405mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, COATED:mg	ORAL	40.2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	16mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	110.6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	42.25mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	4.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:TOPICAL:DISC:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1BK9DDD24E	PPG-12/SMDI COPOLYMER:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1BK9DDD24E	PPG-12/SMDI COPOLYMER:TOPICAL:LOTION:%w/w	TOPICAL	3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0057334FAB	PPG-20 METHYL GLUCOSE ETHER DISTEARATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G6ZWA1Q43P	PPG-26 OLEATE:TOPICAL:CREAM:%w/w	TOPICAL	4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9DLQ4CIU6V	PROLINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.8%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9DLQ4CIU6V	PROLINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.34%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
T75W9911L6	PROPANE:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
T75W9911L6	PROPANE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	55%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
JHU490RVYR	PROPIONIC ACID:TOPICAL:OINTMENT:%w/w	TOPICAL	2.7%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
96F264O9SV	PROPYL ALCOHOL:TOPICAL:OINTMENT:%w/w	TOPICAL	10%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
96F264O9SV	PROPYL ALCOHOL:TOPICAL:POWDER:mg/mg	TOPICAL	0.4mg/mg TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
96F264O9SV	PROPYL ALCOHOL:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:CONCENTRATE:mg/1ml	ORAL	0.2mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.07mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, FILM COATED:mg	ORAL	0.04mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.04mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:TOPICAL:GEL:%w/w	TOPICAL	0.05%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D08K3S51E	PROPYLENE CARBONATE:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	56.55%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):SOLUTION/ DROPS:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	10%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:BUCCAL:FILM:mg	BUCCAL	1.48mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:DENTAL:OINTMENT:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:DENTAL:PASTE:%w/w	DENTAL	0.5%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:DENTAL:SOLUTION:%w/w	DENTAL	2%w/w DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	63.4%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	5%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	50.33%w/v INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:NASAL:SOLUTION:mg/100ml	NASAL	12000mg/100ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:NASAL:SPRAY:mg/1ml	NASAL	49.7mg/1ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:NASAL:SPRAY, METERED:mg/1ml	NASAL	50mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	1.5%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.44%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.75%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.6%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.75%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, COATED:mg	ORAL	25mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	1.7mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	14.6mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:DROPS:mg/1ml	ORAL	200mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:ELIXIR:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION, CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:AEROSOL, METERED:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:GEL:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:OINTMENT:%w/w	RECTAL	3.6%w/w RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	10%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	25%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	1.4%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	1.4%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBLINGUAL:SPRAY:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:AEROSOL:%w/w	TOPICAL	19.2%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:CLOTH:mg/mg	TOPICAL	0.03mg/mg TOPICAL CLOTH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	30%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:EMULSION:%w/w	TOPICAL	8%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:GEL, METERED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:JELLY:%w/w	TOPICAL	20%w/w TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:LOTION, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:OINTMENT, AUGMENTED:%w/w	TOPICAL	65%w/w TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SHAMPOO:%w/w	TOPICAL	8%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SPONGE:%w/w	TOPICAL	40%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SUSPENSION:%w/v	TOPICAL	5.28%w/v TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SUSPENSION/ DROPS:%w/v	TOPICAL	0.75%w/v TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SWAB:%w/w	TOPICAL	34.6%w/w TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	58.13mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	6.4%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:GEL:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:SUPPOSITORY:mg	VAGINAL	252mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:TAMPON:mg	VAGINAL	62.1mg VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:EMULSION:mg/1ml	ORAL	0.15mg/1ml ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:POWDER:mg	ORAL	718mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:SUSPENSION:mg/1ml	ORAL	0.15mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5Z492UNF9O	PROPYLENE GLYCOL DIACETATE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	3%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5Z492UNF9O	PROPYLENE GLYCOL DIACETATE:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	3%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5Z492UNF9O	PROPYLENE GLYCOL DIACETATE:TOPICAL:CREAM:%w/w	TOPICAL	10%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
581437HWX2	PROPYLENE GLYCOL DICAPRYLATE:TOPICAL:CREAM:%w/w	TOPICAL	10%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RT9P9S09QI	PROPYLENE GLYCOL MONOCAPRYLATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:TOPICAL:GEL:%w/w	TOPICAL	3%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	9.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:LOTION:%w/w	TOPICAL	4.69%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:OINTMENT:%w/w	TOPICAL	8%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:OINTMENT, AUGMENTED:%w/w	TOPICAL	2%w/w TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:VAGINAL:CREAM:%w/w	VAGINAL	7%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:VAGINAL:SUPPOSITORY:mg	VAGINAL	135mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
MZM1I680W0	PROPYLENE GLYCOL MONOSTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	9.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
MZM1I680W0	PROPYLENE GLYCOL MONOSTEARATE:TOPICAL:LOTION:%w/w	TOPICAL	3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
MZM1I680W0	PROPYLENE GLYCOL MONOSTEARATE:TOPICAL:OINTMENT:%w/w	TOPICAL	8%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:AURICULAR (OTIC):DROPS:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:BUCCAL:FILM:mg	BUCCAL	0.22mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:DENTAL:PASTE, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INFILTRATION:INJECTION:mg	INFILTRATION	0.35mg INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.03%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.02%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	0.4mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION, SUSPENSION:%w/v	INTRAMUSCULAR	0.02%w/v INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:SOLUTION:%w/v	INTRAMUSCULAR	0.02%w/v INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	0.8mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	0.02%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:DROPS:mg	NASAL	14mg NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:JELLY:mg	NASAL	140mg NASAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:SOLUTION:mg	NASAL	140mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:SPRAY:mg	NASAL	0.2mg NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.02%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.01%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.01%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.22mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CONCENTRATE:mg/5ml	ORAL	2.5mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:ELIXIR:mg	ORAL	200mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	4mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION:mg	ORAL	100mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	0.2mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION:mg/5ml	ORAL	200mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SYRUP:mg/5ml	ORAL	200mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET:mg	ORAL	0.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, CHEWABLE:mg	ORAL	0.14mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, COATED:mg	ORAL	0.8mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.12mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, FILM COATED:mg	ORAL	0.04mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:PARENTERAL:INJECTION:	PARENTERAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:ENEMA:%w/w	RECTAL	0.02%w/w RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:SOLUTION:%w/v	RECTAL	0.02%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.01%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.02%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.04%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:EMULSION:%w/w	TOPICAL	0.06%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:JELLY:%w/v	TOPICAL	0.03%w/v TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:LIQUID:%w/w	TOPICAL	0.1%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:OINTMENT:%w/w	TOPICAL	0.2%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.03%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SOLUTION:%w/v	TOPICAL	0.1%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SPRAY:%w/w	TOPICAL	0.8%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:URETHRAL:JELLY:%w/v	URETHRAL	0.03%w/v URETHRAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:CREAM:%w/w	VAGINAL	0.1%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:GEL:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:TABLET:mg	ORAL	0.06mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.1mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:INTRADERMAL:INJECTION:%w/v	INTRADERMAL	0.13%w/v INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.04%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.01%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8ZQ0AYU1TT	PULLULAN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E40U03LEM0	QUATERNIUM-15:TOPICAL:CREAM:%w/w	TOPICAL	0.02%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
E40U03LEM0	QUATERNIUM-15:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
E40U03LEM0	QUATERNIUM-15:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
LIT014L4RH	QUATERNIUM-15 CIS-FORM:TOPICAL:CREAM:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
YS08XHA860	RACEMENTHOL:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
YS08XHA860	RACEMENTHOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:ORAL:TABLET:mg	ORAL	0.09mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.13mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:TOPICAL:SHAMPOO:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
TLM2976OFR	RIBOFLAVIN:ORAL:TABLET:mg	ORAL	0.03mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
I2D0F69854	RICINOLEIC ACID:VAGINAL:GEL:%w/w	VAGINAL	1%w/w VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET, COATED:mg	ORAL	10mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	8.99mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
FST467XS7D	SACCHARIN:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.23%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:DENTAL:POWDER, DENTIFRICE:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:DROPS:mg/1ml	ORAL	20mg/1ml ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:ELIXIR:mg/1ml	ORAL	2mg/1ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:GRANULE, FOR SOLUTION:mg	ORAL	16mg ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SOLUTION:mg/1ml	ORAL	10mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SUSPENSION:mg/5ml	ORAL	12.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:TABLET:mg	ORAL	1.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:TABLET, CHEWABLE:mg	ORAL	0.9mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.05%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	0.05%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:TOPICAL:OINTMENT:%w/w	TOPICAL	0.5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5101OP7P2I	SACCHARIN CALCIUM:ORAL:SOLUTION:mg/5ml	ORAL	17.5mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5101OP7P2I	SACCHARIN CALCIUM:ORAL:SYRUP:mg	ORAL	0.5mg ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:BUCCAL:TABLET:mg	BUCCAL	0.4mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:GEL:%w/w	DENTAL	0.3%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:OINTMENT:NA	DENTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:PASTE:%w/w	DENTAL	0.3%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.2%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:SOLUTION:%w/v	DENTAL	0.05%w/v DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:ELIXIR:mg/5ml	ORAL	15mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:GRANULE, FOR SOLUTION:mg/120ml	ORAL	5.5mg/120ml ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	533.2mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SUSPENSION:mg/5ml	ORAL	5000mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SYRUP:mg/5ml	ORAL	50mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, FILM COATED:mg	ORAL	2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, FOR SUSPENSION:mg	ORAL	0.5mg ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:WAFER:mg	ORAL	8mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RECTAL:SOLUTION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RECTAL:TABLET:mg	RECTAL	0.6mg RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	0.05%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RESPIRATORY (INHALATION):SOLUTION:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	0.2mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.15%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.09%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.09%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:NASAL:DROPS:mg/1ml	NASAL	0.5mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:NASAL:SOLUTION:mg/1ml	NASAL	0.5mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:EMULSION:mg/1ml	ORAL	0.4mg/1ml ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:LIQUID:mg/5ml	ORAL	1.5mg/5ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	18.75mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SUSPENSION:mg/5ml	ORAL	16.65mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SYRUP:mg/5ml	ORAL	3.96mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:TABLET:mg	ORAL	97mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:TABLET, CHEWABLE:mg	ORAL	7.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:TABLET, FILM COATED:mg	ORAL	0.35mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:WAFER:mg	ORAL	4.8mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:RECTAL:SOLUTION:%w/v	RECTAL	0.67%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A9CO00M9HV	SACCHARIN SODIUM MONOHYDRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
65UEH262IS	SAFFLOWER OIL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
78ZX2PFG2Z	SASSAFRAS OIL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	3.5%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
452VLY9402	SERINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
452VLY9402	SERINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.18%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:INTRAMUSCULAR:INJECTION:%v/v	INTRAMUSCULAR	70%v/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
K49155WL9Y	SHEA BUTTER:TOPICAL:LOTION:%w/w	TOPICAL	2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE:mg	ORAL	34.48mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	29mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	75.01mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:SUSPENSION:mg/1ml	ORAL	3mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, COATED:mg	ORAL	30mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	21.44mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	213.24mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, FILM COATED:mg	ORAL	4.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:SUBLINGUAL:FILM:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:CAPSULE:mg	ORAL	0.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:ORAL:POWDER, FOR SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:TOPICAL:CREAM:%w/w	TOPICAL	0.4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:BUCCAL:TABLET:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:DENTAL:GEL:%w/w	DENTAL	19%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:DENTAL:PASTE:%w/w	DENTAL	34%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:NASAL:GEL:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE:mg	ORAL	100mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, COATED PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE:mg	ORAL	5000mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, DELAYED RELEASE:mg	ORAL	3.2mg ORAL GRANULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, FOR SOLUTION:mg/120ml	ORAL	1.8mg/120ml ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DELAYED RELEASE PARTICLES:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:RECTAL:SUPPOSITORY:mg	RECTAL	14mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:RESPIRATORY (INHALATION):CAPSULE:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:RESPIRATORY (INHALATION):POWDER:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TOPICAL:CREAM:%w/w	TOPICAL	3.4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TOPICAL:GEL:%w/w	TOPICAL	0.25%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	49mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:CREAM:%w/w	VAGINAL	1.01%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:GEL:%w/w	VAGINAL	8%w/w VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:TAMPON:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
9T3UU8T0QK	SILODRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
9T3UU8T0QK	SILODRATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2YZU14UIFP	SODIUM 1,2-ETHANEDISULFONATE:ORAL:SOLUTION:mg/5ml	ORAL	1mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2YZU14UIFP	SODIUM 1,2-ETHANEDISULFONATE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.02%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SOLUTION/ DROPS:%w/w	AURICULAR (OTIC)	0.03%w/w AURICULAR (OTIC) SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.68%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRACAVITARY:INJECTION:ml	INTRACAVITARY	0.1ml INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRADERMAL:INJECTION:mg	INTRADERMAL	1.6mg INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.97%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAOCULAR:SOLUTION:mg	INTRAOCULAR	3.9mg INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:LIQUID:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.39%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:EMULSION:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.07%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.24%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:POWDER, FOR SOLUTION:mg	ORAL	0.1mg ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:SYRUP:mg/5ml	ORAL	21.45mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:PARENTERAL:INJECTION:mg	PARENTERAL	103.7mg PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:PARENTERAL:INJECTION, POWDER, FOR SOLUTION:mg	PARENTERAL	12.5mg PARENTERAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.16%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:LIQUID:%w/v	SUBCUTANEOUS	0.2%w/v SUBCUTANEOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:SOLUTION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBMUCOSAL:INJECTION, SOLUTION:%w/v	SUBMUCOSAL	0.08%w/v SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.47%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	0.25%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.09%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:SOLUTION:mg	INTRAVENOUS	177mg INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.03%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:ORAL:SOLUTION:mg	ORAL	177mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:ORAL:SYRUP:mg/1ml	ORAL	4.1mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.16%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:SUBCUTANEOUS:SOLUTION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:CAPSULE:mg	ORAL	80mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:SYRUP:mg/1ml	ORAL	3mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:TOPICAL:LIQUID:%w/w	TOPICAL	0.25%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
058TS43PSM	SODIUM ALUMINOSILICATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
058TS43PSM	SODIUM ALUMINOSILICATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:INTRADERMAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRADERMAL	0.5mg INTRADERMAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	2.88%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:SUSPENSION, EXTENDED RELEASE:mg/5ml	ORAL	16.4mg/5ml ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:TABLET:mg	ORAL	15mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	0.5mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:DENTAL:GEL:%w/w	DENTAL	0.08%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:DENTAL:PASTE:%w/w	DENTAL	0.08%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.5%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	4.8%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	0.1%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:CAPSULE:mg	ORAL	8.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:ELIXIR:mg/5ml	ORAL	5.02mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:GRANULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:GRANULE, EFFERVESCENT:mg	ORAL	60mg ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET:mg	ORAL	30mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, COATED:mg	ORAL	0.2mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.34mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:RECTAL:ENEMA:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:RECTAL:GEL:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:CREAM:%w/w	TOPICAL	0.2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.1%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:SPONGE:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:BUCCAL:TABLET:mg	BUCCAL	42mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	35mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	1000mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAPERITONEAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRATHECAL:INJECTION:mg	INTRATHECAL	0.05mg INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	812mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.37%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVITREAL:INJECTION:%w/v	INTRAVITREAL	0.18%w/v INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:GRANULE, EFFERVESCENT:mg	ORAL	267mg ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:GUM, CHEWING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:POWDER, FOR SOLUTION:mg/100ml	ORAL	1250mg/100ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET:mg	ORAL	1300mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, CHEWABLE:mg	ORAL	140mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, COATED:mg	ORAL	10.6mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	30mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	2.56mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	2%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.32%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.32%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:ORAL:CONCENTRATE:mg/1ml	ORAL	0.95mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.01%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.1%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A9IO7TF4S0	SODIUM BISULFATE ACETONE:INFILTRATION:INJECTION:mg	INFILTRATION	2mg INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.08%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.32%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRACARDIAC:INJECTION:%w/v	INTRACARDIAC	0.1%w/v INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.32%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.66%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	51.8mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAPERITONEAL:INJECTION:%w/v	INTRAPERITONEAL	0.66%w/v INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	0.32%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	50mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	51.8mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.05%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IONTOPHORESIS:SOLUTION:%w/v	IONTOPHORESIS	0.06%w/v IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IRRIGATION:INJECTION:%w/w	IRRIGATION	0.66%w/w IRRIGATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.06%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.06%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.06%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:CAPSULE:mg	ORAL	0.36mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:CONCENTRATE:mg/1ml	ORAL	0.5mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:SOLUTION:mg	ORAL	1mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:RESPIRATORY (INHALATION):INHALANT:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	0.3%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.3%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.1%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.22%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:CREAM:%w/w	TOPICAL	0.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:POWDER, FOR SOLUTION:%w/v	TOPICAL	0.1%w/v TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.06%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
75E63I9H07	SODIUM BITARTRATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	306mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.3%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.11%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.1%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.03%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V1Q1CE5CWQ	SODIUM C10-18 ALKANESULFONATES:TOPICAL:SHAMPOO, SUSPENSION:%w/w	TOPICAL	2.5%w/w TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:BUCCAL:TABLET:mg	BUCCAL	20mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INFILTRATION:INJECTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRA-ARTERIAL:INJECTION, SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	32.4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	630mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVASCULAR:INJECTION, SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	241mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	1000mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.01%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	6mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:GUM, CHEWING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET:mg	ORAL	10.4mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:TOPICAL:SOAP:%w/w	TOPICAL	0.5%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:INTRA-ARTERIAL:INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:INTRACARDIAC:INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	6mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7ZBS06BH4B	SODIUM CETOSTEARYL SULFATE:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T95DR77GMR	SODIUM CHLORATE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.45%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AURICULAR (OTIC):SOLUTION:	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.9%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:DENTAL:INJECTION:%w/v	DENTAL	0.4%w/v DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:DENTAL:POWDER, DENTIFRICE:mg/mg	DENTAL	0.03mg/mg DENTAL POWDER, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ENDOTRACHEAL:INJECTION:	ENDOTRACHEAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ENDOTRACHEAL:POWDER, FOR SUSPENSION:mg	ENDOTRACHEAL	46.76mg ENDOTRACHEAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ENDOTRACHEAL:SUSPENSION:mg	ENDOTRACHEAL	7.6mg ENDOTRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:INJECTION:	EPIDURAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:INJECTION, SOLUTION:	EPIDURAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:SOLUTION:%w/v	EPIDURAL	0.9%w/v EPIDURAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INFILTRATION:INJECTION:	INFILTRATION		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INFILTRATION:INJECTION, SOLUTION:	INFILTRATION		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:INJECTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRA-ARTERIAL	1.35mg INTRA-ARTERIAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:INJECTION, SOLUTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRABURSAL:INJECTION:mg	INTRABURSAL	9mg INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACARDIAC:INJECTION:	INTRACARDIAC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAUDAL:INJECTION:	INTRACAUDAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAUDAL:INJECTION, SOLUTION:%w/v	INTRACAUDAL	0.7%w/v INTRACAUDAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAVITARY:INJECTION:%w/v	INTRACAVITARY	0.82%w/v INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRADERMAL:INJECTION:mg	INTRADERMAL	7mg INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.9%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	226mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAMUSCULAR	0.86%w/v INTRAMUSCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:LIQUID:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:SUSPENSION:mg	INTRAMUSCULAR	9mg INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAOCULAR	0.86%w/v INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAOCULAR:SOLUTION:mg	INTRAOCULAR	6.4mg INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAPERITONEAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRAPERITONEAL	226mg INTRAPERITONEAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAPERITONEAL:SOLUTION:%w/v	INTRAPERITONEAL	0.54%w/v INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAPLEURAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRAPLEURAL	226mg INTRAPLEURAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	0.9%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION:mg	INTRATHECAL	196mg INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRATHECAL	1.35mg INTRATHECAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION, SOLUTION:	INTRATHECAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATUMOR:INJECTION:%w/v	INTRATUMOR	1.2%w/v INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATYMPANIC:SUSPENSION:%w/w	INTRATYMPANIC	0.43%w/w INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVASCULAR:INJECTION:%w/v	INTRAVASCULAR	0.86%w/v INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVASCULAR:SOLUTION:NA	INTRAVASCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	0.62%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	487mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	0.86%w/v INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, SUSPENSION:%w/v	INTRAVENOUS	0.9%w/v INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:LIQUID:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVESICAL:INJECTION, SOLUTION:	INTRAVESICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVITREAL:INJECTION:%w/v	INTRAVITREAL	10%w/v INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVITREAL:INJECTION, SUSPENSION:	INTRAVITREAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IONTOPHORESIS:SOLUTION:%w/v	IONTOPHORESIS	0.6%w/v IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	3.1mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:DROPS:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:JELLY:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:LIQUID:mg/1ml	NASAL	7.4mg/1ml NASAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SOLUTION:mg	NASAL	330mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:DROPS:%w/w	OPHTHALMIC	0.08%w/w OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.06%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SOLUTION:%w/w	OPHTHALMIC	0.9%w/w OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.9%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SUSPENSION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.51%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:ELIXIR:mg	ORAL	1mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, CHEWABLE:mg	ORAL	7.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, COATED:mg	ORAL	54.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	335.1mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	46.8mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PARENTERAL:INJECTION:	PARENTERAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PARENTERAL:INJECTION, SOLUTION:%w/v	PARENTERAL	0.8%w/v PARENTERAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PERIDURAL:INJECTION:mg	PERIDURAL	8.07mg PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PERINEURAL:INJECTION:	PERINEURAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RECTAL:ENEMA:%w/w	RECTAL	0.7%w/w RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RECTAL:SOLUTION:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RECTAL:SUPPOSITORY:mg	RECTAL	52.5mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):INHALANT:mg	RESPIRATORY (INHALATION)	3mg RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):POWDER:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):SOLUTION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):SUSPENSION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RETROBULBAR:INJECTION:%w/v	RETROBULBAR	0.86%w/v RETROBULBAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.9%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBARACHNOID:INJECTION, SOLUTION:%w/v	SUBARACHNOID	0.9%w/v SUBARACHNOID INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	77mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:%w/v	SUBCUTANEOUS	0.68%w/v SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, POWDER, FOR SUSPENSION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, SOLUTION, CONCENTRATE:%w/v	SUBCUTANEOUS	0.86%w/v SUBCUTANEOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.8%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:LIQUID:%w/v	SUBCUTANEOUS	0.7%w/v SUBCUTANEOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.8%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBMUCOSAL:INJECTION:	SUBMUCOSAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBMUCOSAL:INJECTION, SOLUTION:%w/v	SUBMUCOSAL	16%w/v SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:CREAM:%w/w	TOPICAL	0.4%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:GEL:%w/w	TOPICAL	0.18%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:LOTION:%w/v	TOPICAL	0.3%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SHAMPOO:%w/w	TOPICAL	6%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SOAP:%w/w	TOPICAL	1.26%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.9%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SOLUTION/ DROPS:%w/v	TOPICAL	0.86%w/v TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SUSPENSION:%w/v	TOPICAL	0.32%w/v TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SUSPENSION/ DROPS:%w/v	TOPICAL	0.23%w/v TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SYSTEM:mg	TOPICAL	3.1mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:VAGINAL:GEL:%w/w	VAGINAL	10%w/w VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
518XTE8493	SODIUM COCOYL ISETHIONATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	1%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
436LS6U35Y	SODIUM DESOXYCHOLATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
436LS6U35Y	SODIUM DESOXYCHOLATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	41mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
RPF7Z41GAW	SODIUM DITHIONATE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
RPF7Z41GAW	SODIUM DITHIONATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2K5B8F6ES1	SODIUM DITHIONITE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	1mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	3mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	3mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	0.1%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	3mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R6Q3791S76	SODIUM GLUCONATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	3mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R6Q3791S76	SODIUM GLUCONATE:ORAL:SOLUTION:mg/1ml	ORAL	2.5mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R6Q3791S76	SODIUM GLUCONATE:ORAL:TABLET:mg	ORAL	59mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.8%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AURICULAR (OTIC):SOLUTION/ DROPS:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AURICULAR (OTIC):SUSPENSION:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:BUCCAL:FILM:mg	BUCCAL	0.09mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	2mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:INJECTION:ADJ PH	DENTAL	ADJ PH DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:PASTE:%w/w	DENTAL	0.6%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:SOLUTION:ADJ PH	DENTAL	ADJ PH DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ENDOTRACHEAL:INJECTION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ENDOTRACHEAL:POWDER, FOR SUSPENSION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ENDOTRACHEAL:SUSPENSION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:INJECTION, SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EXTRACORPOREAL:INJECTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INFILTRATION:INJECTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INFILTRATION:INJECTION, SOLUTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTERSTITIAL:INJECTION:ADJ PH	INTERSTITIAL	ADJ PH INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-AMNIOTIC:INJECTION:ADJ PH	INTRA-AMNIOTIC	ADJ PH INTRA-AMNIOTIC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTION:mg	INTRA-ARTERIAL	176mg INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTION, SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTION, SOLUTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTION, SUSPENSION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:SUSPENSION, EXTENDED RELEASE:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACARDIAC:INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAUDAL:INJECTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAUDAL:INJECTION, SOLUTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAVITARY:INJECTION:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAVITARY:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADERMAL:INJECTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADERMAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADERMAL:SUSPENSION, EXTENDED RELEASE:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADISCAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRADISCAL	ADJ PH INTRADISCAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:INJECTION, SUSPENSION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:SUSPENSION, EXTENDED RELEASE:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	176mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	7.01mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAMUSCULAR	0.35%w/v INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.13%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, SUSPENSION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:LIQUID:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:mg	INTRAMUSCULAR	5.4mg INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAOCULAR:SOLUTION:ADJ PH	INTRAOCULAR	ADJ PH INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAPERITONEAL:INJECTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAPERITONEAL:SOLUTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASPINAL:INJECTION:ADJ PH	INTRASPINAL	ADJ PH INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:INJECTION, SUSPENSION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:SUSPENSION, EXTENDED RELEASE:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION:mg	INTRATHECAL	176mg INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION, SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATUMOR:INJECTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATUMOR:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVASCULAR:INJECTION, SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVASCULAR:SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	176mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, EMULSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	136.55mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	78.36mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	2.83%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	2.78%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION, CONCENTRATE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVESICAL:INJECTION, SOLUTION:ADJ PH	INTRAVESICAL	ADJ PH INTRAVESICAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVITREAL:INJECTION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVITREAL:INJECTION, SUSPENSION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IONTOPHORESIS:SOLUTION:ADJ PH	IONTOPHORESIS	ADJ PH IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SOLUTION:mg	NASAL	20mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SPRAY:ADJ PH	NASAL	ADJ PH NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SPRAY, METERED:ADJ PH	NASAL	ADJ PH NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:DROPS:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.02%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	1.85%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.05%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.59%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SUSPENSION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE:mg	ORAL	60mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, COATED:mg	ORAL	0.08mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.01mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	0.25mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	1.5mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CONCENTRATE:mg/5ml	ORAL	10mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:ELIXIR:ADJ PH	ORAL	ADJ PH ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:EMULSION:ADJ PH	ORAL	ADJ PH ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:FILM, SOLUBLE:mg	ORAL	1.84mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:GRANULE, FOR SUSPENSION:ADJ PH	ORAL	ADJ PH ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:LIQUID:mg/5ml	ORAL	2mg/5ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:POWDER, FOR SOLUTION:ADJ PH	ORAL	ADJ PH ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SUSPENSION:mg	ORAL	400mg ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SYRUP:mg/5ml	ORAL	71mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:INJECTION, SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PERIDURAL:INJECTION:ADJ PH	PERIDURAL	ADJ PH PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PERINEURAL:INJECTION:ADJ PH	PERINEURAL	ADJ PH PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PERIODONTAL:SOLUTION:ADJ PH	PERIODONTAL	ADJ PH PERIODONTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RECTAL:ENEMA:%v/v	RECTAL	0.44%v/v RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RECTAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	RECTAL	ADJ PH RECTAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RECTAL:SOLUTION:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):AEROSOL, METERED:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):POWDER:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):SOLUTION:%w/v	RESPIRATORY (INHALATION)	8%w/v RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RETROBULBAR:INJECTION:ADJ PH	RETROBULBAR	ADJ PH RETROBULBAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SOFT TISSUE:INJECTION, SUSPENSION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBARACHNOID:INJECTION, SOLUTION:ADJ PH	SUBARACHNOID	ADJ PH SUBARACHNOID INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCONJUNCTIVAL:INJECTION:ADJ PH	SUBCONJUNCTIVAL	ADJ PH SUBCONJUNCTIVAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	31.45mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	1%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION, SUSPENSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SUSPENSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SUSPENSION, EXTENDED RELEASE:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBMUCOSAL:INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBMUCOSAL:INJECTION, SOLUTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:AEROSOL, FOAM:ADJ PH	TOPICAL	ADJ PH TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	2.72%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:DISC:ADJ PH	TOPICAL	ADJ PH TOPICAL DISC	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:EMULSION:%w/w	TOPICAL	0.2%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:GEL:%w/w	TOPICAL	3.2%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:JELLY:ADJ PH	TOPICAL	ADJ PH TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:LIQUID:ADJ PH	TOPICAL	ADJ PH TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:LOTION, AUGMENTED:ADJ PH	TOPICAL	ADJ PH TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:OINTMENT:ADJ PH	TOPICAL	ADJ PH TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:OINTMENT, AUGMENTED:%w/w	TOPICAL	0.11%w/w TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SHAMPOO:ADJ PH	TOPICAL	ADJ PH TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SOLUTION/ DROPS:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SPONGE:ADJ PH	TOPICAL	ADJ PH TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SUSPENSION/ DROPS:ADJ PH	TOPICAL	ADJ PH TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SWAB:%w/w	TOPICAL	0.01%w/w TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	0.85mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:GEL, METERED:%w/w	TRANSDERMAL	7%w/w TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:URETERAL:SOLUTION:ADJ PH	URETERAL	ADJ PH URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:URETHRAL:SOLUTION:ADJ PH	URETHRAL	ADJ PH URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:VAGINAL:CREAM:%w/w	VAGINAL	0.19%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:VAGINAL:GEL:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DY38VHM5OD	SODIUM HYPOCHLORITE:ORAL:SUSPENSION:mg/1ml	ORAL	3mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
F5WR8N145C	SODIUM IODIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	10mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
F5WR8N145C	SODIUM IODIDE:TOPICAL:SPONGE:%w/w	TOPICAL	0.74%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
F5WR8N145C	SODIUM IODIDE:VAGINAL:DOUCHE:%w/w	VAGINAL	0.75%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INFILTRATION:INJECTION, SOLUTION:%v/v	INFILTRATION	0.17%v/v INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAPERITONEAL:SOLUTION:%w/v	INTRAPERITONEAL	0.45%w/v INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	18.7mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:ORAL:SUSPENSION:mg/1ml	ORAL	20mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:TOPICAL:SOLUTION:%w/w	TOPICAL	0.93%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:INTRACARDIAC:INJECTION:%w/v	INTRACARDIAC	0.18%w/v INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	0.18%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.18%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.18%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ZZQ59TY3KG	SODIUM LAURETH-2 SULFATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	47.6%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:ORAL:CAPSULE:mg	ORAL	3.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:ORAL:TABLET:mg	ORAL	0.91mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:TOPICAL:SHAMPOO:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:TOPICAL:SPRAY:%w/w	TOPICAL	0.1%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
410Q7WN1BX	SODIUM LAURETH-5 SULFATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	38%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
632GS99618	SODIUM LAUROYL SARCOSINATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
632GS99618	SODIUM LAUROYL SARCOSINATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	12.5%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
632GS99618	SODIUM LAUROYL SARCOSINATE:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.75%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:BUCCAL:TABLET:mg	BUCCAL	5.18mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:DENTAL:GEL:%w/w	DENTAL	1.47%w/w DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:DENTAL:PASTE:%w/w	DENTAL	1.5%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	1.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	0.06mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	3.3mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:SUSPENSION:mg	ORAL	705mg ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:SUSPENSION, EXTENDED RELEASE:mg/1ml	ORAL	0.02mg/1ml ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, EFFERVESCENT:mg	ORAL	1.5mg ORAL TABLET, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10.5mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:RESPIRATORY (INHALATION):CAPSULE:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:RESPIRATORY (INHALATION):POWDER:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.1mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:GEL:%w/w	TOPICAL	0.05%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:LOTION:%w/w	TOPICAL	0.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	65%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	40%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SPONGE:%w/w	TOPICAL	5%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:GEL:%w/w	VAGINAL	0.2%w/w VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:POWDER:mg	VAGINAL	3mg VAGINAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
D0Y70F2B9J	SODIUM LAURYL SULFOACETATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.75%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
D0Y70F2B9J	SODIUM LAURYL SULFOACETATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	3%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:EPIDURAL:INJECTION:%w/v	EPIDURAL	0.05%w/v EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INFILTRATION:INJECTION:%w/v	INFILTRATION	0.5%w/v INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INFILTRATION:INJECTION, SOLUTION:%w/v	INFILTRATION	0.05%w/v INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.2%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRABURSAL:INJECTION:%w/v	INTRABURSAL	0.2%w/v INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRACARDIAC:INJECTION:%w/v	INTRACARDIAC	0.09%w/v INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.1%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAMUSCULAR:INJECTION:%w/v	INTRAMUSCULAR	27.5%w/v INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAMUSCULAR:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAMUSCULAR	0.15%w/v INTRAMUSCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAOCULAR	0.15%w/v INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAPERITONEAL:INJECTION:%w/v	INTRAPERITONEAL	0.33%w/v INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	27.5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	0.03%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	0.15%w/v INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IONTOPHORESIS:SOLUTION:%w/v	IONTOPHORESIS	0.05%w/v IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	0.5mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.2%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.1%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:CAPSULE:mg	ORAL	0.36mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:CONCENTRATE:mg/1ml	ORAL	2mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:LIQUID:mg/5ml	ORAL	1mg/5ml ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SUSPENSION, EXTENDED RELEASE:mg/5ml	ORAL	5mg/5ml ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:TABLET:mg	ORAL	8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:TABLET, CHEWABLE:mg	ORAL	0.2mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:PERIDURAL:INJECTION:NA	PERIDURAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:PERINEURAL:INJECTION:%w/v	PERINEURAL	0.05%w/v PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:RECTAL:TABLET:mg	RECTAL	2mg RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.3%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.1%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBCUTANEOUS:INJECTION, SOLUTION, CONCENTRATE:%w/v	SUBCUTANEOUS	0.15%w/v SUBCUTANEOUS INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBMUCOSAL:INJECTION:	SUBMUCOSAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBMUCOSAL:INJECTION, SOLUTION:%w/v	SUBMUCOSAL	5%w/v SUBMUCOSAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.2%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:LOTION:%w/v	TOPICAL	0.2%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:SOAP:%w/w	TOPICAL	0.36%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.32%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:SYSTEM:mg	TOPICAL	0.5mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GQ3AN47ZIY	SODIUM METAPHOSPHATE, INSOLUBLE:TOPICAL:SOAP:%w/w	TOPICAL	1.44%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
JVL98CG53G	SODIUM METHYL COCOYL TAURATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	65%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3L6NN8ZZKU	SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3L6NN8ZZKU	SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3L6NN8ZZKU	SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	INTRAVENOUS	0.32%w/v INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8M4L3H2ZVZ	SODIUM NITRATE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	1.18%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
399SL044HN	SODIUM OLEATE:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:BUCCAL:MOUTHWASH:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRADERMAL:INJECTION:%w/v	INTRADERMAL	0.2%w/v INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	10.6mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	24.75mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.14%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	10.6mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	24.75mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.14%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:NASAL:SOLUTION:mg/1ml	NASAL	1.89mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.81%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	0.29%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.2%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:CAPSULE:mg	ORAL	36mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:INJECTION:mg	ORAL	10.35mg ORAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:SOLUTION:mg/5ml	ORAL	27mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:SUSPENSION:mg	ORAL	40mg ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:SYRUP:mg/1ml	ORAL	1.5mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:TABLET:mg	ORAL	16mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.38%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.15%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:SOAP:%w/w	TOPICAL	0.21%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRADERMAL:INJECTION:%w/v	INTRADERMAL	0.2%w/v INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	40mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	40mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	200mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	40mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	32.5mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:NASAL:SPRAY:mg	NASAL	0.86mg NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:NASAL:SPRAY, METERED:mg/1ml	NASAL	3mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.51%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.43%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:CONCENTRATE:mg/5ml	ORAL	17mg/5ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:LOZENGE:mg	ORAL	31mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:SOLUTION:mg/1ml	ORAL	40mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:SYRUP:mg/5ml	ORAL	13.7mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	2.98mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:TOPICAL:CREAM:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:TOPICAL:OINTMENT:%w/w	TOPICAL	0.03%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:TRANSMUCOSAL:LOZENGE:mg	TRANSMUCOSAL	28mg TRANSMUCOSAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:BUCCAL:FILM:mg	BUCCAL	0.35mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRALESIONAL:INJECTION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	139.2mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAOCULAR:INSERT:mg	INTRAOCULAR	0.02mg INTRAOCULAR INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRATHECAL:INJECTION, SOLUTION:	INTRATHECAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	0.28%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	139.2mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	15mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:LIQUID:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVESICAL:INJECTION, SOLUTION:mg	INTRAVESICAL	38.25mg INTRAVESICAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SOLUTION:mg	NASAL	5mg NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SPRAY:mg/0.1ml	NASAL	0.21mg/0.1ml NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1.21%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.4%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:CAPSULE:mg	ORAL	40mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:FILM, SOLUBLE:mg	ORAL	0.05mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:LOZENGE:mg	ORAL	31mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SYRUP:mg/1ml	ORAL	3.5mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, FILM COATED:mg	ORAL	0.01mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TROCHE:mg	ORAL	28mg ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	0.03mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.11%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.09%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:CREAM:%w/w	TOPICAL	0.36%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:SOLUTION/ DROPS:%w/v	TOPICAL	0.14%w/v TOPICAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:NASAL:SPRAY, METERED:mg/1ml	NASAL	3mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.2%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:SOLUTION:mg/1ml	ORAL	2.5mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:SUSPENSION:mg/120ml	ORAL	1030mg/120ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.14%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.14%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:TOPICAL:CREAM:%w/w	TOPICAL	0.25%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:TOPICAL:GEL:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.39%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.67%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.06%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.06%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	0.3%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.5%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.56%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRA-ARTICULAR:INJECTION, SUSPENSION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	200mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	80mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAMUSCULAR	279.27mg INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.34%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	200mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	80mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	279.27mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVITREAL:INJECTION:%w/v	INTRAVITREAL	1.33%w/v INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVITREAL:INJECTION, SUSPENSION:	INTRAVITREAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:NASAL:SPRAY, METERED:mg/1ml	NASAL	4.86mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	2.15%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	2.15%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.48%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.48%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:CAPSULE:mg	ORAL	500mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET:mg	ORAL	80mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, COATED:mg	ORAL	0.22mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	16.24mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	70mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	105mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SOFT TISSUE:INJECTION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.38%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	3.2mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	3.43mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.38%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:CREAM:%w/w	TOPICAL	0.34%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:LOTION:%w/w	TOPICAL	1.59%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:OINTMENT:%w/w	TOPICAL	0.15%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:SOLUTION:%w/w	TOPICAL	49.78%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:SPONGE:%w/w	TOPICAL	0.9%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:VAGINAL:DOUCHE:%w/w	VAGINAL	0.15%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:BUCCAL:FILM, SOLUBLE:mg	BUCCAL	0.03mg BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRA-ARTICULAR:INJECTION, SUSPENSION:%w/v	INTRA-ARTICULAR	0.68%w/v INTRA-ARTICULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRALESIONAL:INJECTION, SUSPENSION:%w/v	INTRALESIONAL	0.68%w/v INTRALESIONAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:%w/v	INTRAMUSCULAR	0.18%w/v INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRAMUSCULAR:INJECTION, SUSPENSION:%w/v	INTRAMUSCULAR	0.68%w/v INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	13.2mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:IONTOPHORESIS:SYSTEM:mg	IONTOPHORESIS	14.2mg IONTOPHORESIS SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.31%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:ORAL:SOLUTION:mg/5ml	ORAL	25mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:ORAL:SYRUP:mg/5ml	ORAL	0.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:SOFT TISSUE:INJECTION, SUSPENSION:%w/v	SOFT TISSUE	0.68%w/v SOFT TISSUE INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	0.22mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:SUBCUTANEOUS:INJECTION, SUSPENSION:%w/v	SUBCUTANEOUS	0.07%w/v SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:CREAM:%w/w	TOPICAL	0.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.2%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:LOTION:%w/w	TOPICAL	0.3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:LOTION, AUGMENTED:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:SOLUTION:%w/v	TOPICAL	0.1%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:SYSTEM:mg	TOPICAL	14.2mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:AURICULAR (OTIC):DROPS:%w/w	AURICULAR (OTIC)	1.1%w/w AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.13%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:BUCCAL:FILM:mg	BUCCAL	1.09mg BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	18.81mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.62%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:mg	INTRAMUSCULAR	7.5mg INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAOCULAR:INSERT:mg	INTRAOCULAR	0.01mg INTRAOCULAR INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVASCULAR:INJECTION:%w/v	INTRAVASCULAR	0.01%w/v INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	12.8mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	18.81mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.62%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:SOLUTION:mg	INTRAVENOUS	40mg INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVESICAL:SOLUTION:mg	INTRAVESICAL	0.12mg INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.78%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.46%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.65%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	0.44%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:SYRUP:mg/1ml	ORAL	0.7mg/1ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET:mg	ORAL	4.18mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	23.4mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	30.97mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	33.1mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	0.2mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	1.1mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:LOTION:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	1%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:SOLUTION:%w/v	TOPICAL	0.47%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:VAGINAL:CREAM:ADJ PH	VAGINAL	ADJ PH VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	12.8mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRATHECAL:INJECTION, SOLUTION:%w/v	INTRATHECAL	0.01%w/v INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	12.8mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	1.6mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.3%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	1.15%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.3%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	SUBCUTANEOUS	1.3mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	0.3%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:TOPICAL:GEL:%w/w	TOPICAL	0.02%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRA-ARTICULAR:INJECTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRA-ARTICULAR:INJECTION, SUSPENSION:%w/v	INTRA-ARTICULAR	0.04%w/v INTRA-ARTICULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRALESIONAL:INJECTION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRALESIONAL:INJECTION, SUSPENSION:	INTRALESIONAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	1.84mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAMUSCULAR	15.55mg INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTION, SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:%w/v	INTRAMUSCULAR	0.38%w/v INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRASYNOVIAL:INJECTION, SUSPENSION:	INTRASYNOVIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVASCULAR:INJECTION:mg	INTRAVASCULAR	0.15mg INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	13.61mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	15.55mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVESICAL:SOLUTION:mg	INTRAVESICAL	0.12mg INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVITREAL:INJECTION:%w/v	INTRAVITREAL	0.86%w/v INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.04%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1.27%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.04%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:CAPSULE:mg	ORAL	600mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:INJECTION:mg	ORAL	10.06mg ORAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:SYRUP:mg/5ml	ORAL	20.6mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:TABLET:mg	ORAL	31.72mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	35mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:TABLET, FILM COATED:mg	ORAL	0.11mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:SOFT TISSUE:INJECTION, SUSPENSION:	SOFT TISSUE		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:SUBCUTANEOUS:SUSPENSION:%w/v	SUBCUTANEOUS	0.07%w/v SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:LOTION, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:SOLUTION:%w/v	TOPICAL	0.46%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A752Q30A6X	SODIUM PHOSPHATE, TRIBASIC:BUCCAL:FILM, SOLUBLE:mg	BUCCAL	0.03mg BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A752Q30A6X	SODIUM PHOSPHATE, TRIBASIC:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A752Q30A6X	SODIUM PHOSPHATE, TRIBASIC:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SX01TZO3QZ	SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SX01TZO3QZ	SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
B70850QPHR	SODIUM PHOSPHATE, TRIBASIC, DODECAHYDRATE:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
B70850QPHR	SODIUM PHOSPHATE, TRIBASIC, DODECAHYDRATE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	4.3mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	4.3mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	88mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:TABLET:mg	ORAL	88mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	24.5mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	4.3mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X65D416703	SODIUM PHOSPHITE:INTRAMUSCULAR:INJECTION, POWDER, FOR SOLUTION:mg	INTRAMUSCULAR	20mg INTRAMUSCULAR INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X65D416703	SODIUM PHOSPHITE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P1BM4ZH95L	SODIUM POLYMETAPHOSPHATE:BUCCAL:SOLUTION:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P1BM4ZH95L	SODIUM POLYMETAPHOSPHATE:ORAL:SUSPENSION:mg/1ml	ORAL	1mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:OPHTHALMIC:SUSPENSION:%v/v	OPHTHALMIC	0.25%v/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.25%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	170.4mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	12.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:SUSPENSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O352864B8Z	SODIUM PYROPHOSPHATE:BUCCAL:SOLUTION:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O352864B8Z	SODIUM PYROPHOSPHATE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	1%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O352864B8Z	SODIUM PYROPHOSPHATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	12mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
469OTG57A2	SODIUM PYRROLIDONE CARBOXYLATE:TOPICAL:LOTION:%w/w	TOPICAL	5.2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
WIQ1H85SYP	SODIUM SALICYLATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	250mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
IJF18F77L3	SODIUM SILICATE:TOPICAL:SOAP:%w/w	TOPICAL	0.36%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:BUCCAL:TABLET:mg	BUCCAL	10mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	16.71mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET:mg	ORAL	876mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	10mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H8AV0SQX4D	SODIUM STARCH GLYCOLATE TYPE A:SUBLINGUAL:TABLET:mg	SUBLINGUAL	10mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SP4S77AHO6	SODIUM STARCH GLYCOLATE TYPE B:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SP4S77AHO6	SODIUM STARCH GLYCOLATE TYPE B:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SP4S77AHO6	SODIUM STARCH GLYCOLATE TYPE B:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SP4S77AHO6	SODIUM STARCH GLYCOLATE TYPE B:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET:mg	ORAL	9.48mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.85mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	8.4mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, GELATIN COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:GRANULE, FOR SOLUTION:mg/120ml	ORAL	18.2mg/120ml ORAL GRANULE, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	3.74mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, COATED:mg	ORAL	1.18mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	16mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
U16QOD6C4E	SODIUM SUCCINATE HEXAHYDRATE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	27mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	1.2%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:OPHTHALMIC:SUSPENSION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:ORAL:TABLET:mg	ORAL	182mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	16.24mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	5%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:TOPICAL:SOAP:%w/w	TOPICAL	0.05%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	1.14%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.15%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:OPHTHALMIC:SOLUTION/ DROPS:%w/w	OPHTHALMIC	0.17%w/w OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	1.2%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:ORAL:TABLET:mg	ORAL	96mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:RESPIRATORY (INHALATION):SOLUTION:%w/w	RESPIRATORY (INHALATION)	0.03%w/w RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:TOPICAL:SOLUTION:%w/v	TOPICAL	0.15%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:AURICULAR (OTIC):SOLUTION:%w/v	AURICULAR (OTIC)	0.02%w/v AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:EPIDURAL:INJECTION:%w/v	EPIDURAL	0.1%w/v EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	0.1%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRA-ARTICULAR:INJECTION, SOLUTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	0.1%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.2%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:CAPSULE:mg	ORAL	0.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:CONCENTRATE:mg/1ml	ORAL	0.3mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:SUSPENSION:mg/1ml	ORAL	1.15mg/1ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:SOFT TISSUE:INJECTION:%w/v	SOFT TISSUE	0.1%w/v SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.15%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:TOPICAL:SHAMPOO:%w/w	TOPICAL	0.05%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
07RIK6QMEW	SODIUM TALLOWATE, BEEF:TOPICAL:SOAP:%w/w	TOPICAL	80%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QTO9JB4MDD	SODIUM TARTRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QTO9JB4MDD	SODIUM TARTRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QTO9JB4MDD	SODIUM TARTRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	0.4%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	0.4%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.5%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.31%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SUSPENSION:%w/w	OPHTHALMIC	0.32%w/w OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SUSPENSION/ DROPS:%w/w	OPHTHALMIC	3.15%w/w OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:CAPSULE:mg	ORAL	20mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:SOLUTION:mg/1ml	ORAL	22mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:SOLUTION/ DROPS:mg/1ml	ORAL	0.5mg/1ml ORAL SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.1%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0IYT1O31N	SODIUM THIOSULFATE ANHYDROUS:INTRAVENOUS:SOLUTION:mg	INTRAVENOUS	1.9mg INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0IYT1O31N	SODIUM THIOSULFATE ANHYDROUS:ORAL:SOLUTION:mg	ORAL	2mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0IYT1O31N	SODIUM THIOSULFATE ANHYDROUS:ORAL:TABLET:mg	ORAL	0.06mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5HK03SA80J	SODIUM TRIPOLYPHOSPHATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E939MCU4ID	SOLVENT ORANGE 2:ORAL:TABLET, COATED:mg	ORAL	0.07mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E939MCU4ID	SOLVENT ORANGE 2:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:OPHTHALMIC:EMULSION:%w/v	OPHTHALMIC	0.1%w/v OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.2%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.2%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:CAPSULE:mg	ORAL	0.94mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.94mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, CHEWABLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.03mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.16mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.15%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:LOTION:%w/w	TOPICAL	0.2%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:OINTMENT:%w/w	TOPICAL	0.1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:ORAL:CAPSULE:mg	ORAL	19.08mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:ORAL:CAPSULE, LIQUID FILLED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:ORAL:ELIXIR:ml/15ml	ORAL	0.6ml/15ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:CAPSULE:mg	ORAL	0.08mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:EMULSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:SUSPENSION:mg/5ml	ORAL	2.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:AEROSOL:%w/w	TOPICAL	4.74%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:CREAM:%w/w	TOPICAL	0.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:GEL:%w/w	TOPICAL	1%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE:mg	ORAL	153.9mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	1.7mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE, LIQUID FILLED:mg	ORAL	10mg ORAL CAPSULE, LIQUID FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:SOLUTION:mg/1ml	ORAL	150mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, COATED:mg	ORAL	0.13mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:RECTAL:SUPPOSITORY:mg	RECTAL	22mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.2%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:EMULSION:%w/w	TOPICAL	2.5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	2.33mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:CREAM:%w/w	TOPICAL	2%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:LIQUID:%w/w	TOPICAL	2%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:LOTION:%w/v	TOPICAL	0.08%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:SYSTEM:mg	TOPICAL	10.5mg TOPICAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:ORAL:SUSPENSION:mg/5ml	ORAL	62.5mg/5ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.55%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	0.75%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:LOTION:%w/w	TOPICAL	2.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SPRAY:%w/w	TOPICAL	4.58%w/w TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.15%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:VAGINAL:CREAM:%w/w	VAGINAL	5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0W8RRI5W5A	SORBITAN SESQUIOLEATE:RECTAL:OINTMENT:%w/w	RECTAL	2%w/w RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0W8RRI5W5A	SORBITAN SESQUIOLEATE:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	1.5mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:RESPIRATORY (INHALATION):AEROSOL, METERED:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	0.86%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6LUM696811	SORBITAN TRISTEARATE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6LUM696811	SORBITAN TRISTEARATE:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:DENTAL:PASTE:%w/w	DENTAL	14.6%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	14%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRA-ARTICULAR:INJECTION:%w/v	INTRA-ARTICULAR	45%w/v INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRALESIONAL:INJECTION:%w/v	INTRALESIONAL	45%w/v INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRASYNOVIAL:INJECTION:%w/v	INTRASYNOVIAL	45%w/v INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	1.04%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:NASAL:SOLUTION:mg/1ml	NASAL	25mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	6.7%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	4.6%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CONCENTRATE:mg/1ml	ORAL	600mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:ELIXIR:mg	ORAL	833.3mg ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:GUM, CHEWING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:POWDER:mg	ORAL	0.05mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SOLUTION, CONCENTRATE:mg/1ml	ORAL	300mg/1ml ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SYRUP:mg/5ml	ORAL	4370mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET:mg	ORAL	337.28mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, COATED:mg	ORAL	12.96mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.01mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:RECTAL:SUSPENSION:%w/v	RECTAL	46.18%w/v RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	4.7%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:SUBCUTANEOUS:INJECTION, SOLUTION:%w/v	SUBCUTANEOUS	4.7%w/v SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	50.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	4.95%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:CREAM:%w/w	TOPICAL	36.8%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	15%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:EMULSION:%w/w	TOPICAL	7%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:LIQUID:%w/w	TOPICAL	1%w/w TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:LOTION:%w/w	TOPICAL	10.7%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:OINTMENT:%w/w	TOPICAL	10%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:VAGINAL:CREAM:%w/w	VAGINAL	36.8%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:NASAL:SPRAY, METERED:mg/1ml	NASAL	64.5mg/1ml NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:TOPICAL:LOTION:%w/w	TOPICAL	10.7%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8KW3E207O2	SORBITOL SOLUTION:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L7HT8F1ZOD	SOYBEAN:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L7HT8F1ZOD	SOYBEAN:TOPICAL:EMULSION:%w/w	TOPICAL	3%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	10%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	20%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	10%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTION, SOLUTION, CONCENTRATE:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:TABLET, CHEWABLE:mg	ORAL	0.14mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	50%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:TOPICAL:SOLUTION:%w/w	TOPICAL	5.82%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1T6N4D9YV6	SOYBEAN PHOSPHATIDYLCHOLINE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J7I2T6IV1N	SPEARMINT:ORAL:SOLUTION:ml/5ml	ORAL	0.04ml/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J7I2T6IV1N	SPEARMINT:ORAL:TABLET:mg	ORAL	0.09mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J7I2T6IV1N	SPEARMINT:ORAL:TABLET, CHEWABLE:mg	ORAL	2.1mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J7I2T6IV1N	SPEARMINT:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.06mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	27.6%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:ORAL:SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:ORAL:SUSPENSION:mg/20ml	ORAL	0.59mg/20ml ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:ORAL:SYRUP:mg/5ml	ORAL	0.12mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.4mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P86KHA8V3K	SPERMACETI:TOPICAL:CREAM:%w/w	TOPICAL	11%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P86KHA8V3K	SPERMACETI:VAGINAL:CREAM:%w/w	VAGINAL	3%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:ORAL:POWDER:mg	ORAL	0.02mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2.23%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:CREAM:%w/w	TOPICAL	6%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:SOLUTION:%w/w	TOPICAL	1%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
67H76LFL3V	STANNIC CHLORIDE:TOPICAL:SOAP:%w/w	TOPICAL	0.2%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRADERMAL:INJECTION, POWDER, FOR SOLUTION:mg	INTRADERMAL	0.08mg INTRADERMAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	3.4mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	0.25mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	0.42mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:mg	SUBCUTANEOUS	0.08mg SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R30H55TN67	STANNOUS CHLORIDE ANHYDROUS:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	0.05mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R30H55TN67	STANNOUS CHLORIDE ANHYDROUS:TOPICAL:SOAP:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3FTR44B32Q	STANNOUS FLUORIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	0.73mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6JS9U5611X	STANNOUS TARTRATE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	0.08mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:BUCCAL:TABLET:mg	BUCCAL	16.6mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:CAPSULE, COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:CONCENTRATE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:PASTILLE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8I089SAH3T	STARCH, POTATO:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8I089SAH3T	STARCH, POTATO:ORAL:TABLET, COATED:mg	ORAL	1.37mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8I089SAH3T	STARCH, POTATO:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4DGK8B7I3S	STARCH, RICE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	301mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
24SC3U704I	STARCH, TAPIOCA:ORAL:CAPSULE:mg	ORAL	100mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
24SC3U704I	STARCH, TAPIOCA:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.75mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:TABLET:mg	ORAL	65.59mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:TABLET, FILM COATED:mg	ORAL	49mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0OUO26BB88	STEARALKONIUM CHLORIDE:TOPICAL:LOTION:%w/w	TOPICAL	3.15%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
25FFJ4209Z	STEARAMIDOETHYL DIETHYLAMINE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
25FFJ4209Z	STEARAMIDOETHYL DIETHYLAMINE:VAGINAL:CREAM:%w/w	VAGINAL	2.5%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FD0913P475	STEARETH-10:RECTAL:AEROSOL, FOAM:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FD0913P475	STEARETH-10:TOPICAL:AEROSOL, FOAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4OH5W9UM87	STEARETH-100:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4OH5W9UM87	STEARETH-100:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	1.09%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:LOTION:%w/w	TOPICAL	0.4%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0Q8IK9E08	STEARETH-20:TOPICAL:CREAM:%w/w	TOPICAL	4.15%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
53J3F32P58	STEARETH-21:TOPICAL:CREAM:%w/w	TOPICAL	3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
53J3F32P58	STEARETH-21:TOPICAL:LOTION:%w/w	TOPICAL	3%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:BUCCAL:MOUTHWASH:mg/1ml	BUCCAL	0.75mg/1ml BUCCAL MOUTHWASH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	1.09%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:TOPICAL:CREAM:%w/w	TOPICAL	12%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:BUCCAL:TABLET:mg	BUCCAL	6mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:EMULSION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	1203mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, COATED:mg	ORAL	42.4mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	10mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:SUBCUTANEOUS:IMPLANT:mg	SUBCUTANEOUS	1.04mg SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:SUBCUTANEOUS:PELLET:mg	SUBCUTANEOUS	0.97mg SUBCUTANEOUS PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:SUBLINGUAL:TABLET:mg	SUBLINGUAL	9mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	8%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	3%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:EMULSION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:OINTMENT:%w/w	TOPICAL	15%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:SHAMPOO:%w/w	TOPICAL	9.7%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:SOAP:%w/w	TOPICAL	6%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:SUSPENSION:%w/w	TOPICAL	1.75%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	4%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:VAGINAL:CREAM:%w/w	VAGINAL	15%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4V4H07OJB9	STEARIC DIETHANOLAMIDE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4V4H07OJB9	STEARIC DIETHANOLAMIDE:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3FV1C68XOP	STEARIC HYDRAZIDE:TOPICAL:SOAP:%w/w	TOPICAL	0.35%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
G6EP177239	STEAROYL POLYOXYL-32 GLYCERIDES:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
G6EP177239	STEAROYL POLYOXYL-32 GLYCERIDES:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
G6EP177239	STEAROYL POLYOXYL-32 GLYCERIDES:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	72mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:POWDER:mg	ORAL	0.11mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	244mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:AEROSOL:%w/w	TOPICAL	0.53%w/w TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	4%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:LOTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:SUSPENSION:%w/w	TOPICAL	2.01%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:VAGINAL:SUPPOSITORY:mg	VAGINAL	8.5mg VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:POWDER, FOR SUSPENSION:mg/5ml	ORAL	20mg/5ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:SYRUP:mg/5ml	ORAL	2.5mg/5ml ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	1mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
K7S96QM8DV	STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:SOLUTION:mg/1ml	ORAL	0.01mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET:mg	ORAL	125.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET, CHEWABLE:mg	ORAL	2.86mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:TOPICAL:GEL:ADJ PH	TOPICAL	ADJ PH TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:GRANULE:mg	ORAL	5.4mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, EFFERVESCENT:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, FILM COATED:mg	ORAL	0.18mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:BUCCAL:LOZENGE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:BUCCAL:TABLET:mg	BUCCAL	109mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:BUCCAL:TROCHE:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTABLE, LIPOSOMAL:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	19.5%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, EMULSION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	900mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, SOLUTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	INTRAVENOUS	9.4%w/v INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	59.8mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CONCENTRATE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:ELIXIR:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:LIQUID:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:LOZENGE:mg	ORAL	1255mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:PASTILLE:mg	ORAL	426mg ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, COATED:mg	ORAL	516.42mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	295.33mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	284.54mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, FILM COATED:mg	ORAL	200mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	119.12mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TROCHE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:WAFER:mg	ORAL	155.2mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:RECTAL:SOLUTION:%w/v	RECTAL	35.42%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:RECTAL:SUPPOSITORY:NA	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:INJECTION:mg	SUBCUTANEOUS	47.75mg SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:INJECTION, SUSPENSION, EXTENDED RELEASE:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	109mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:TRANSMUCOSAL:LOZENGE:mg	TRANSMUCOSAL	100.35mg TRANSMUCOSAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
33X4X4B90S	SUCROSE DISTEARATE:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3OSQ643ZK5	SUCROSE PALMITATE:ORAL:TABLET:mg	ORAL	1.25mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70FD1KFU70	SULFUR:INTRAVENOUS:INJECTION:NA	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.02%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:ENDOTRACHEAL:INJECTION:ADJ PH	ENDOTRACHEAL	ADJ PH ENDOTRACHEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:EPIDURAL:INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:EPIDURAL:INJECTION, SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	566mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAPERITONEAL:INJECTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRATHECAL:INJECTION, SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	566mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IRRIGATION:INJECTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:OPHTHALMIC:SOLUTION:%w/w	OPHTHALMIC	0.02%w/w OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:OPHTHALMIC:SOLUTION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:PARENTERAL:INJECTION, POWDER, FOR SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):CAPSULE:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):SOLUTION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:TOPICAL:CREAM:ADJ PH	TOPICAL	ADJ PH TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:TOPICAL:SOLUTION:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J1P7893F4J	SULFUROUS ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
08MNR5YE2R	SYNTHETIC BEESWAX:TOPICAL:CREAM:%w/w	TOPICAL	3.5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T7A20Y888Y	TAGATOSE:ORAL:SOLUTION:mg/15ml	ORAL	200mg/15ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
T7A20Y888Y	TAGATOSE:RECTAL:SOLUTION:%w/v	RECTAL	1.33%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:BUCCAL:GUM, CHEWING:NA	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:BUCCAL:TABLET:mg	BUCCAL	15mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	14mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:ELIXIR:mg/5ml	ORAL	4.5mg/5ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:GRANULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:GRANULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET:mg	ORAL	1000mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, COATED:mg	ORAL	320.75mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DELAYED RELEASE PARTICLES:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, FOR SUSPENSION:mg	ORAL	2mg ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:RECTAL:TABLET:mg	RECTAL	32.4mg RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:SUBLINGUAL:TABLET:mg	SUBLINGUAL	32.4mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:TOPICAL:OINTMENT:%w/w	TOPICAL	74.6%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:TOPICAL:POWDER:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAMUSCULAR:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	0.23%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTION, POWDER, FOR SOLUTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	20mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.5%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:SOLUTION, CONCENTRATE:%w/v	INTRAVENOUS	0.5%w/v INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:PELLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:POWDER, FOR SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, COATED:mg	ORAL	10mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:RECTAL:SUPPOSITORY:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:SUBLINGUAL:TABLET:NA	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
GR35AH6YDN	TERPENE RESIN:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
GR35AH6YDN	TERPENE RESIN:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
MD83SFE959	TERT-BUTYL ALCOHOL:TOPICAL:GEL:%w/w	TOPICAL	0.12%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
C12674942B	TERT-BUTYLHYDROQUINONE:VAGINAL:CREAM:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
TJ904HH8SN	TETRACHLOROETHYLENE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	702mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
1HTE449DGZ	TETRAXETAN:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:AURICULAR (OTIC):DROPS:NA	AURICULAR (OTIC)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:AURICULAR (OTIC):SOLUTION:%w/w	AURICULAR (OTIC)	0.01%w/w AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.01%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	0.3mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	0.3mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:NASAL:DROPS:mg/1ml	NASAL	0.01mg/1ml NASAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:NASAL:SOLUTION:mg/1ml	NASAL	0.01mg/1ml NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.01%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SOLUTION/ DROPS:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SUSPENSION/ DROPS:%v/v	OPHTHALMIC	1%v/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2ZD004190S	THREONINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.45%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2ZD004190S	THREONINE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	160mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2ZD004190S	THREONINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.12%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2UK410MY6B	THYME OIL:TOPICAL:OINTMENT:%w/w	TOPICAL	0.1%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
3J50XA376E	THYMOL:ORAL:POWDER, FOR SOLUTION:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
3J50XA376E	THYMOL:RESPIRATORY (INHALATION):LIQUID:%w/w	RESPIRATORY (INHALATION)	0.01%w/w RESPIRATORY (INHALATION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:FILM:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:FILM, SOLUBLE:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:DENTAL:PASTE:%w/w	DENTAL	0.5%w/w DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:DENTAL:PASTE, DENTIFRICE:%w/w	DENTAL	0.4%w/w DENTAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:INTRAUTERINE:SUPPOSITORY, EXTENDED RELEASE:mg	INTRAUTERINE	1mg INTRAUTERINE SUPPOSITORY, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:OPHTHALMIC:INSERT, EXTENDED RELEASE:mg	OPHTHALMIC	0.4mg OPHTHALMIC INSERT, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	4.4mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:DROPS:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:POWDER:mg	ORAL	2mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:RESPIRATORY (INHALATION):CAPSULE:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:RESPIRATORY (INHALATION):POWDER:mg	RESPIRATORY (INHALATION)	2mg RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:GEL:%w/w	TOPICAL	0.06%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:LOTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:OINTMENT:%w/w	TOPICAL	5%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:SHAMPOO, SUSPENSION:%w/v	TOPICAL	3%w/v TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:SOAP:%w/w	TOPICAL	1%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TRANSDERMAL:FILM, EXTENDED RELEASE:NA	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:VAGINAL:SUPPOSITORY:NA	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:INTRAVENOUS:INJECTION, EMULSION:%w/v	INTRAVENOUS	0.02%w/v INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:ORAL:CAPSULE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:ORAL:CAPSULE, COATED:mg	ORAL	0.25mg ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:ORAL:TABLET:mg	ORAL	0.08mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:BUCCAL:TABLET:mg	BUCCAL	5mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:POWDER, FOR SUSPENSION:mg/1ml	ORAL	60mg/1ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET, COATED:mg	ORAL	7.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET, DELAYED RELEASE:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	7mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:WAFER:mg	ORAL	32mg ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:SUBLINGUAL:TABLET:mg	SUBLINGUAL	5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:TOPICAL:JELLY:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7YIN7J07X4	TREHALOSE DIHYDRATE:INTRADERMAL:INJECTION, POWDER, FOR SOLUTION:	INTRADERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7YIN7J07X4	TREHALOSE DIHYDRATE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7YIN7J07X4	TREHALOSE DIHYDRATE:SUBCUTANEOUS:INJECTION, POWDER, FOR SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	1.21mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	5.1mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CONCENTRATE:mg/1ml	ORAL	50mg/1ml ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, COATED:mg	ORAL	1mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, FILM COATED:mg	ORAL	15.12mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:TRANSDERMAL:SYSTEM:mg	TRANSDERMAL	22.1mg TRANSDERMAL SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:BUCCAL:TABLET:mg	BUCCAL	99.2mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE:mg	ORAL	11.01mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	32.73mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, CHEWABLE:mg	ORAL	130mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, COATED:mg	ORAL	40mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	333.3mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, FILM COATED:mg	ORAL	21.8mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	99.2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
6P92858988	TRICAPRILIN:EPIDURAL:INJECTION, SUSPENSION, LIPOSOMAL:%w/v	EPIDURAL	0.03%w/v EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
6P92858988	TRICAPRILIN:INFILTRATION:INJECTABLE, LIPOSOMAL:%w/v	INFILTRATION	0.2%w/v INFILTRATION INJECTABLE, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
6P92858988	TRICAPRILIN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.45mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
113C650IR1	TRICHLOROETHANE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
113C650IR1	TRICHLOROETHANE:ORAL:TABLET, COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:ORAL:AEROSOL, METERED:mg/1ml	ORAL	650mg/1ml ORAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:RESPIRATORY (INHALATION):AEROSOL, METERED:%w/w	RESPIRATORY (INHALATION)	27.88%w/w RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:RESPIRATORY (INHALATION):AEROSOL, SPRAY:%w/w	RESPIRATORY (INHALATION)	24.4%w/w RESPIRATORY (INHALATION) AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:TOPICAL:AEROSOL, POWDER:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:TOPICAL:AEROSOL, SPRAY:%w/w	TOPICAL	74%w/w TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
G624N6MSBA	TRIDECETH-10:TOPICAL:SOLUTION:%w/w	TOPICAL	4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
E8458C1KAA	TRIETHANOLAMINE LAURYL SULFATE:TOPICAL:CREAM:%w/w	TOPICAL	0.13%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
E8458C1KAA	TRIETHANOLAMINE LAURYL SULFATE:TOPICAL:EMULSION:%w/w	TOPICAL	10.78%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
E8458C1KAA	TRIETHANOLAMINE LAURYL SULFATE:TOPICAL:SHAMPOO:%w/v	TOPICAL	75.3%w/v TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:INTRAMUSCULAR:INJECTION, POWDER, FOR SUSPENSION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, COATED PELLETS:mg	ORAL	9.16mg ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, DELAYED RELEASE PELLETS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
06YD7896S3	TRIHYDROXYSTEARIN:TOPICAL:CREAM:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
06YD7896S3	TRIHYDROXYSTEARIN:TOPICAL:OINTMENT:%w/w	TOPICAL	3%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0A6MDS9SLT	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S):TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	171.17mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0A6MDS9SLT	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S):TRANSDERMAL:SYSTEM:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9N5G1G3D3H	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S):TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9N5G1G3D3H	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S):TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
5VBE2X0WG0	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S):TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
5VBE2X0WG0	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S):TRANSDERMAL:FILM, EXTENDED RELEASE:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRA-ARTICULAR:INJECTION, SOLUTION:	INTRA-ARTICULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRACARDIAC:INJECTION:	INTRACARDIAC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:INJECTION, SOLUTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:SOLUTION:%w/v	INTRAMUSCULAR	0.03%w/v INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:mg	INTRAOCULAR	5.48mg INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAOCULAR:SOLUTION:	INTRAOCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg	INTRAVENOUS	235.2mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVITREAL:INJECTION, SUSPENSION:%w/v	INTRAVITREAL	0.17%w/v INTRAVITREAL INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IRRIGATION:INJECTION, SOLUTION, CONCENTRATE:%w/v	IRRIGATION	0.55%w/v IRRIGATION INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:NASAL:SPRAY:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:NASAL:SPRAY, METERED:	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.45%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:OPHTHALMIC:SUSPENSION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:ELIXIR:mg/1ml	ORAL	0.47mg/1ml ORAL ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SYRUP:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET, CHEWABLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET, FILM COATED:mg	ORAL	200mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:PARENTERAL:INJECTION:%w/v	PARENTERAL	0.48%w/v PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:RESPIRATORY (INHALATION):POWDER:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:RESPIRATORY (INHALATION):SOLUTION:	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:RESPIRATORY (INHALATION):SUSPENSION:%w/v	RESPIRATORY (INHALATION)	0.05%w/v RESPIRATORY (INHALATION) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBCUTANEOUS:INJECTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBCUTANEOUS:INJECTION, SOLUTION:	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBLINGUAL:FILM:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBLINGUAL:TABLET:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:CLOTH:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:CREAM:%w/w	TOPICAL	0.3%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:GEL:%w/w	TOPICAL	0.18%w/w TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:LOTION:%w/w	TOPICAL	0.32%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	2.6%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:SOLUTION:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
K3E0U7O8KI	TRISODIUM HEDTA:TOPICAL:SOAP:%w/w	TOPICAL	0.4%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
K3E0U7O8KI	TRISODIUM HEDTA:TOPICAL:SOLUTION:%w/w	TOPICAL	0.4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:%w/v	INTRAVENOUS	0.02%w/v INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:NASAL:DROPS:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:NASAL:SOLUTION:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:NASAL:SPRAY:NA	NASAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:RECTAL:AEROSOL, METERED:ADJ PH	RECTAL	ADJ PH RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2.6%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:CREAM:%w/w	TOPICAL	1%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:CREAM, AUGMENTED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:EMULSION:%w/w	TOPICAL	0.5%w/w TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:GEL, METERED:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:LIQUID:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:LOTION:%w/w	TOPICAL	3.5%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:POWDER:mg/mg	TOPICAL	0.02mg/mg TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:SHAMPOO:%w/w	TOPICAL	3.7%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:SOAP:%w/w	TOPICAL	0.08%w/w TOPICAL SOAP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:SOLUTION:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:SPONGE:%w/w	TOPICAL	11%w/w TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TRANSDERMAL:GEL:	TRANSDERMAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TRANSDERMAL:GEL, METERED:%w/w	TRANSDERMAL	1%w/w TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:VAGINAL:AEROSOL, FOAM:%w/w	VAGINAL	2%w/w VAGINAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:VAGINAL:CREAM:%w/w	VAGINAL	0.75%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ENDOTRACHEAL:SUSPENSION:mg	ENDOTRACHEAL	2.42mg ENDOTRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRA-ARTERIAL:INJECTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRA-ARTERIAL:INJECTION, SOLUTION:	INTRA-ARTERIAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAMUSCULAR:INJECTION, SOLUTION:%w/v	INTRAMUSCULAR	1.21%w/v INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRATHECAL:SOLUTION:%w/v	INTRATHECAL	0.12%w/v INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRATYMPANIC:SUSPENSION:%w/w	INTRATYMPANIC	0.56%w/w INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVASCULAR:INJECTION, SOLUTION:	INTRAVASCULAR		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVASCULAR:SOLUTION:%w/v	INTRAVASCULAR	0.12%w/v INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:INJECTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:INJECTION, POWDER, FOR SUSPENSION:mg	INTRAVENOUS	6.06mg INTRAVENOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%w/v	INTRAVENOUS	0.24%w/v INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:INJECTION, SOLUTION:	INTRAVENOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	0.12%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.75%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%w/w	OPHTHALMIC	0.8%w/w OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SOLUTION/ DROPS:%w/v	OPHTHALMIC	0.8%w/v OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SUSPENSION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:SOLUTION:mg/1ml	ORAL	1.21mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:TABLET:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:RECTAL:SOLUTION:%w/v	RECTAL	0.12%w/v RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:RESPIRATORY (INHALATION):SOLUTION:%w/v	RESPIRATORY (INHALATION)	0.01%w/v RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:TOPICAL:SOLUTION:%w/w	TOPICAL	8.4%w/w TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:TRANSDERMAL:GEL:%w/w	TRANSDERMAL	0.1%w/w TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:URETHRAL:SOLUTION:%w/v	URETHRAL	0.12%w/v URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8DUH1N11BX	TRYPTOPHAN:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	1.65mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8DUH1N11BX	TRYPTOPHAN:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.05%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
C5H0QJ6V7F	TURPENTINE OIL:RESPIRATORY (INHALATION):LIQUID:NA	RESPIRATORY (INHALATION)		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:AURICULAR (OTIC):SUSPENSION:%w/v	AURICULAR (OTIC)	0.05%w/v AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:GEL:%w/w	OPHTHALMIC	0.05%w/w OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SOLUTION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SOLUTION/ DROPS:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SUSPENSION:%w/v	OPHTHALMIC	0.3%w/v OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SUSPENSION/ DROPS:%w/v	OPHTHALMIC	0.3%w/v OPHTHALMIC SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:TOPICAL:SOLUTION:%w/v	TOPICAL	0.1%w/v TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:TOPICAL:SUSPENSION/ DROPS:%w/v	TOPICAL	0.03%w/v TOPICAL SUSPENSION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
K3D86KJ24N	UNDECYLENIC ACID:TOPICAL:SPRAY:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:ORAL:TABLET, COATED:mg	ORAL	0.02mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:ORAL:TABLET, EFFERVESCENT:mg	ORAL	60mg ORAL TABLET, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.01mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:TOPICAL:SYSTEM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:VAGINAL:CREAM:%w/w	VAGINAL	0.64%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:VAGINAL:DOUCHE:%w/w	VAGINAL	8%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:VAGINAL:INSERT:	VAGINAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
HG18B9YRS7	VALINE:INTRAVENOUS:INJECTION:%w/v	INTRAVENOUS	0.84%w/v INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
HG18B9YRS7	VALINE:INTRAVENOUS:INJECTION, SOLUTION:%w/v	INTRAVENOUS	0.2%w/v INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
Q74T35078H	VANILLA BEAN:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:CAPSULE:mg	ORAL	0.94mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.94mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:ELIXIR:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:LIQUID:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:POWDER, FOR SUSPENSION:mg/1ml	ORAL	2mg/1ml ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SOLUTION:mg/5ml	ORAL	2.5mg/5ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, CHEWABLE:mg	ORAL	2.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, COATED:mg	ORAL	65.5mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	3.4mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.26mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
N78PI4C683	VERSETAMIDE:INTRAVENOUS:INJECTION:mg	INTRAVENOUS	25.4mg INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
O03S90U1F2	VITAMIN E POLYETHYLENE GLYCOL SUCCINATE:ORAL:CAPSULE:mg	ORAL	300mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
O03S90U1F2	VITAMIN E POLYETHYLENE GLYCOL SUCCINATE:ORAL:SOLUTION:mg/1ml	ORAL	300mg/1ml ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
O03S90U1F2	VITAMIN E POLYETHYLENE GLYCOL SUCCINATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
O03S90U1F2	VITAMIN E POLYETHYLENE GLYCOL SUCCINATE:ORAL:TABLET, FILM COATED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
B6E5W8RQJ4	WHITE PETROLATUM:OPHTHALMIC:OINTMENT:%w/w	OPHTHALMIC	97%w/w OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
B6E5W8RQJ4	WHITE PETROLATUM:TOPICAL:AEROSOL, FOAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
B6E5W8RQJ4	WHITE PETROLATUM:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
B6E5W8RQJ4	WHITE PETROLATUM:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, COATED:mg	ORAL	3mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.08mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	14mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, FILM COATED:mg	ORAL	0.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:RECTAL:SUPPOSITORY:mg	RECTAL	265mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	2%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:CREAM, AUGMENTED:%w/w	TOPICAL	10%w/w TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:LOTION:%w/w	TOPICAL	1%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:OINTMENT:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:OINTMENT, AUGMENTED:%w/w	TOPICAL	6.75%w/w TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:VAGINAL:CREAM:%w/w	VAGINAL	2%w/w VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
TTV12P4NEE	XANTHAN GUM:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	0.6%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%w/w	OPHTHALMIC	0.6%w/w OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:OPHTHALMIC:SUSPENSION:	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:CAPSULE:mg	ORAL	0.01mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:FILM, SOLUBLE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:GRANULE, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:LOZENGE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER:mg	ORAL	275mg ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR SOLUTION:mg/5ml	ORAL	10mg/5ml ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, EXTENDED RELEASE:mg	ORAL	186.8mg ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION/ DROPS:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, CHEWABLE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, FILM COATED:mg	ORAL	0.08mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:mg	ORAL	0.03mg ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	0.15mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TROCHE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:RECTAL:ENEMA:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:RECTAL:SUSPENSION:	RECTAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:AEROSOL, FOAM:%w/w	TOPICAL	0.27%w/w TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:CREAM:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:GEL:	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:LOTION:%w/v	TOPICAL	0.3%w/v TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:SUSPENSION:%w/w	TOPICAL	0.11%w/w TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:BUCCAL:GUM, CHEWING:	BUCCAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:FILM, SOLUBLE:mg	ORAL	4.76mg ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:PASTE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	4223mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:SOLUTION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:SUSPENSION:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:SUSPENSION, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET:mg	ORAL	15.04mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET, ORALLY DISINTEGRATING:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:SUBLINGUAL:SPRAY:	SUBLINGUAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE, LIQUID FILLED:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET:mg	ORAL	3.22mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET, COATED:mg	ORAL	213.7mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	0.1mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.01mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET, SUGAR COATED:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:TOPICAL:CREAM:%w/w	TOPICAL	5%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:TOPICAL:OINTMENT:%w/w	TOPICAL	20%w/w TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
80N308T1NN	ZEIN:ORAL:TABLET:mg	ORAL	5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, COATED:mg	ORAL	25mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, EXTENDED RELEASE:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, FILM COATED:mg	ORAL	5.75mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
J41CSQ7QDS	ZINC:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:SUBCUTANEOUS:INJECTION, POWDER, FOR SUSPENSION:mg	SUBCUTANEOUS	2.3mg SUBCUTANEOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:TOPICAL:SWAB:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
EQR32Y7H0M	ZINC CARBONATE:SUBCUTANEOUS:INJECTION, POWDER, FOR SUSPENSION:mg	SUBCUTANEOUS	1.6mg SUBCUTANEOUS INJECTION, POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:INTRADERMAL:INJECTION:mg	INTRADERMAL	7mg INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:NA	OPHTHALMIC		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:INTRAVENOUS:SOLUTION:%w/v	INTRAVENOUS	3.11%w/v INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:RECTAL:SUPPOSITORY:mg	RECTAL	375mg RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:RESPIRATORY (INHALATION):SOLUTION:%w/v	RESPIRATORY (INHALATION)	3.11%w/v RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:SUBCUTANEOUS:INJECTION:%w/v	SUBCUTANEOUS	0.02%w/v SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:SUBCUTANEOUS:INJECTION, SUSPENSION:NA	SUBCUTANEOUS		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:TOPICAL:LOTION:%w/w	TOPICAL	16%w/w TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:BUCCAL:TABLET:mg	BUCCAL	2.5mg BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:CAPSULE:mg	ORAL	2.04mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:SYRUP:NA	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET:	ORAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET, COATED:mg	ORAL	1.82mg ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	36mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET, FILM COATED:mg	ORAL	15.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	2.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:TOPICAL:CREAM:%w/w	TOPICAL	6%w/w TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:TOPICAL:OINTMENT:NA	TOPICAL		https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:TOPICAL:POWDER:mg/mg	TOPICAL	0.1mg/mg TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:TOPICAL:SHAMPOO:%w/w	TOPICAL	2%w/w TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
89DS0H96TB	ZINC SULFATE:VAGINAL:DOUCHE:%w/w	VAGINAL	5%w/w VAGINAL DOUCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
